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Disorders of the brain and nervous system result in more hospitalizations and
lost productivity than any other disease group. Electroencephalography (EEG),
which measures brain electrical signals from the scalp, is a common neuro-monitoring
technique used for diagnostic, rehabilitative, and therapeutic purposes. Understand-
ing EEG quantitatively and its neural correlates with patient characteristics could
inform the safety and efficacy of technologies that rely on EEG. In this disserta-
tion, a large clinical data set comprised of over 35,000 recordings as well as data
from previous research experiments are utilized to better quantify characteristics of
neurological activity.
We first propose non-parametric methods of evaluating consistency of quanti-
tative EEG features (qEEG) by applying novel statistical approaches. These results
provide data-driven methods of identifying qEEG and their spatial characteristics
ideal for various applications, and determining consistencies of novel features using
existing data.
These qEEG are commonly used in feature-based machine learning applica-
tions. Further, EEG-driven deep learning has shown promising results in distin-
guishing recordings of subjects. To better understand the performance of these two
machine learning approaches, we assess their ability to distinguish between subjects
taking different anticonvulsants. Our methods could successfully discriminate be-
tween patients taking either anticonvulsant and those taking no medications solely
from neural activity with similar performance from both feature-based and deep
learning approaches.
With feature-based methods, it is easier to interpret which qEEG have the
most impact on algorithm performance. However, deep learning applications in EEG
can present difficulty in understanding and investigating underlying neurophysiolog-
ical implications. We propose and validate a method to investigate frequency band
importance in EEG-driven deep learning models. The easy perturbation EEG algo-
rithm for spectral importance (easyPEASI) is simpler than previous methods and
is applied to classifications investigated in this work.
Until this point, our work used well segmented EEG from clinical settings.
However, EEG is usually corrupted by noise which can degrade its utility. We
formulate and validate novel approaches to score electrophysiological signal quality
based on the presence of noise from various sources. Further, we apply our method
to compare and evaluate the performance of existing artifact removal algorithms.
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This dissertation is mainly comprised of four research chapters. Three of these
chapters have been published or submitted for publication and are presented exactly
as submitted, with changes only made for formatting considerations.
To provide more context, Chapter 1 includes an extensive background of many
of the methods used in the research chapters. Theory and proofs presented in
this chapter are mainly from textbooks and foundational papers. Some derivations
are included in detail while others omitted because of space constraints. A brief
introduction on electroencephalography (EEG) is also provided. Topics covered in
the introduction are: electroencephalography, power spectral density, quantitative
EEG features, artifact removal algorithms, Kruskal-Wallis statistical tests, density
estimation, and machine learning. Original contributions to the area of quantitative
characterizations of electrophysiological neural activity are presented in Chapters 2,
3, 4, and 5; another smaller work is included in Appendix A. Each of these chapters
begins with an overview outlining the chapter at a high level.
Chapter 2 presents a study on the consistency of quantitative electroencephalog-
raphy features in a large clinical data set. This work has been published in the
Journal of Neural Engineering in 2019 [95].
Chapter 3 presents a study on deep learning and feature based medication
classifications from EEG in a large clinical data set. This work has been submitted
for publication in a journal and is in peer review.
Chapter 4 presents a study on the development of easyPEASI, a simple method
to identify important spectral features of EEG in deep learning models. This work
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has been submitted for publication as a conference proceeding for a conference with
a machine learning focus and is in peer review.
Chapter 5 presents a study quantifying signal quality from unimodal and mul-
timodal sources with application to EEG with ocular and motion artifacts. This
work has not yet been submitted for publication. It is expected some or all elements
of this chapter will be submitted for publication in the future.
Chapter 6 briefly concludes and summarizes the works of this dissertation,
their novel contributions to the field, and potential future directions.
Finally, Appendix A presents a smaller study on EEG spectral connectivity
analysis in a large clinical population. This work applies existing methods to our
larger data set and though presents interesting results is not included in the main
text of this dissertation. Methods used exclusively in this appendix, mainly graph
theory and spectral graph theory, are not discussed in the introduction. This work
has been published as a conference proceeding as part of the 9th IEEE/EMBS Neural
Engineering (NER) conference in 2019 [93].
Online resources, including software and future publications, for reproducibil-
ity and future applications of this dissertation can be found at dnahmias.com.
iii
Dedication
Mami lapin, merci pour tout.
iv
(This page intentionally left blank)
v
Acknowledgments
I owe gratitude to so many people who have made this dissertation possible
and because of whom I will cherish this experience forever.
First and foremost I would like to thank my advisor Dr. Kimberly Kontson
for giving me an invaluable opportunity to work on meaningful, challenging, and
interesting projects over the past four years at the US Food and Drug Administra-
tion. Her support and faith in me as I chose projects and dove in is something I will
always be thankful for. Of course as I inevitably ran into hurdles, she always made
herself available for help and advice. It has been a pleasure to work with and learn
from such a wonderful and extraordinary individual. I have always felt lucky to have
her as an advisor and mentor. I look forward to continue working with her even as
this chapter of my research career comes to a close as a colleague and friend. As
I have said many times before, “Thank you Kim,” for all your support throughout
these years, I will be forever grateful.
I would also like to thank my co-advisor, Professor Jonathan Simon from
the electrical and computer engineering department at UMD. Without his support
throughout my graduate career, this dissertation would not have been possible.
He was always available to discuss my progress and give guidance, and for that I
am grateful. Thanks are also due to Professor Rama Chellappa, Professor Behtash
Babadi, and Professor Ed Bernat for agreeing to serve on my dissertation committee
and for sparing their invaluable time reviewing the manuscript.
I would be remiss if I did not mention Dr. Eugene Civillico. He has been
vi
a great mentor throughout these past few years and guide through the field of
neuroscience. No matter how mathematical I made things, he always found a way
to keep us grounded in the application, importance, and impact of our work. And
to my colleagues in the Human Device Interaction lab at the FDA, Sophie, J.J., and
Chris, you have all enriched my experience in so many ways. I could not have asked
for better lab-mates.
Above all, I owe my deepest thanks to my family, who have always been there
for me and supportive through everything in my life. Je suis lá grâce á vous tous.
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Chapter 1: Introduction
Disorders of the brain and nervous system, of which there are more than 1,000,
result in more hospitalizations and lost productivity than any other disease group
[24], [144]. The World Health Organization estimated that neurological diseases
make up 11% of the world’s disease burden, not including mental health and addic-
tion disorders, and affect up to one billion people worldwide [122], [144]. Electroen-
cephalography (EEG), which measures brain electrical signals from the scalp, is a
common neuro-monitoring technique used in both clinical and research settings for
diagnostic, rehabilitative, and therapeutic purposes. EEG is typically non-invasive,
mobile, and relatively inexpensive which makes it a promising neuro-monitoring
method for widespread use on large populations.
The prevalence and availability of physiological data from portable non-invasive
devices is growing at a rapid rate. How we use and quantify these data could ef-
fect the safety and effectiveness of medical devices that depend of them. This work
aims to leverage new big data sources that have recently become available to better
understand population-level quantitative characteristics of neural activity.
To achieve this aim we bring together topics discussed in this chapter. We
begin with some basic background on EEG followed by common analytical methods
1
used in EEG research including spectral analysis, quantitative features, and artifact
removal. Next we discuss a statistical test used throughout the dissertation, the
Kruskal-Wallis test. As a segue into machine learning methods we present density
estimation since these methods are often used both in statistical and machine learn-
ing applications. Finally, we discuss both feature-based (support vector machines)
and deep learning-based (deep convolutions neural networks) methods in machine
learning that are used throughout this dissertation. Altogether, applying quantita-
tive methods such as machine learning and statistical approaches to large data sets,
we can better characterize EEG data and advance our understanding of quantitative
characteristics of neural activity from EEG.
Overview
The purpose of this chapter is to give a brief overview and background on
methods used in this dissertation. Of course it would be impossible to give a proper
and thorough treatment of all fields we draw upon in this work. Rather the goal is to
give some background on specific methods used. Theory and proofs presented in this
chapter are mainly drawn from textbooks and foundational papers. Certain sections
topics, and their respective references should more detail be desired by the reader,
are: electroencephalography [11], [134], [125]; power spectral density [109], [108],
[101], [53], [137], [10]; quantitative EEG features [125]; artifact removal algorithms
[143], [45], [1], [9], [63]; Kruskal-Wallis statistical tests [114], [113], [126], [79], [77];
density estimation [103], [116], [34]; machine learning [47], [136], [13], [32], [19].
2
1.1 Electroencephalography (EEG)
This section gives a brief introduction on EEG adapted from the ‘Handbook of
EEG Interpretation’ and ‘Niedermeyer’s Electroencephalography: Basic Principles,
Clinical Applications, and Related Fields’ [134], [125].
Non-invasive surface EEG monitors the electrical activity of the brain from
electrodes placed on the scalp. This is characterized by the voltage changes as-
sociated with the post-synaptic potentials from large synchronized activations of
neocortical pyramidal cells. This was first measured in humans by Hans Berger in
1924 [11]. The mechanism within neurons that create this action potential, voltage,
that is measured through surface electrodes is the exchange of sodium and potasium
ions in and out of the cells. Adenosine Triphosphate (ATP) provides the energy for
proteins to push out the sodium ions while pulling in the potassium ions through
the cell. This makes the outside of the cells more positively charged and the neurons
more negatively charged. This rapid exchange is the source of the action potentials
that are measured. In general, only through the summation of a large collective
activity of many neurons with similar spatial orientation can an EEG signal be
detected from the scalp.
In terms of EEG electrodes and capturing the electrophysiolgical signals, these
electrodes should maintain an impedance between 100 to 5000 Ohms. Electrodes
placed usually follow a standard naming and corresponding placement convention.











Table 1.1 EEG lead labels and locations
A second letter of ‘z’ designates an electrode placed on the midline of the
scalp. Even numbers refer to electrodes placed on the right hemisphere, and odd
numbered electrodes refer to electrodes placed on the left hemisphere.
The placement of these electrodes usually follow was is called the 10-20 system
which uses anatomical landmarks on the scalp. The numbers ‘10-20’ refer to the
intervals of 10% or 20% used for electrode placement. For the center-line, we consider
the top 180◦ of the scalp. Starting at eye level at the front of the head we go up
10% (18◦) to find the first electrode locations. Then we move up 20% (36◦) to find
the next electrode site. Moving 20% (36◦) again, we arrive at the top of the head.
The remaining sites between the top of the head and the back of the head are placed
in a similar fashion in reverse, moving down from the top by 20% (36◦), then 20%
(36◦) again, and finally 10% (18◦). Electrodes are also placed based on these same
percentages away from the midline of the head around the sides of scalp. This was
initially introduced by H. H. Jasper in 1958 [64]. This has also since been extended
to the 10-10 and 10-20 systems for the inclusion of more electrodes and higher spatial
resolution [100]. The main electrode layout with 19 channels, used in three of our
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research chapters and appendix, is shown in Figure 1.1. The final research chapter
used recordings with 32 and 64 channel EEG 10-20 extended layouts, shown in Figure
1.2a and Figure 1.2b, respectively. We note that some electrodes overlap since these











Figure 1.1 10-20 EEG electrode layout with 19 channels.
Each of the lobes referred to in the EEG electrode naming scheme have been
studied extensively and have each been associated with specific cognitive functions.
The frontal lobe is the region of the brain where conscious thoughts and decisions are
made. Also, the frontal lobe contains motor areas where voluntary motor movements
are controlled. The parietal lobe integrates information from external sources as
well as internal sensory information such as muscles, and eyes. The parietal lobe
is also responsible for combining all of these senses and stimuli into a coherent



























































































(b) 64 channel extended 10-20 layout.
Figure 1.2 Extended 10-20 EEG electrode layout with (a) 32 (b) 64 channels.
without parietal lobe. Further, the parietal lobe is often studied for feelings of
agency. The temporal lobe is responsible for long-term memory. It also includes
the hippocampus, which is a central structure for memory. The left temporal cortex
is responsible for language comprehension, and production, including Broca’s area.
Finally, the occipital lobe is where visual processing occurs. The occipital lobe is
located in the rearmost part of the brain. There is no actual Central lobe, so C
electrodes in EEG are generally used for identification purposes only.
EEG signals themselves usually range from 1−200µV. Figure 1.3 shows a sam-
ple of EEG recording for one minutes of time across 19 channels. As we see, it can
be difficult to interpret the underlying neurological activity directly from these sig-
nals. For these reasons developing quantitative representations and interpretations
of EEG has been an active area of research.
6
Figure 1.3 Sample EEG trace across 19 channels.
Until recently, the most common quantitative method has generally been spec-
tral analysis of EEG. Different ranges of frequency vary in amplitude. In general,
EEG spectrum follows a 1/f trend, decreasing in power as the frequency increases.
For practical purposes, the range of frequencies that are usually considered of inter-
est is below 50Hz. In addition, in terms of frequency information Figure 1.4 shows
a sample power spectrum density (PSD) of a single EEG channel, with certain fre-
quency bands marked. In general ranges of frequencies have been grouped together
into established bands commonly analyzed and referred to in EEG research [99].
The exact cut-off frequencies of each band vary slightly depending on EEG appli-
cations or studies. In this research, we generally refer to the following frequency
ranges for each bands: δ(delta) : 1 − 4Hz, θ(theta) : 4 − 8Hz, α(alpha) : 8 − 12Hz,
µ(mu) : 12 − 16Hz, β(beta) : 16 − 25Hz, γ(gamma) : 25 − 40Hz. These frequency
ranges are based on the band definitions in Niedermeyer’s Electroencephalography
except with the introduction of a µ band labeling the lower frequencies of the β
7
band separately [125]. Each of these bands have established normal properties as
well as many studies linking changes in spectral properties to physiological or clinical
differences that could not all be detailed here [134].
Figure 1.4 Sample power spectrum density of channel O1.
1.2 Power spectral density
With spectral analysis of EEG common, we briefly outline power spectral
density (PSD) estimation. For all spectral estimation methods, we assume that the
signal has finite energy, that is x[t] ∈ L2(R). Formally, the energy spectral density
can be defined for a discrete signal as follows.
Definition 1.2.1. Using the definition of the discrete time Fourier transform (DTFT),
DTFT (x[t]) = F{x}[eiω] we have energy spectral density to be
S[ω] = |F{x}[eiω]|2 (1.1)
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writing S[ω] in lieu of S[eiω].
The essence of the spectral estimation problem is that we wish to estimate
S[ω], how the total power of a signal is distributed over frequency given finite sta-
tionary data. In particular, we focus on non-parametric methods of spectral analysis.
Specifically, a spectral estimation method that has commonly been used is the Welch
method [142]. For a sampled signal x[n], n = 1, . . . , N , we let
xj[n] = x[(j − 1)K + n], n = 1, . . . ,M ; j = 1, . . . , S (1.2)
be the jth part of the signal. (j − 1)K denotes the starting point for the jth
sequence. If K = M then the sequences do not overlap, thus S = N/M. Usually,
K = M/2 and so there are S ≈ 2M/N parts, with 50% overlap between successive



















and with the DTFT we see





F{w}(ω − ψ)φp(ψ)dψ, (1.5)
9
where P = 1
M
∑M
n=1 |v[n]|2 is the power of the temporal window. So, the Welch
estimate of the power spectrum is found by computing the average windowed peri-







The Welch method, which allows for overlap, unlike the Bartlett method,
enables more periodograms to be averaged [7], [8]. This is done to decrease the
variance in the estimated PSD. Further, applying the window in the periodogram
computation is again intended to allow for more control over the bias and resolution
of the estimated PSD.
1.3 Quantitative EEG features
In addition to frequency band analysis, quantitative EEG research also uses
quantitative features to represent EEG and analyze differences between populations.
Below we define EEG features used throughout our work. Though many qEEG
features exist, we chose to focus on these qEEG features based on their use in
seizure research and other EEG consistency studies [29], [50]. For each of these
features, they are computed on each EEG channel separately.
1.3.1 Spectral features
We first begin with features computed from the PSD of an EEG trace.
For frequency bands: `(lower) :< 1Hz, δ(delta) : 1 − 4Hz, θ(theta) : 4 − 8Hz,
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α(alpha) : 8−12Hz, µ(mu) : 12−16Hz, β(beta) : 16−25Hz, γ(gamma) : 25−40Hz.




∀f P [f ]
, ∀b ∈ {`, δ, θ, α, µ, β, γ} (1.7)




P [ω],∀b ∈ {`, δ, θ, α, µ, β, γ} (1.8)
where P [ω] = 1
N ·SR |(F{X})[ω]|







N = #X, the cardinality of X, and SR the sampling rate.












1.3.2 Time domain features
Next we describe features that were computed using the EEG recording di-
rectly. For these features we use S the starting index and N the ending index.
We start with information theoretic features of EEG.













where xs[i] = x[i] + min{X}.




0, if x[i] < Tmean(X)
1, otherwise
(1.11)
and LZC is computed through [92]. Based on methods from [5], [59].
We next define standard statistical measures also used to quantify EEG.
Minimum value,
MIN = min{xS, . . . , xN}. (1.12)
Maximum value,









where Xsort is a sorted X and #X is the cardinality of X.
Variance,


















































]2 − 3. (1.18)








































where a0 = V AR(X), a1 = V AR(X
(1)), and where X(n) is the nth discrete differ-









where a2 = V AR(X
(2)).
1.4 Artifact removal in EEG
Artifact removal in EEG is an area of active research. It is a common and
usually the most burdensome step in pre-processing EEG before analysis. Even when
noise sources are known, artifacts cannot be directly subtracted from EEG signals
and more sophisticated methods are needed to remove them. It is generally difficult
to do in an automated fashion and usually requires manual review for consistent and
accurate artifact removal. Because most of the data we used were well segmented and
recorded in controlled clinical settings, we generally did not apply artifact removal
algorithms. However in our last research chapter, as an application to one of our
developed methods, we evaluate the effectiveness of automated artifact removal
methods. Below we give some background and formulations that are the bases of
the artifact removal algorithms used.
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1.4.1 Independent component analysis
When EEG electrodes record electrical activity, both neural activity and ar-
tifacts from other physiological sources are generally mixed together. The presence
of artifactual noise corrupts the neural signal of interest limiting its interpretability
and utility. To motivate independent component analysis (ICA) in the context of
EEG, recall that neural activity is recorded from a collection of electrodes from the
scalp. However, as electrical activity permeates through the brain and skull, each
electrode records a combination of neural and muscle activity from multiple sources
in the brain and body. The goal of ICA, and more broadly blind source separation
(BSS), is to identify and separate the sources of electrical activity, neural or artifac-
tual, for each EEG electrode. If we assume that the signals are being linearly mixed,
then for the set of electrode recordings, X, and separate neural activity sources, S,
we can define
X = AS, (1.26)
where A is called the mixing matrix. If we had either A or S, then we could solve
for the other by inverting the system of equations. However, we know neither the
mixing coefficients nor the neural activity and only have the recorded EEGs, X.
We first assume that each source provides statistically independent data at each
time instant. In practice this assumption does not need to be strictly true to ob-
tain accurate solutions. Further, it is necessary that the independent components
have non-Gaussian distributions. Otherwise, an orthogonal mixing matrix cannot
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be estimated since uncorrelated jointly Gaussian variables are necessarily indepen-
dent, and therefore A cannot be identified and only estimated up to an orthogonal
transform.
In general, most ICA algorithms are designed to solve the un-mixing matrix,
W = A−1, the inverse of A. That is, algorithms look to find the solution to
WX ≈ S (1.27)
Once the ICA components are solved for, in the case of artifact removal, spe-
cific components that represent the noise sources (e.g., eye movement, muscles, and
motion) are removed. That is, once all components {w1, . . . , wn} are solved, for
i = 1, . . . n, algorithms set wi = 0 if i is identified a noise source.
However, even when W is solved for, a difficulty is identifying which compo-
nents represent noise and which are relevant neural activity. Though most artifact
removal algorithms do not allow automated application, there are several meth-
ods that have been developed to identify artifactual components automatically. In
particular we use multiple artifact removal algorithm (MARA) [143], [62] and au-
tomated artifact removal (AAR) [45], [69], [70]. These algorithms and component
identification methods are described when applied in our research in Chapter 5.
1.4.1.1 Pre-processing
To solve ICA several pre-processing steps simplify theory and algorithms, be-
ginning with centering X by imposing that the recorded data have zero mean. This
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is usually followed by whitening the data so that elements of X are uncorrelated
and have unit variance, that is E[X̃X̃T ] = I, where X̃ is the covariance matrix of
X.
We define the whitening transform, sometimes referred to as zero component
analysis (ZCA), as follows [32].
Definition 1.4.1. If we consider data X[n, i], where n ∈ {1, . . . , N} are each data
point and i ∈ {1, . . . ,M} the sample index, then the whitening transform is defined
as,
Xwhitened = Z ·X, (1.28)
where
ZN×N = U · diag(1/√S+ε) · UT (1.29)
with ε = 1× 10−5, included for numerical reasons, and where
ΣN×N = UN×N · diag(SN×1) · UTN×N (1.30)
is the singular value decomposition of ΣN×N , the covariance matrix of XN×M . Note
for vector SN×1, diag(S) is a diagonal N × N matrix with elements of S on the
diagonal and zero everywhere else.
This transform can be thought of as scaling the variance across each dimension
in the data to be equivalent. In other-words, the data space may initially be different
sizes in each dimension but is transformed to a hyper-sphere. Once pre-processed
there are several approaches to solving the ICA, we briefly outline two that are used
17
in our work here.
1.4.1.2 FastICA
Adapted from ‘Independent Component Analysis’, the first is a classic ap-
proach called FastICA and uses extrema of functions which measure non-Gaussianity
of data [1], [57]. Kurtosis, the fourth-order moment of a random variable, is zero
for Gaussian random variables and generally non-zero for all other non-Gaussian
random variables, is an example of a measure of non-Gaussianity. Here kurt(x) =
E[x4] − 3(E[x2])2 = E[x4] − 3 because of x’s unit variance, E[x2] = 1. However,
kurtosis when estimated from measured samples is sensitive to outliers and thus not
a robust measure of non-Gaussianity.
A more robust measure of non-Gaussianity of data is Negentroy. Entropy of




P (X = xi) log (P (X = xi)). (1.31)
A fundamental result of information theory is that a Gaussian variable has the
largest entropy among all random variables of equal variance and therefore can be
used as a measure of non-Gaussianity [26]. We define Negentropy, a measure of
non-Gaussianity that is zero for Gaussian variables and non-negative, as
N(x) = H(xgauss)−H(x), (1.32)
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where differential entropy H(x) =
∫
f(x) log (f(x))dx and xgauss is a Gaussian ran-
dom variable with the same convariance matrix as x. Though this presents a some-
what optimal measure of non-Gaussianity, estimating negentropy would require es-
timating the PDF which can be difficult and computationally complex. Therefore,
approximations of negentropy are used.
An early approximation, which has been proven to converge globally, used kur-
tosis such that N(x) ≈ (1/12)E[x3]2 + (1/48) kurt(x)2, where x ∼ N (0, 1) is assumed.
However, the same non-robustness issues arise for this approximation. Therefore,




κi (E[Gi(x)]− E[Gi(ν)])2 , (1.33)
where Gi are generally any non-quadratic function, κi are positive constants, and
ν ∼ N (0, 1), a Gaussian variable with zero mean and unit variance. We see setting
p = 2 with G1(x) = x
3, G2(x) = x
4, κ1 = 1/12, and κ = 1/48 yields the kurtosis-based
approximation, noting that E[ν3] = 0. For p = 1, we have
N(x) ≈ κ1(E[G1(x)])2. (1.34)
More generally for p = 2
N(x) ≈ κ1(E[G1(x)])2 + κ2(E[G2(x)]− E[G2(ν)])2, (1.35)
where G1 is an odd function and G2 even.
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For the implementations of FastICA, generally,
G1(x) = tanh (a1x) (1.36)






where 1 ≤ a1 ≤ 2, often simply a1 = 1.
So to optimize the approximation of the negentropy to determine the un-
mixing components w, if we consider for simplicity p = 1, we seek to optimize
E[G(wTx)]. By the Kuhn-Tucker conditions, the optima of E[G(wTx)] with ‖w‖ = 1
constraint are at points where
E[xG′(wTx)]− βw = 0, (1.38)
where β = E[wToptxG
′(wToptx)]. If we apply Newton’s method for iterations,
w+ = w − (J(w))−1f(w), (1.39)
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= E[xG′′(wTx)xT ]− βI (1.41)
= E[xxTG′′(wTx)]− βI (1.42)
≈ E[xxT ]E[G′′(wTx)]− βI, by approximation (1.43)
= E[G′′(wTx)]I − βI, since whitened data, E[xxT ] = I. (1.44)
Inverting J(w) and plugging it into Equation 1.39 we have,
w+ = w − E[xG
′(wT x)]−βw
E[G′′(wT x)]−β (1.45)
w+(β − E[G′′(wTx)]) = w(β − E[G′′(wTx)]) + E[xG′(wTx)]− βw, (1.46)
multiplying both sides by β − E[G′′(wTx)]
= E[xG′(wTx)− E[G′′(wTx)] (1.47)
This update rule along with normalizing w = w+/‖w+‖ presents a basic form of
FastICA for a single component. To estimate all components w1, . . . , wn, we must
decorrelate the outputs wTi x after each iteration to prevent different components
from converging to the same maxima. This can be achieved through Gram-Schmidt
decorrelation. Thus, we can formulate the FastICA algorithm below where wi are
the column vectors of the unmixing matrix W [58].
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Algorithm FastICA
1: wi ← initialized randomly
2: w+i ← E[XG′(wTi X)]− E[G′′(wTi X)]wi




4: if i 6= 1 then










8: if Not converged then Return to line 2
9: else
10: i← i+ 1
11: Return to line 1
FastICA has several properties that make it an effective algorithm for solving
ICA. The algorithm’s convergence is cubic, making it fast and, unlike gradient-based
algorithms, there is no learning rate or other tuneable parameters, making it easy
to use and produce consistent results.
1.4.1.3 SOBI
Another method used to solve the ICA problem is second order blind identi-
fication (SOBI). Adapted from ‘A blind source separation technique using second-
order statistics’ [9], this method utilizes the time coherence of the source signals.
Unlike other methods like FastICA, the SOBI method relies solely on stationary
second-order statistics based on a joint diagonalization of a set of covariance ma-
trices. In this case, whitening the data is considered essential and part of the
algorithm implementation. This formulation assumes that the source signals s(t)
is either a deterministic ergodic sequence or a stationary multivariate process, with
E[s(t+τ)s(t)∗] = diag[ρ1(τ), . . . , ρn(τ)], where (·)∗ denotes the conjugate transpose.
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So we can define the autocovariance of si(t) as
ρi(τ) = E[si(t+ τ)s
∗
i (t)], 1 ≤ i ≤ n. (1.48)
With this we have the covariance matrices of X as
R(τ) = E[x(t+ τ)x∗(t)] = ARs(τ)A
H (1.49)
with (·)H the complex conjugate transpose of a matrix.
We now consider the whitened covariance matrices, R(τ) = ZR(τ)ZH . We
see R(τ) are simply the covariance matrices of the whitened data X. We also note
the result that for any whitening matrix Z there exists a unitary matrix U , that is
UUH = UHU = I, such that ZA = U . Thus, we can also see A can be found by,
A = Z#U (1.50)
where (·)# is the Moore-Penrose pseudoinverse. Therefore, by combining these
results and Equation 1.49 we see
R(τ) = URs(τ)U
H . (1.51)
Since U is unitary and Rs(τ) is diagonal, a whitened covariance matrix is diag-
onalized by the unitary transform, U , which can be found as a unitary diagonalizing
matrix of R(τ), for some lag τ .
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Next we briefly introduce the notion of joint diagonalization. We define the





where the unitary diagonalization of M is equivalent to zeroing off(V HMV ) for
some unitary matrix V . So, if M = UDUH , with D a diagonal matrix with distinct
elements, setting off(V HMV ) = 0, we have V = U . We can now consider the set
M = {M1, . . . ,MK}, a unitary matrix is considered to be a joint diagonalizer ofM
if it minimizes the non-negative function
C(M, V ) =
K∑
k=1
off(V HMkV ). (1.53)
So, if each M ∈ M can be unitarily diagonalized by U , Mk = UDkUH , then
U is a joint diagonalizer of M and can be proven to be unique. Computationally,
a joint diagonalizer can be found through a generalization of the Jacobi method for
diagonalization of a single Hermitian matrix [44].
With these notions in place we can now outline the SOBI algorithm [9].
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Algorithm SOBI
1: R̂(0)← Estimate of R(0) from T samples
2: λ1, . . . , λn ← n largest eigenvalues of R̂(0)
3: h1, . . . , hn ← n corresponding eigenvectors of R̂(0)
4: σ̂2 ← Average of the m− n smallest eigenvalues of R̂(0)
5: Ẑ ← [(λ1 − σ̂2)−(1/2)h1, . . . , (λn − σ̂2)−(1/2)hn]H
6: Xwhitened ← ẐX
7: for τ ∈ {τj|j = 1, . . . , K} do R̂(τ)← E[Xwhitened(t+ τ)Xwhitened(t)]
8: Û ← Joint diagonalizer of set {R̂(τj)|j = 1, . . . , K}
9: Â← Ẑ#Û
10: ŝ(t)← ÛHŴx(t)
where for line 4 comes from the white noise assumption and R(0) is an m×n matrix.
Overall, the SOBI algorithm begins by estimating the sample covariance R(0)
along with its eigenvalues and corresponding eigenvectors. Using these and esti-
mated noise variance we estimate the whitening matrix Z. The unitary matrix U
is determined as the joint diagonalizer of a set of estimates of whitened covariance
matrices for fixed time lags. Finally, with estimates of U and Z we can compute
the mixing matrix, A, and subsequently the source signals, s(t), by Equation 1.50
and Equation 1.27, respectively. SOBI’s implementation has been found outperform
other ICA solution methods in terms of speed and accuracy [118].
1.4.2 H-infinity filtering
We investigate two types of noise that commonly affect EEG recordings. The
first is the most commonly researched type, ocular artifacts, which generally come
from eye movements and blinking. The second is motion artifacts that are generally
more present when walking or performing other physical tasks. H∞ filtering is a
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linear adaptive filtering method that guarantees robustness where small modeling
errors and external noise, such as ocular artifacts, do not cause large estimate errors.
However, when linear models do not handle certain types of artifacts well, such as
motion, a common non-linear representation of dynamic systems known as Volterra
series can be used. So, we define the formulation of H∞ filtering [52] applied to
ocular artifact removal [73] as well as an extension of this formulation with Volterra
series [89] to remove motion artifacts [72], adapted from these prior publications.
We begin with the following definition,
Definition 1.4.2. We let h2 denote the vector space of square-summable complex-





denotes the complex conjugation. Let T be a transfer operator that maps an input












For adaptive time-varying filtering, we assume that an output sequence {di}
follows a linear filter model
di = h
T
i wi + vi (1.55)
where hTi = [hi1, . . . , hin] is the known input vector, wi unknown filter time-varying
weights we wish to estimate, and {vi} is an unknown disturbance sequence that
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might include modelling errors. Further, we let ŵi = F(d0, . . . , di−1) denote the
estimate of wi given observations {dj} and {hj} from time zero up to and including
time i− 1, and define the output prediction error as
ei = h
T
i wi − hTi x̂i. (1.56)
We note that since the time-variation in xi, δxi = xi+1 − xi, is unknown, it is
also considered as a disturbance. So, for every estimator F , there will be a transfer
operator from disturbances {µ− 12 (x0 − x̂0), {vj}ij=0, q−
1
2{δxj}ij=0}, to the prediction
errors {ej}ij=0, where q is a positive constant that reflects a-priori knowledge of how
quickly the weight vector wi is time-varying (q ≈ 10−8 for slow signals). We denote
this transfer operator as Tg,i(F).
We can then formulate the problem of finding estimates of time-varying weights,
ŵ = F(d0, . . . , di−1), such that the optimal H∞ estimation method minimizes












So, in context of EEG formulation for ocular noise (measured by electroocu-
lography (EOG)) we let di ≡ si be the measured primary signal and hi ≡ ri be the
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reference measurements from EOG electrodes which yield,

















P̃−1i + (1− γ−2)rirTi
)−1
+ qI. (1.63)
Here ŵi+1 is the estimated weight per channel for sample i + 1, ri is the
vector of reference measurements, si is the measured signal of interest, and P̃i is
the noise convariance matrix initialized by P̃0 = µI, with constant µ. Further,
γ is the bound on the energy-to-energy gain from the disturbances to the output
estimation error and is important for filter performance, since it defines the levels
of disturbance that will be tolerated by the H∞ filter. As γ gets closer to one, the
filter behavior gets closer to the optimal filter behavior. In an optimal H∞ filter
γ < 1 provides a guaranteed robust performance under all levels of disturbances
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that effects the system. In the above formulation the weights are assumed to be
time-varying with unknown variation dynamics, and the change δŵ is formulated
as an unknown disturbance on the system. Hence the above formulation is valid for
the inequality γ2 ≤ 1 + qr where r is the supremum of the measured disturbances
[73].
Next, we define a second-order Volterra series of degree N extension of H∞












using the linear H∞ filtering formulation above. wl1,i and wl2,i represent the Volterra
kernel identified through the time-varying H∞ adaption rule.
In the implementation used on data in our work, filter order of N = 3 was
used. Further, when applying the Volterra series extension for motion artifacts,
the selection of the reference signal that is used to identify the motion artifacts in
EEG signals is critically important [72]. 3-axis acceleration values, after gravity
compensation using the quaternion of the IMU were used as the reference signal.
As such, the 3-axis acceleration values for reference were
di = w1,iaccx,i + w2,iaccy,i + w3,iaccz,i, (1.65)
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1.5 Kruskal-Wallis statistical test
In general, we use non-parametric statistical tests throughout this work. Para-
metric tests involve an underlying assumption that the data can be parameterized
since it follows known distributions. In this case, estimates for these parameter can
be computed for the data and be used in statistical tests. An example of this is
data, z, from a Normal distribution which can parameterized by a mean, µ, and a
variance, σ2 can be written as z ∼ N (µ, σ2). However, when data does not follow
known distributions, we must apply non-parametric statistical methods. The ma-
jority of the these methods rely on the ranks of values of the data so to use the data
directly rather than parameterize it. In order to determine whether a parametric or
non-parametric test should be used there are several tests for determining whether
data is distributed normally. Research has shown that through Monte Carlo simu-
lation, that the Shapiro-Wilk test has the best power for a given significance when
compared to the Anderson-Darling, Kolmogrov-Smirnov, and Lilliefors tests [113].
Thus, we use the Shapiro-Wilk test when evaluating the normality assumptions of
data.
In particular, throughout our work we use the Kruskal-Wallis test as a non-
parametric statistical test. The Kruskal-Wallis test is meant to compare the distri-
butions of scores on quantitative variables obtained from two or more groups [77].
It can therefore be thought of as an analysis of variance (ANOVA) for independent
samples. However, unlike an ANOVA, it is used when the data are not clearly nor-
mally distributed, the dependent variables are ordinally measured, or are collected
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from too small of a sample size.
The null hypothesis, H0, for this test is that the populations represented by
the conditions, groups or samples, have the same median of scores on the quantita-
tive response variable and thus distributed similarly. If we were to reject the null
hypothesis and accept the alternative hypothesis, H1, then that would imply that
the populations’ medians differ statistically.
Given some data, D = {x, y}, of length N , where each data point x is assigned
a group, y, with G total groups. Each x is given a rank starting at 1 corresponding
to its value in ascending order. Tied values receive a rank of the average across the
ranks they occupy. For each group we compute the square of the sum of all ranks in
that group, r2g , and the number of data points in each group, ng. It should be the
case that D has
∑G
g=1 ng = N data samples. To use this method, the test statistic,










− 3(N + 1). (1.66)
χ2 (chi-square) tests, such as the Kruskal-Wallis test, are often used to deter-
mine whether there is a significant difference between the expected frequencies and
the observed frequencies in one or more categories. The test statistics used in these
hypothesis tests generally follow a χ2 distribution so long as the number of samples
is greater than five for each group [79]. Therefore, the sampling distribution of H
approximates that of a χ2 distribution, particularly when there are five or more data
points per group, ng ≥ 5, ∀g ∈ {1, . . . , G}. So, H can be compared to the critical
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χ2 distribution value to test H0. With degrees of freedom, df = ming∈G{ng} − 1,
and a p−value, we can determine Hcritical = χ
2(df, p).
Finally, if H ≤ Hcritical then we fail to reject H0. Otherwise, if H > Hcritical then
we reject H0 and accept H1.
If G > 2, and H0 is rejected, pairwise comparisons may be needed to determine
if any pairs of groups fail to reject H0.
1.6 Density estimation
When we have data but wish to estimate a model that represents the distribu-
tion of the data, kernel density estimation (KDE) presents a non-parametric method
to do so.
The following formulation of KDE was first presented both by E. Rosenblatt
and E. Parzen [116], [103]. For {x1, x2, . . . , xN} which is assumed are independent
and identically distributed data sampled from a distribution, we begin by formu-
lating an estimator of the cumulative density function (CDF), F (x) = P [X ≤ x].
So we can estimate F (x) by F̂n(x) =
1
n
· {number of xi ≤ x}. This can also be
considered the frequency of occurrence estimator of F (x).
From this we can formulate the estimation of the probability density distri-
bution (PDF), f(x). By definition we have f(x) = d
dx
F (x). So, we see from the
fundamental theorem of calculus we can estimate fn(x) by
f̂n(x) =












1/2, if |u| ≤ 1
0, otherwise.
(1.69)












This result is known as a uniform KDE since K(u) is the PDF of a uniform
distribution. However, other kernels, K, can be used to estimate the distributions.











which satisfies the conditions that
∫∞
−∞K(x)dx = 1 and K(x) = K(−x). We further
chose the bandwidth, h, the size of the kernel at each point, through Scott’s Rule,
h = n−1/(d+4), with n the number of data points and d the dimensionality of the
data [34]. The bandwidth is a smoothing parameter that controls the trade-off
between bias and variance in the resulting distribution. A larger bandwidth leads
to a smoother density distribution with higher bias, while a smaller bandwidth leads
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to less smooth density distribution with higher variance. Finally, we note that as
h → 0, the kernel approaches the Dirac delta function and f̂(x) approaches the
exact density of the data which would be a set of impulses located at each point.
1.7 Machine learning
Several of our works use machine learning methods. This section introduces
some notions in machine learning and detail specific methods used in our research.
Under the assumption that similar data is represented spatially close to each other,
the simplest case in machine learning is that the data be clustered into appropriate
groups based on its labels. Simpler methods that aim to solve this type of prob-
lem include the K-means clustering algorithm or Gaussian mixture models (GMM),
which are equivalent when all variances in all dimensions are equal [47]. A large draw
back of these methods however is that as the dimensionality of the data increases
they do not tend to perform as well. Thus, other methods are explored in more
depth. The main feature based method we use is kernel support vector machines
(kSVM), which has been adapted from ‘A Tutorial on Support Vector Machines
for Pattern Recognition’ [19]. Finally, a brief introduction, motivated by example,
and some of the methods used in deep convolutional neural networks (DCNN) are
adapted from the relevant parts of ‘Deep Learning’, which expands on these methods
in much more detail [47].
In the case of machine learning application in these works, we mostly consider
labeled, supervised machine learning methods. That is, consider datasets such that
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{Xi, yi} where X is the data and y the data’s label. Data was generally be sepa-
rated into training and testing, sometimes called validation, sets. Machine learning
algorithms and parameters are computed solely on the training data subset. The
method’s efficacy is determined by the classification accuracies of estimating yi, the
labels, of the testing subset and comparing these estimates to the true labels.
1.7.1 Support vector machines
The theory and basis of SVMs has been introduced some time ago [139]. How-
ever, it is still prevalent and used as a feature-based classification method because
of its efficacy. This topic requires a great deal of general and convex optimization
methods. Exact solutions methods and derivations of these optimizations are not
presented here [17], [38].
Training data is labeled as {Xi, yi}, i = 1, . . . , `, yi ∈ {−1, 1}, Xi ∈ Rd. Now
suppose there exists a hyperplane which separates the positive and negative labeled
data, either +1 for one class, or −1 for the other class. The points X which lie on
the hyperplane satisfy w · X + b = 0, where w is the normal to the hyperplane,
|b|/‖w‖ is the perpendicular distance from the hyperplane to the origin, and ‖w‖
the Euclidean norm of w. We now let d+ and d− be the shortest distance from
the separating hyperplane to the closest positive and negative training samples,
respectively. The margin for the separating hyperplane can be defined as d+ + d−.
So in the separable case, all the training data will satisfy the following equations,
Xi ·w + b ≥ +1, yi = +1 (1.72)
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Xi ·w + b ≤ −1, yi = −1 (1.73)
and combining these inequalities,
yi(Xi ·w + b)− 1 ≥ 0 ∀ i (1.74)
We can now consider points that satisfy equality in Equation 1.72. These
points would lie on hyperplane H1 : Xi · w + b = 1 with normal w and distance
from the origin |1−b|/‖w‖. Similarly, we can consider points that satisfy equality in
Equation 1.73. These points would lie on hyperplane H2 : Xi · w + b = −1 with
normal w and distance from the origin |−1−b|/‖w‖. So, d+ = d− = 1/‖w‖ and the
distance between these two hyperplanes, called the margin, is 2/‖w‖. Since H1 and
H2 are parallel, with the same normal, and no training points between them, the
pair of hyperplanes can be found to give the maximum margin by minimizing ‖w‖2,
subject to Equation 1.74.
Since this is a constrained optimization problem, the SVM optimization prob-
lem can be stated in a Lagragian formulation. So for each inequality constraint
from Equation 1.74, we let αi, i = 1, . . . , ` be Lagrange multipliers. For equality
constraints, the Lagrange multipliers are unconstrained. However, with the inequal-
ity constraint, ci ≥ 0, constraint equations are multiplied by positive Lagrange












The primal optimization formulation, LP , can now be solved by minimizing
LP with respect w, b. The solution will also require the gradients with respect to
all αi vanish and αi ≥ 0.
Since this is a convex quadratic programming problem, we can equivalently
formulate a dual optimization problem, LD. Maximizing LD subject to where the
gradient of LD vanishes with respect to w, b, and αi ≥ 0. The specific dual formu-







αiyi = 0 (1.77)












If we let b = 0, thus requiring the hyperplanes to contain the origin and
omitting condition from Equation 1.77 in higher dimensions, this reduces the degrees
of freedom by one. Further, it is worth noting that these formulations of the SVM
optimization problem satisfy the Karush-Kuhn-Tucker (KKT) conditions [38].
The data analyzed however does not always follow a linearly separable case.
Thus, the constraints from Equations 1.72 and 1.73 need to be relaxed when nec-
essary otherwise no solution will be found. To do this we introduce slack variables,
37
ζi = 1, . . . , `. So, the constraints become
Xi ·w + b ≥ +1− ζi, yi = +1 (1.79)
Xi ·w + b ≤ −1 + ζi, yi = −1 (1.80)
ζi ≥ 0∀i (1.81)
When an error occurs, the associated ζi > 1. Thus,
∑
i ζi is the upper bound
on the number of training errors. So, the objective function is changed to assign an











with C is a now a parameter.
A larger C corresponds to a higher penalty for errors [25]. We note that the
optimization problem has several nice desired properties depending on the value
of k. The problem remains a convex optimization problem with any positive k, a
quadratic optimization problem for k = 1, 2, and the slack variable ζi and their











j αiαjyiyj(Xi ·Xj) (1.83)
Subject to: 0 ≤ αi ≤ C (1.84)
and
∑
i αiyi = 0. (1.85)





where Ns is the number of support vectors. The main difference between the sepa-
rable case here is that the αi have an upper bound of C.














where µi are the Lagrangian multipliers applied to ensure ζi ≥ 0.
Finally, to extend this method even further to non-linear separation and hy-
perplanes we note that the data only appears as a dot product in Equations 1.83,
1.84, and 1.85. If the data is mapped to some Euclidean space, H, Φ : Rd → H,
then the training would only depend on Φ(Xi) ·Φ(Xj) in H. Further, allowing for a
kernel function K(Xi, Xj) = Φ(Xi) · Φ(Xj), would allow the training procedure to
only depend on K. Thus, the optimization will find a linear separation in a different
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j αiαjyiyjK(Xi, Xj) (1.88)
Subject to: 0 ≤ αi ≤ C (1.89)
and
∑
i αiyi = 0 (1.90)






if and only if for any g(x) ∈ L2,
∫
R2
K(x, y)g(x)g(y)dxdy ≥ 0. (1.92)
Kernel functions investigated here include
Polynomial Kernel:
K(x, y) = (x · y + 1)p (1.93)
Radial Basis Function (RBF) Kernel:




Kernel parameters have a significant effect on the decision boundaries learned
during training. The degree of the polynomial kernel and the width parameter of
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the Gaussian kernel control the flexibility of the resulting classifier. The lowest
degree polynomial, p = 1, turns out to be the linear kernel, which may not perform
well when non-linear relationships between features exist. For the Gaussian kernel,
this expression is essentially zero if the distance between x and y is much larger
than 1/√γ. That is, for a fixed x it is restricted to a specific region around y. The
support vector expansion, Equation 1.95, is a sum of Gaussian bumps centered
around each support vector. When γ is small a given data point x has a non-zero
kernel value relative to other support vectors. Therefore, the whole set of support
vectors affects the value of the discriminant function at x. This results in a smooth
decision boundary. As γ is increased the support vector’s neighborhood increases,
which leads to more curvature in the decision boundary. When γ is large the RBF
γ parameter is more likely to lead the classifier to overfitting the data. The degree
of the polynomial kernel, p, and the Gaussian kernel parameter, γ, determine the
flexibility of the resulting SVM in fitting the data. If this complexity parameter
is too large, over-fitting will likely occur [124]. In general one can think of these
kernels as a form of measuring similarity.
Further, there exists a choice of hyperparameter of the soft-margin constant, C.
For a large value of C, a large penalty is assigned to errors and margin errors. That
is, points closest to the hyperplane affect its orientation, resulting in a hyperplane
that comes close to several other data points. When C is decreased, those points
close to the hyperplane may become margin errors and the hyperplane’s orientation
would be changed, providing a much larger margin for the rest of the data.
Once the optimization problem is solved based on the training subset of the
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data, it can be tested by assigning test data, Xt, to sgn(w ·Xt + b) in the linearly




αiyiΦ(si) · Φ(Xt) + b =
Ns∑
i=1
αiyiK(si, Xt) + b (1.95)
where si are the support vectors.
Generally, when applying kSVM to a set of features several transforms on
the data can be applied to produce better results and normalize data if they are
on different scales. In general a transform is also determined based solely on the
training data and applied to both the training data and later the testing data.
Specifically, we apply max normalization to features used with kSVM in our
classifications which we define here.
Definition 1.7.1. If we consider training data X[n, i] and testing set Xt[n, i], where
n ∈ {1, . . . , N} are each data point and i ∈ {1, . . . ,M} the sample index, then the




, ∀n ∈ {1, . . . , N}, i ∈ {1, . . . ,M} (1.96)
















(X[n, i]), ∀n ∈ {1, . . . , N} (1.99)
In this case the transform values for each data point, Xµ[n] and Xmax[n],
are determined by the samples from the training set only. This transform rescales
all features to be [0, 1], allowing for them all to be weighted more equally during
training since different scales and magnitudes across features can weight importance
higher values during training kSVM models.
1.7.2 Deep convolutional neural networks
The field of neural networks, particularly in the context of machine learning
and signal classification has a long history. Full derivations of each element of
modern day DCNN are not presented here. Rather, by example, we consider a
DCNN used in our works and expand upon its elements and layers shown in Figure






Pooling Convolution Pool Conv Pool Conv Pool Dense network(Classifier)


































Figure 1.5 Deep convolutional neural network architecture. Convolutions are shown
in yellow and all have stride 1x3, across the temporal dimension. Max pool layers
are shown in green. The classification is determined by the class with the highest
output probability.
Our work focused on feed-forward neural networks which do not include feed-
back within the network where the outputs of the model are used again as inputs.
in essence are a collection of nodes that have the following properties.
The basic building block of neural networks consist of nodes with weighted
connections. They are biologically inspired by neurons with their connections and
activations by simulating neuronal connections and firings. Traditional neural net-
works would simply consist of an input layer with nodes equal to the size of the
input space and an output layer equal to the number of classes of interest. The
goal of a neural network is for weights of each node to be assigned in a manner that
makes the network behave as a function that separates the classes. However, it was
quickly understood that more complicated functions could not be estimated with
these networks. The classical example of these simple networks failure can be seen
in non-linearly separable cases, such as the exclusive or (XOR). Thus a hidden layer
was added between the input and output layers. Further, simply having multiple
layers is not quite enough since it is clear that he composition of two linearly op-
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eration can be reduced to a single linear operation. So, each layer also includes a
non-linearity. In general, most neural networks at each layer apply an affine trans-
formation controlled by learned parameters followed by a non-linear function applied
to the transformed input, also known as an activation function. Combining these
components, the universal approximation theorem can be stated [55], [28].
Definition 1.7.2. The Universal Approximation Theorem states that a Feedforward
network with linear output units and at least one hidden layer with a squashing non-
linear activation function can approximate any continuous function on a closed and
bounded subset of Rn, also known as Borel measurable, from one finite dimensional
space to another with any desired non-zero error given that the network has enough
hidden units [47].
Though in theory only these three layers are needed, in practice it has been
found that adding more layers and increasing the depth of the network rather than
increasing the width of each layer has performed well.
1.7.2.1 Convolutional layers
Rather than using only fully connected layers, convolutional layers have re-
cently become widely used since they allow for weights in filters to be learned.
These embedded filters act as feature extractors that can then fed into traditional
architectures for classification. Similar to the one dimensional convolution, the two
dimensional discrete convolution used here can be stated as,
Definition 1.7.3. For signal I and convolution kernel K, the two dimensional
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convolution is defined as,





I[m,n]K[i−m, j − n] (1.100)
The main motivation for using this convolutions stem from having sparse con-
nectivity, share parameters, and is translation invariant, that is the output of the
operation preserves translations applied to the input. Unlike dense neural networks
that connect each node in layers to each other, using kernels, which are usually much
smaller than the input dimension, allows for sparse connectivity. The kernel is still
able to connect to the input by translating, or striding through the input, producing
an output at each step. This notion of the same kernel striding through the input
data is also what gives rise to the shared parameters of convolution kernels across
the input. Finally, translation invariance comes from the fact that if a translation
were to be applied to I before being convolved with K that it would in fact be
equivalent to applying that same translation to (I ∗K).
1.7.2.2 Activation functions and non-linearities
The rectified linear Unit (ReLU) function, ReLU(x) = max (0, x), is commonly
used since it yields a non-linear transform needed but it is close to linear since it is
based on piecewise linear functions with two linear pieces. Since it is nearly linear it
preserves many of the properties that make optimizing linear functions easier with
gradient based methods. An extension to the ReLU non-linearity is the exponential
linear unit (ELU) [23].
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α(ex − 1) , x < 0
x , x ≥ 0
(1.101)
Ideally, as a non-linearity function is fed into the back-propagation algorithm,





αex , x < 0
1 , x ≥ 0
(1.102)





ELU(x) + α , x < 0
1 , x ≥ 0
(1.103)
ELU is a strong alternative to the commonly used ReLU function since it can
generate negative outputs and smooth slowly until its output equals −α.
1.7.2.3 Pooling
A pooling function replaces the input of a location with a summative oper-
ation of that location and other nearby outputs. For example, the max pooling
operation finds the maximum value within a rectangular neighborhood [147]. In all
cases, pooling helps to make the representation become approximately invariant to
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small translations of the network input. Invariance to translation means that if we
translate the network input by a small amount, the values of most of the pooled
outputs will not change. Invariance to small, local, translation is important if the
presence of a feature is more important than its location. Alternatively, pooling
can be viewed as adding an infinitely strong prior that the mapping function, con-
volution, or dense layer learns must be invariant to small translations. When this
is true, it can greatly improve the network’s performance. In general, pooling over
spatial regions produces a translation invariant functions. However, if we pool over
the inputs of differently oriented convolutions, the features can learn which small
transformations to become invariant to. Similar to the convolution kernels, pooling
operators have a specified size, usually much smaller than the input size, which they
stride across the input giving a result at each step.
1.7.2.4 Dropout
To consider dropout, we first note that it finds theoretical motivation in boot-
strap aggregating [131]. Bootstrap aggregating looks to reduce generalization error
in neural networks by combining several separately trained models. The idea is
that this ensemble methods will use several models that are unlikely to generate
the same errors on the test set. Dropout training is not quite the same as ensemble
training. In the case of bootstrap aggregating, the models are all independently
trained. On the other hand, in the case of dropout, the models share parameters
with each other, inheriting a different subset of parameters from the different neural
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networks. However, this parameter sharing makes it possible to represent an ex-
ponential number of models with dropout. The principle is to train on sub-models
that do not include the outputs. Dropout trains the ensemble consisting of all sub-
networks that can be formed by removing non-output units from the sub-networks.
Training with dropout usually makes use of a minibatch-based learning algorithm
that makes small steps, such as stochastic gradient descent. For each minibatch, a
random sample of a different mask is applied to all of the input and hidden units
of the network. The mask for each unit is sampled independently from all other
units. The probability of sampling a mask value of one, where a unit is included,
is a hyperparameter of dropout. Once the sub-network has been generated after
applying the binary mask, forward propagation, back-propagation, and the learning
update are performed as usual.
1.7.2.5 Batch normalization
With the increased complexity of deep learning models and the amount of data
used to train them, training a full deep network can take a significant amount of
time. Batch normalization is a method of normalizing internal convariates of layers
so that higher learning rates can be used to potentially reduce the number of training
steps and training time required [61]. It applies adaptive re-parametrization, again
motivated by the difficulty of training very deep models that involve the composition
of several functions or layers. The gradient and learning algorithms inform the
network on how to update each parameter given that the other layers do not change.
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In practice, all of the layers are updated simultaneously. We let H, structured as
a design matrix, be a minibatch of activations of the layer to normalize, with the
activations for each example in a row of H. H is normalized by replacing it with
H ′ = H−µ
σ
, where µ is a vector containing the mean of each unit and σ is a vector
containing the standard deviation of each unit. Further, as with all other functions
applied to the input, the back-propagation learning algorithm is also applied to
this transformation so that the gradient will never increase the mean or standard
deviation. During training, µ and σ may be replaced by running averages that allow
for the model to be evaluated on a single example, without needing definitions of µ
and σ that depend on an entire minibatch. In convolutional networks it is important
to apply the same normalizing µ and σ within a feature map so that the statistics
of the feature map remain the same regardless of spatial location.
1.7.2.6 Objective functions
If we simply wished to minimize the distance between the network output and
target output values, a least squares cost function may be appropriate. However,
since in most cases the network is learning the distribution for p(y|x, θ) for output
y given data x and learned parameters θ, we can use the cross-entropy cost function
to evaluate errors between the training data and the model’s predictions. This in
essence is solving for the maximum likelihood. The cost function can be understood
as the negative log-likelihood, or equivalently the cross-entropy, between training
data and model’s output.
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Definition 1.7.5. The cross-entropy cost function is defined as,
J(θ) = −Ex,y∼pdata log pmodel(y|x) (1.104)
For two classes, it would be possible to use a classic activation function on the
last layer,





However, to construct a probability distribution over several binary variables
we can use the Softmax function,






where z = x−maxi(xi) is usually computed for numerical reasons to avoid overflow
issues in computation. Further, C denotes the number of classes of interest.
This is a useful function when dealing with probabilities since softmax(x) ∈
(0, 1). Further, the Sigmoid function saturates with large positive or negative num-
bers allowing for a flat function when its input is introduced to small changes. Thus
the Softmax cross-entropy loss function for two class problems investigated in this
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ci log (yi) + (1− ci) log (1− yi) (1.107)




, and ci the class label for each input.
1.7.2.7 Back-propagation
The back-propagation algorithm is in essence a recursive application of the











We can recursively apply the chain rule to obtain back-propagation. In the
case of the neural network used (1.5), we have the function
Out = softmax(ELU(C4(ELU(C3(ELU(C2(ELU(C1(x))))))))) (1.109)
So, to learn the appropriate weights, w we wish to compute ∂Output
∂wi
. We let y =
ELU(C1(x)), z = ELU(C2(y)), v = ELU(C3(z)), k = ELU(C4(v)), Out =














For each weight in the network, the particular path can be traced and used in
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the computation for the chain rule and back-propagation. [47]
1.7.2.8 Learning algorithms
In order to find the optimal value to solve the objective function we look to
solve, for a general objective function f(x), xobj = argminf(x). Through gradient
based optimization, we see from the basic derivative that it tells us how to change x
in order to make small changes in f(x). We know that f(x− ε · sign(f ′(x))) < f(x)
for a small enough ε, that is, we can reduce f(x) by moving x in small steps in
the opposite sign of the derivative. This leads to gradient decent in the simplest
case. This method finds local critical points, such as a minimum, maximum, or
saddle point. In general xn = xn−1 − ε∇xf(x) where we call ε the learning rate.
An extension of this that is widely used is stochastic gradient descent (SDG). The
insight that led to this algorithm is to consider the gradient as an expectation. A
set of samples, a minibatch, of size m, is drawn from the training set. The gradient





(i), y(i), θ) and parameters are updated by
θ ← θ− εg. Unlike convex function optimization, these non-convex functions can be
optimized but without convergence guarantees. We can also add momentum to this
learning method to accelerate learning. The momentum algorithm accumulates an
exponentially decaying moving average of past gradients and continues to move in
their current direction. It introduces v, the velocity, and its effect is determined by
the hyper-parameter α ∈ [0, 1], where the larger α is relative to ε, the more previous
gradients affect the current gradient direction. The gradient update is then adjusted
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to be









θ ← θ + v (1.112)









Specifically, the Adam learning algorithm, whose name comes from adaptive
momentum estimation, uses these methods and is a widely used method, including
in our DCCN model [74]. Adam combines benefits from two other extensions to
SGD, namely adaptive gradient algorithm (AdaGrad) and root mean square propa-
gation (RMSProp). Momentum is used as an estimate of the mean with exponential
weighting of the gradient. Specifically, the algorithm calculates an exponential mov-
ing average of the gradient and the squared gradient, and the parameters control
the decay rates of these moving averages. Further, Adam includes bias corrections
to both the means, uncentered variance, and the momentum, to account for the bias
of these moment estimates towards zero, which are calculated after calculating the
biased estimates.
1.7.2.9 Architectures and layers
The two dimensional convolution can be further extended from the one defined
previously. This is considered an affine transformation. The output of which is led
to a non-linearity. For the pooling layer is important when we care more about
whether some feature is present rather than where exactly it is.
54
A typical layer of a convolution network consists of three stages. In the first
stage, the layer performs several convolutions in parallel to produce a set of linear
feature maps. In the second stage, each feature map is run through a nonlinear
activation function, such as the ELU function. This stage is sometimes called the
detector stage. In the third stage, we use a pooling function to modify the output
of the layer further, for instance to enforce local translation invariance. In addition
to these classical three stages, modern deep networks have also began to apply
methods at each of these stages to improve learning further, including dropout and
batch normalization.
Finally, after several of these three stage layers, depending of the depth of
the network, the output can be fed into a dense layer that act as a classifier on
the features that have been identified and computed by the three stage convolution
layers. In general, the loss function acts as as non-linearity at this stage as well. In
the case of multinomial outputs, it is desired that the outputs be probability-like
values. To show each of the methods applied in the deep network, Figure 1.6 shows
the Sequential model used in the implementation of the DCNN model in Figure 1.5.






(conv_time): Conv2d (1, 25, kernel_size=(10, 1), stride=(1, 1))
(conv_spat): Conv2d (25, 25, kernel_size=(1, 19), stride=(1, 1), bias=False)
(bnorm): BatchNorm2d(25, eps=1e-05, momentum=0.1, affine=True)
(conv_nonlin): Expression(expression=elu)
(pool): MaxPool2d(kernel_size=(3, 1), stride=(1, 1), dilation=(3, 1))
(pool_nonlin): Expression(expression=identity)
(drop_2): Dropout(p=0.5)
(conv_2): Conv2d (25, 50, kernel_size=(10, 1), stride=(1, 1), dilation=(3, 1), bias=False)
(bnorm_2): BatchNorm2d(50, eps=1e-05, momentum=0.1, affine=True)
(nonlin_2): Expression(expression=elu)
(pool_2): MaxPool2d(kernel_size=(3, 1), stride=(1, 1), dilation=(9, 1))
(pool_nonlin_2): Expression(expression=identity)
(drop_3): Dropout(p=0.5)
(conv_3): Conv2d (50, 100, kernel_size=(10, 1), stride=(1, 1), dilation=(9, 1), bias=False)
(bnorm_3): BatchNorm2d(100, eps=1e-05, momentum=0.1, affine=True)
(nonlin_3): Expression(expression=elu)
(pool_3): MaxPool2d(kernel_size=(3, 1), stride=(1, 1), dilation=(27, 1))
(pool_nonlin_3): Expression(expression=identity)
(drop_4): Dropout(p=0.5)
(conv_4): Conv2d (100, 200, kernel_size=(10, 1), stride=(1, 1), dilation=(27, 1), bias=False)
(bnorm_4): BatchNorm2d(200, eps=1e-05, momentum=0.1, affine=True)
(nonlin_4): Expression(expression=elu)
(pool_4): MaxPool2d(kernel_size=(3, 1), stride=(1, 1), dilation=(81, 1))
(pool_nonlin_4): Expression(expression=identity)




Figure 1.6 DCNN model implementation in PyTorch software, adapted from [123].
Finally, we describe here the feature maps and layers in the deep convolutional
network shown in Figure 1.5 and detailed in Figure 1.6.
• The first layer has 10 × 1 convolution kernels with 3 × 1 strides across time.
We see it does not stride across channels. This process is done 25 times to
create 25 feature maps.
• The second layer has 25 ×#-of-channels convolution kernels with stride 1 in
time. Each convolution is across the channels, collapsing this dimension, and
fed to 25 linear units. Again, this is done 25 times to create 25 of 1 × 198
feature maps that are run through an ELU non-linearity.
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• The third layer is simply a max-pooling layer.
• The fourth layer has 25× 10 convolution kernels with stride of 3 in time. The
convolution is done across channels and time with each feature map, and run
through an ELU non-linearity. This is done 50 times.
• The fifth layer is a max-pooling layer.
• The sixth layer has 50× 10 convolution kernels with stride of 3 in time. The
convolution is done across channels and time with each feature map, and run
through an ELU non-linearity. This is done 100 times.
• The seventh layer is a max-pooling layer.
• The eight layer has 100× 10 convolution kernels with stride of 3 in time. The
convolution is done across channels and time with each feature map, and run
through an ELU non-linearity. This is done 200 times.
• The ninth layer is a max-pooling layer.
• The tenth and final layer is a 200×2 dense network layer, with input of 200×1
and output 1× 2 for each class, with softmax non-linearity at each node and
optimized on a cross-entropy loss function to estimate predicted probabilities.
• The output with the highest probability determines the predicted class.
So, for #-of-channels = 19, there are [(10 × 1) × 19] × 25 + [25 × 19] × 25 +
[25× 10]× 50 + [50× 10]× 100 + [100× 10]× 200 + [200× 2] = 279, 525 weights in
the DCNN.
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This deep convolutional neural network model is used throughout our work,
in Chapter 3 and Chapter 4 with 19 EEG channels, and Chapter 5 with 20 EEG
channels.
1.8 Conclusion
Methods and background presented in this introduction are used throughout.
Relevant sections are referenced when a method is discussed or used in each of the
following chapters. These four chapters present original contributions to the area of
quantitative characterizations of electrophysiological neural activity.
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Chapter 2: Consistency of Quantitative Electroencephalography Fea-
tures in a Large Clinical Data Set
Overview
This chapter presents work that was published in the Journal of Neural Engi-
neering in 2019 [95].
We developed data driven methods to evaluate consistency metrics of quantita-
tive EEG features and validated them using EEG data of clinically normal recordings
from the Temple University Health EEG Corpus.
Motivation: For diagnostic purposes, EEG recordings are usually interpreted
by trained professionals through visual inspection; however, variation in visual in-
terpretations of EEG has been shown to account for 37% of the variance in EEG
diagnoses. An alternative is to use quantitative EEG (qEEG) features. In order
to understand the salience of observed qEEG changes across individuals or within
the same individual, it is necessary to establish the consistency metrics for qEEG
features.
Approach: For our stationarity metric we applied Kruskal-Wallis tests to all
subjects and evaluated all ten combinations of five epoch lengths. Averages of all
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percent of subjects with significant statistical comparisons were used to determine
stationarity levels. For our inter-subject consistency metric we applied Kruskal-
Wallis tests to subjects with two sessions and compared different subjects to each
other over 100 iterations. Finally for our intra-subject consistency metric we applied
Kruskal-Wallis tests to subjects with two sessions and comparing subjects’ sessions
to each other.
Validation: We validated our stationarity metric by comparing results to
coefficients of variation, which can also represent stationarity for certain features,
and found both methods to produce consistent results. To validate our inter- and
intra-subject consistency metrics we obtained correlation coefficients to evaluate the
relationship between inter- and intra-subject consistency of features and confirm
results with our novel methods.
Application: We applied this framework to evaluate the consistency of 30
commonly used quantitative EEG features. We found in general that features with
normalizing constants were more stationary (n = 4, 313). We also found entropy,
median, skew, and kurtosis of EEG to behave as baseline EEG metrics with high
inter-subject consistency (n = 419). Finally, other spectral and signal shape fea-
tures had stronger intra-subject consistency and thus are better for distinguishing
individuals (n = 419).
Research impact: These results provide data-driven non-parametric meth-
ods of identifying EEG features and their spatial characteristics ideal for various




Electroencephalography (EEG), which measures brain electrical signals from
the scalp, is a common neuro-monitoring technique used in both clinical and re-
search settings. EEG is typically non-invasive and relatively inexpensive. For di-
agnostic purposes, EEG recordings are usually interpreted by trained professionals
through visual inspection; however, variation in visual interpretations of EEG has
been shown to account for 37% of the variance in EEG diagnoses [43]. An alternative
is to use numerical quantities computed mathematically and reproducibly from the
raw EEG. Such quantities are referred to as quantitative EEG features, or simply
qEEG.
In general, neurophysiological measurements such as qEEG have great poten-
tial as biomarkers [110]. They directly track neural population activity with high
temporal resolution, allowing for objective measurements of cognitive function and
communication between brain regions [65]. Numerous qEEG features are under
study as biomarkers for neurological and mental health disorders, including ADHD,
epilepsy, and brain injury, and for behavioral states including specific movement
intent [81], [78], [106]. Despite this increasing variety of applications with public
health importance, little is known about the consistency and variability of base-
line qEEG features in healthy individuals [129]. Because the population variance of
qEEG features could impact the efficacy of medical devices that use this information
for treatment or diagnosis, a better understanding of baseline qEEG in a healthy
population is essential.
61
Many factors other than the underlying biology may influence the values of
qEEG features. For example, features may be computed over the entire duration of
a recording, or from sliding windows, or epochs, of consecutive samples. The choice
of epoch length may influence the feature’s value; this effect is referred to as the
feature’s stationarity or time-dependence. Previous studies have investigated the
stationarity of spectral features of EEG and the influence of epoch length with up
to 109 subjects through analysis of coefficients of variation (COV) [87], [130].
In order to understand the salience of observed qEEG changes across individ-
uals or within the same individual, it is necessary to establish the consistency of fea-
tures for a single subject across multiple EEG recording sessions (i.e. intra-subject
consistency) and across subjects (i.e. inter-subject consistency). The intra-subject
and inter-subject consistency of EEG features have also been studied on a limited
number of subjects varying from 5 to 148 subjects [49], [50], [97], [96], with many
of these studies focusing only on spectral features [42], [119], [40], [39].
With the availability of big data resources, such as the Temple University
Health EEG Corpus, it is now possible to expand these types of analyses to a
larger group of subjects and examine feature consistency under noisy, less controlled,
conditions [51]. This study goes beyond previously reported consistency analyses
of qEEG features by evaluating several time- and frequency-domain features using
data from several thousand subjects to examine the stationarity and consistency of
qEEG features within and between subjects. Unlike most previous studies in which
subjects’ EEGs are recorded under known conditions, this study is retrospective
and based on a population of clinical recordings. It cannot be not known which
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activities or tasks the subjects were performing during the EEG recordings used in
this study. The features examined are therefore task-agnostic.
With data collection from wearable and even ingestible biosensors increasing
at a rapid rate, and with regulatory interest in real-world data also increasing, both
the volume of available observational biometric data and its potential utility if prop-
erly understood are growing rapidly. If these data are to be useful, it is critically
important to understand the distributions of quantitative parameters that may be
extracted from them. Human EEG data is a particularly important data type in
this regard because of its relevance to a myriad of public health challenges. In this
study, by performing analysis removed from any specific condition and with a large
population, we hoped to identify characteristics that might be more universally rep-
resentative than those observed under more controlled conditions, and thus establish
a baseline useful for interpreting future data of this type. The aim of this study is to
present novel methods of evaluating the consistency of qEEG features in a healthy
population in order to inform the efficacy of future medical products utilizing the
qEEG to treat, diagnose, or rehabilitate a patient population.
2.2 Methods











Inter- v. intra-subject consistency
Feature analysesSource data
Figure 2.1 Data processing and analysis flowchart.
2.2.1 Data set: Defining ‘normal’
Data from the Neural Engineering Data Consortium (NEDC) EEG Corpus
from Temple University Health, version 1.0.0 were used in this study. This data set
contains 23,257 EEG recording sessions (1.1TB) from 13,551 subjects. Each session
is accompanied by a fully-anonymized text file containing non-identifying patient
characteristics and clinical impressions of the EEG recordings [51]. We used custom
text-mining scripts to extract patient demographics and clinical information from
the clinical reports. Since the recordings in the NEDC database were not all acquired
with the same EEG system (Section 1.1), the channel layouts were not all consistent.
A subset of channels common across most recording sessions was identified and used
in subsequent analyses. From a standard 10-20 electrode montage, the subset of
channels used were: Fp1, Fp2, F3, F4, C3, C4, P3, P4, O1, O2, F7, F8, T3, T4,
T5, T6, Fz, Cz, Pz.
Any session with at least one recording 17 minutes or longer in length was
included in our analysis. The first minute of each recording was excluded to reduce
artifacts often present at the start of an EEG recording [123]. Our analyses were
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applied to the next 16 minutes of EEG recordings, based on recording lengths used
in subsets of the NEDC and for ease of epoching, across the 19 common channels
named above [83].
Consistent with previous EEG feature consistency studies cited, to avoid con-
founds from known EEG pathologies in the analysis of feature consistency, only
EEG recordings deemed clinically normal by a trained professional were included
in the analysis reported here. While some of the individuals presenting with a nor-
mal EEG recording may have an underlying pathology, their recordings were still
included in the analysis since the recording itself was deemed clinically normal. Sub-
group analyses of patient-specific pathologies may be addressed in future work. We
developed an automated labeling method based on textual analysis of the clinical
reports to classify the recordings as normal or abnormal. We tested our labeling
method against the results of a classification of a subset of patient sessions recently
published by the NEDC [83]. Lopez et al. reported 99% inter-rater agreement in
the classification of a subset of 3,017 sessions as clinically normal (n = 1, 529) or
abnormal (n = 1, 488). Our automated labeling method matched the NEDC clas-
sifications with 98.8% accuracy, labeling 1,510 of 1,529 normal and 1,471 of 1,488
abnormal samples correctly [94]. Applying this method to the entire NEDC data
set resulted in a total of 4,313 normal EEG recordings across 3,733 unique subjects,
which comprised the normal EEG data set used in this study (Table 2.1).
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All Recordings Subjects with two visits






Mean age 41.57±18.60, IQR=27 42.01±16.60, IQR=26
(years) (n = 4, 225) (n = 416)
Median time
N/A 324, IQR=785between visits
(days)
Note: IQR - Inter-quartile range
Table 2.1 Normal population demographics.
2.2.2 qEEG features
2.2.2.1 Pre-processing
If necessary, recordings were down-sampled to 100Hz. The data were then
filtered through a 0.5Hz to 50Hz band pass filter, and re-referenced using a com-
mon average. From this pre-processed data, a set of time and frequency domain
features (see column one of Table 2.2) were computed for each of the 19 channels
on each recording. All pre-processing and analyses were done in Python 2.7 us-
ing a combination of available packages and custom developed code (available at
github.com/dbp-osel/qEEG-consistency).
2.2.2.2 Time domain features
A set of of time domain features (Section 1.3.2) were selected based on their
use in seizure research and other EEG consistency studies [29], [50]. The following
time domain features were computed for all epoch lengths: Information theoretic
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(I.T.) features: Shannon entropy of the normalized minimum shifted signal, mean
thresholded Lempel-Ziv complexity (LZC); Statistical features: minimum value,
maximum value, median, variance, standard deviation (SD), skew, kurtosis; Signal
shape features: curve length, energy, non-linear energy, sixth power, complexity,
and mobility. Time domain features were computed on non-overlapping epochs of
7.5, 15, 30, 60, and 120 seconds across each 16 minute recording, resulting in sets of
128, 64, 32, 16, and 8 measurements per channel per recording, respectively.
2.2.2.3 Frequency domain features
In addition to the time-domain features, spectral features (Section 1.3.1) were
computed from Fourier transforms taken over the same epoch lengths. The power
spectral density (PSD) (Section 1.2) of frequency bands commonly analyzed in the
EEG were estimated using the periodogram as follows: `(lower) :< 1Hz, δ(delta) :
1 − 4Hz, θ(theta) : 4 − 8Hz, α(alpha) : 8 − 12Hz, µ(mu) : 12 − 16Hz, β(beta) :
16− 25Hz, γ(gamma) : 25− 40Hz [125]. Both absolute powers and relative powers
were computed, with relative power equal to the power in a frequency band divided
by the total power. The entropy of the normalized periodogram, spectral entropy,
was also computed using the Shanon entropy definition [14].
2.2.3 Feature epochs and sampling
As stated previously, each of the 7.5, 15, 30, 60, and 120 second epoch lengths
resulted in sets of 128, 64, 32, 16, and 8 measurements per channel per recording, re-
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spectively. To control for spurious variability effects based on number of samples, a
subset of eight measurements were used to determine stationarity, intra-subject con-
sistency, and inter-subject consistency of features using non-parametric statistical
methods. The subset of eight measurements was selected by dividing the sequence
of measurements into even eighths and choosing the first measurement of each seg-
ment, that is, choosing the nth measurement from the total of p measurements when
mod(n, p/8) = 0, where the measurement index n is taken to begin at zero.
2.2.4 Stationarity analyses
2.2.4.1 Coefficients of variation
Before computing COVs, we applied a logarithm transform to the feature
values to bring the data closer to a normal distribution [87]. The COV of the natural
log of absolute band powers were then compared across different epoch lengths for
all subjects to determine the feature’s stationarity and stability [87], [130]. COV
was computed as cv = σs/µs, where σs is the sample standard deviation and µs
the sample mean (e.g. subject : all 4,313 subjects, feature: loge(absolute θ power),
channel : Fp1, epoch: 30 seconds, samples: all 32 of 32).
2.2.4.2 Tests of similarity
To expand and test for stationarity on each feature across varying epoch
lengths, ten separate Kruskal-Wallis tests (Section 1.5) were applied to each pairwise
combination across the five epochs (e.g. 120 seconds v. 60 seconds, 120 seconds
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v. 30 seconds, etc.). For each of the 4,313 recordings, the Kruskal-Wallis test was
applied between the eight sampled measurements of the same recording for each
pair of the epoch lengths (e.g. subject : 4,313, feature: non-linear energy, channel :
Fp1, epoch: 30 seconds, samples : {0, 4, 8, 12, 16, 20, 24, 28} of 32 v. subject :
4,313, feature: non-linear energy, channel : Fp1, epoch: 60 seconds, samples : {0,
2, 4, 6, 8, 10, 12, 14} of 16). The null hypothesis of the Kruskal-Wallis test is
that the medians of group of samples are the same implying that the distribution
of the measurements are consistent. The H statistic was computed on ranks and
a p-value obtained using a Chi-Square distribution by Pr[χ2(df − 1) ≥ H], where
df = 8 was the degrees of freedom [77]. For each pairwise comparison of epoch
length, we report these results as the percentage of 4,313 recordings that were found
to have non-significant Kruskal-Wallis results, with p > 0.05, indicating that the
qEEG feature was consistent across the time series for two given epoch lengths.
2.2.5 Intra-subject consistency analysis
Intra-subject consistency of features was assessed using data from subjects
with at least two sessions (n = 419). A Kruskal-Wallis test was applied to the eight
sampled measurements obtained from two sessions for a given subject and epoch
length (e.g. subject : 419, feature: skew, channel : Fp1, epoch: 15 seconds, samples :
{0, 8, 16, 24, 32, 40, 48, 56} of 64, session: 1 v. subject : 419, feature: skew, channel :
Fp1, epoch: 15 seconds, samples : {0, 8, 16, 24, 32, 40, 48, 56} of 64, session: 2). For
15, 30, 60, and 120 second epoch lengths, we report these results as the percentage
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of 419 subjects that were found to have non-significant Kruskal-Wallis results, with
Pr[χ2(df − 1) ≥ H] = p > 0.05, where df = 8, indicating the feature tested was
consistent across sessions for a given subject.
2.2.6 Inter-subject consistency analysis
Inter-subject consistency was also assessed using the subset of measurements
from subjects with at least two sessions for 15, 30, 60, and 120 second epoch lengths
(n = 419). For each of these subjects, the data for each subjects’ second session’s
recording was replaced with data from a random subject. The Kruskal-Wallis test
was then applied as in Section 2.2.5 (e.g. subject : 419, feature: skew, channel : Fp1,
epoch: 120 seconds, samples : {0, 1, 2, 3, 4, 5, 6, 7} of 8, session: 1 v. subject :
92, feature: skew, channel : Fp1, epoch: 120 seconds, samples : {0, 1, 2, 3, 4, 5, 6,
7} of 8, session: 1). The maximum percentage across channels that were found to
have non-significant Kruskal-Wallis results, with p > 0.05, was then taken as the
level of inter-subject consistency. This process was repeated 100 times to generate
a distribution of inter-subject consistency [88].
2.2.7 Intra-subject versus inter-subject consistency analysis: Corre-
lation coefficients
A non-parametric correlation coefficient was used to determine the relation-
ship between intra-subject and inter-subject consistency of features. The absolute
Spearman correlation coefficient, r, was computed to determine the correlations of
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features based on the difference of within subject ranks and between subject ranks
[50]. Spearman correlation values range from 0 ≤ r ≤ 1, where zero implies there is
no correlation and a value of one implies a direct correlation. A single random mea-
surement for each feature from each channel for each of 15, 30, 60, and 120 second
epoch lengths was taken to represent the feature for that subject. The correlation
coefficient was then computed on the 419 subjects × 2 measurements for each fea-
ture, channel, and epoch length combination (e.g. subject : all 419 subjects, feature:
skew, channel : Fp1, epoch: 60 seconds, samples : random 1 of 16, session: 1 v.
subject : all 419 subjects, feature: skew, channel : Fp1, epoch: 60 seconds, samples :
random 1 of 16, session: 2).
There is support for defining a general threshold of moderate or high corre-
lations as above 0.5 and a negligible correlation as below 0.3 [91]. However, with
the current data set, we define a more targeted threshold for negligible correlation
coefficient by computing the correlation coefficients of session one features from a
specific subject and session two features from a random subject (e.g. subject : all
419 subjects, feature: skew, channel : Fp1, epoch: 60 seconds, samples : random 1
of 16, session: 1 v. subject : all 419 subjects shuffled in order, feature: skew, chan-
nel : Fp1, epoch: 60 seconds, samples : random 1 of 16, session: 2). This random
subject correlation can be calculated 100 times for each feature on each channel for
all epoch lengths. By taking the maximum correlation coefficient value that result
from these random correlation calculations, we can define a negligible correlation
coefficient threshold that is more representative of the data [88]. We expected that
features with higher intra-subject consistency from Section 2.2.5 than inter-subject
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consistency from Section 2.2.6 to have higher correlation coefficients while features
with similar intra-subject and inter-subject consistencies to have lower correlation
coefficients.
2.3 Results
If we ultimately seek to understand the relative utility of various qEEG features
for applications such as identifying a subject’s change in brain state or distinguish-
ing one individual from another, we must first understand the variability of these
features in a large and uncontrolled data set. This requires study of the baseline
consistency of these measurements, to inform power calculations and data collec-
tion for future studies. To assess this consistency we computed a set of features as
described in sections 2.2.2.2 and 2.2.2.3, and then performed a series of variability
and consistency assessments: stationarity, intra-subject consistency, inter-subject
consistency, and intra- versus inter-subject consistency. In all cases, non-parametric
statistical methods were used since Shapiro-Wilk’s tests indicated that the qEEG
features were not normally distributed [126].
Results for these four assessments are shown in Table 2.2. Column one lists the
30 features analyzed, grouped by type of feature. Column two shows stationarity
results as described in Section 2.2.4.2. Column three shows inter-subject results
as described in Section 2.2.5. Column four shows inter-subject results as described
in Section 2.2.6. Finally, column five shows intra- versus inter-subject similarity
through correlation coefficient results as described in Section 2.2.7. Further, Figures
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2.2b, 2.3, and 2.4 show representative examples of results in Table 2.2 graphically,
across channels.
2.3.1 Stationarity analyses
Our main strategy for examining stationarity was to make comparisons be-
tween feature distributions computed using different epoch lengths, following the
reasoning that stationary features should be independent of epoch length. How-
ever, given the unknown conditions under which the EEG data were recorded in the
NEDC database, we first sought to replicate simpler COV analyses done previously
on absolute band powers to compare those results with the larger, task-agnostic
data set.
2.3.1.1 Coefficients of variation
COVs were computed as described in Section 2.2.4.1. Figure 2.2a shows the
average cv of 81,947 EEG channels (4,313 subjects × 19 channels per subject) for
each absolute band power using 7.5, 15, 30, 60, and 120 second epoch lengths. We
found that as the epoch length increased, cv values decreased. However, as the epoch
length increased, the amount by which cv decreased was reduced. Figure 2.2b shows
the distribution cv values across all 19 channels for each of the five epoch length for a
single representative feature, absolute θ band power. The cv of the absolute θ band
power decreased quickly with increasing epoch lengths, with smaller decrements
and less variability in the cv across channels at longer epoch lengths. These results
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qEEG Features
Stationarity Intra-subject Inter-subject Intra- v. inter-subject







Relative ` Power 98.66 ± 0.85 66.95 ± 7.04 59.96 ± 4.53 0.29 ± 0.07
Relative δ Power 99.68 ± 0.22 66.23 ± 4.77 58.11 ± 4.53 0.35 ± 0.10
Relative θ Power 99.76 ± 0.27 65.39 ± 4.65 57.58 ± 4.65 0.33 ± 0.08
Relative α Power 99.85 ± 0.19 61.58 ± 5.61 45.47 ± 4.65 0.49 ± 0.05
Relative µ Power 99.84 ± 0.28 63.37 ± 5.13 51.67 ± 5.07 0.39 ± 0.08
Relative β Power 99.83 ± 0.24 59.31 ± 4.77 48.39 ± 4.24 0.43 ± 0.09
Relative γ Power 99.72 ± 0.32 61.46 ± 4.42 49.76 ± 3.34 0.40 ± 0.10
Absolute ` Power 0.00 ± 0.01 67.30 ± 4.83 60.02 ± 4.18 0.23 ± 0.06
Absolute δ Power 0.00 ± 0.00 61.34 ± 6.38 56.68 ± 5.31 0.34 ± 0.08
Absolute θ Power 0.00 ± 0.00 51.19 ± 6.74 42.00 ± 4.36 0.52 ± 0.13
Absolute α Power 0.00 ± 0.01 58.23 ± 5.13 33.77 ± 3.40 0.67 ± 0.05
Absolute µ Power 0.00 ± 0.01 57.04 ± 6.21 37.23 ± 3.40 0.57 ± 0.08
Absolute β Power 0.00 ± 0.00 58.35 ± 6.86 41.95 ± 3.70 0.56 ± 0.10
Absolute γ Power 0.00 ± 0.01 59.67 ± 6.44 51.01 ± 4.06 0.44 ± 0.12
Spectral Entropy 0.08 ± 0.14 65.87 ± 4.77 56.44 ± 4.06 0.31 ± 0.08
I.
T
. Entropy 0.00 ± 0.00 78.64 ± 5.13 73.57 ± 2.92 0.18 ± 0.08








Minimum 1.68 ± 0.37 73.03 ± 5.73 67.90 ± 4.36 0.32 ± 0.12
Maximum 1.63 ± 0.74 72.91 ± 5.79 65.75 ± 4.42 0.31 ± 0.11
Median 100.00 ± 0.00 78.16 ± 7.46 77.80 ± 4.06 0.17 ± 0.15
Variance 99.55 ± 0.48 62.65 ± 7.16 57.16 ± 5.13 0.45 ± 0.14
SD 99.55 ± 0.48 62.65 ± 7.16 57.46 ± 4.59 0.45 ± 0.14
Skew 98.31 ± 1.65 80.91 ± 6.38 78.16 ± 4.00 0.15 ± 0.10











Curve Length 0.00 ± 0.00 60.26 ± 3.94 45.70 ± 4.12 0.38 ± 0.09
Energy 0.00 ± 0.00 59.07 ± 7.58 42.78 ± 4.00 0.56 ± 0.12
Non-linear Energy 99.55 ± 0.48 62.65 ± 7.16 57.16 ± 5.01 0.45 ± 0.14
Sixth Power 99.70 ± 0.37 59.79 ± 7.82 43.20 ± 3.64 0.55 ± 0.11
Mobility 99.46 ± 0.27 61.10 ± 6.86 50.72 ± 3.64 0.35 ± 0.10
Complexity 97.75 ± 1.80 64.44 ± 5.25 52.68 ± 4.30 0.44 ± 0.12
Legend:
≤ 1% ≤ 50% ≤ 0.22
1% < ≤ 99% 50% < ≤ 75% 0.22 < ≤ 0.5
99% < 75% < 0.5 <
Note: I.T. - Information theoretic, LZC - Lempel-Ziv complexity, SD - Standard deviation
Table 2.2 Stationarity results show the median±(range÷2) across channels and all
pairwise comparisons, with highly stationary (green), somewhat stationary (yellow)
and non-stationary (red) features, as percent of subjects (n = 4, 313). Intra-subject
consistency shows the median±(range÷2) across channels and epochs, as percent of
subjects. Inter-subject consistency shows the median±(range÷2) of the max across
channels and epochs of the inter-subject distribution across 100 comparisons, as
percent of subjects. Colors in these two columns reflect the level of consistency of the
feature (n = 419). Intra-subject versus inter-subject consistency shows themedian±
(range ÷ 2) across subjects, channels, and epochs of the correlation coefficients.
Colors in this column reflect how much higher the intra-subject consistency is to
consistencies from the random distribution, maximally 0.22, and the significance of
the correlation (n = 419).
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were consistent with those previously reported [87], [130]. Having established this
baseline concordance, we proceeded to assess stationary, and intra- and inter-subject
consistency for the complete set of features.
a b
Figure 2.2 Coefficient of variation (COV) results: (a) averaged across channels for all
absolute power bands, and (b) example band with channel distribution. (n = 4, 313)
2.3.1.2 Tests of similarity
We next investigated the similarity of feature distributions when computed
from different epoch lengths. To do this we performed a series of Kruskal-Wallis
tests. Each individual test was a comparison of the distributions of a feature
computed from two different epochs. A non-significant (p > 0.05) result there-
fore indicated that, for that subject, the feature in question was not statistically
different between the two epoch lengths. The percentage of subjects with non-
significant Kruskal-Wallis test results when comparing qEEG features from varying
epoch lengths was calculated as described in Section 2.2.4.2. Representative exam-
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ples of results are presented as box plots showing the distribution of the percentage
of tests with p > 0.05 across channels for each epoch length comparison in Figure
2.3. Each panel of this figure summarizes the results for one feature (4313 subjects
× 10 pairwise Kruskal-Wallis tests). There were three main trends revealed from
the population results. For certain features, such as non-linear energy (Figure 2.3a),
we found that nearly all subjects had non-significant Kruskal-Wallis test results, in-
dicating that the computed feature did not statistically differ over different epoch
lengths and therefore had high stationarity. For other features, such as Lempel-Ziv
Complexity (shown in Figure 2.3b), Kruskal-Wallis results showed significant differ-
ences in distribution in some epoch pairs, but not others, indicating that choice of
certain epochs could modulate the distribution of this feature. Lastly, some feature
distributions, such as spectral entropy (Figure 2.3c), gave significant Kruskal-Wallis
results for all epoch pairs, indicating that the computed feature differed statistically
over all tested epoch length choices, and was therefore non-stationary. Table 2.2
provides a summary of stationarity for all analyzed features based on these three
observed trends. As a summary statistic, the median value of the percentage of
subjects for all epoch comparisons was used to categorize each feature. Features
categorized as highly stationary with a median percent of consistent subjects across
all tests greater than 99% are highlighted in column two of Table 2.2 in green. Fea-
tures with a median percent of consistent subjects between 1%-99% were categorized
as somewhat stationary and highlighted in column two of Table 2.2 in yellow. Fea-
tures with a median percent of consistent subjects less than 1% were categorized as
non-stationary and highlighted in column two of Table 2.2 in red. In general, the
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greater the time difference between the pair of epoch lengths compared, the lower
the percent of consistent subjects (Figure 2.3).
a b c
Figure 2.3 Example features for each level of stationarity: (a) highly stationary,
(b) somewhat stationary, (c) non-stationary, with box-plots showing the percent of
consistent comparisons across channels. (n = 4, 313)
2.3.2 Intra-subject and inter-subject consistency analyses
We next examined the question of whether particular features could be used
to distinguish between individuals. This would be of particular interest for features
such as non-linear energy or relative α power, that had been shown in our previous
analysis to be highly epoch-independent or stationary within an individual. Could
this within-individual consistency be used as a “marker” of individuals, or would
the same consistency be observed across individuals?
Intra-subject and inter-subject consistencies were determined by using a Kruskal-
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Wallis test for qEEG features calculated across two sessions for either the same
subject or different subjects, respectively, for various epoch lengths as described in
Sections 2.2.5 and 2.2.6. In Figure 2.4a-b, intra-subject results are displayed as a
box plot of percentage of subjects with non-significant Kruskal-Wallis tests, with
each box plot representing the distribution across channels. The distribution of
inter-subject results are shown as points on the same axes where each of the points
represent the maximum percentage across all channels of one iteration of the com-
parisons of random subjects repeated 100 times. Representative examples of the
intra-subject box plots and inter-subject distributions are shown in Figure 2.4a-b
with skew and absolute α band power.
To distinguish between different levels of consistency we establish 75% as the
high consistency threshold and 50% as a low consistency threshold based on our
observed results. Features that had the highest intra-subject and inter-subject con-
sistencies with at least 75% of the subjects with consistent features were entropy,
median, skew (Figure 2.4b), and kurtosis, highlighted in green in columns three and
four of Table 2.2. On the other hand, features with low inter-subject consistencies,
defined as those consistent across fewer than 50% of subjects, included: relative α,
β, and γ powers, absolute θ, α (Figure 2.4a), µ, and β powers, curve length, energy,
and sixth power, highlighted in column four of Table 2.2 in red. These features
were often found to have higher intra-subject consistencies, as indicated in column
three of Table 2.2. Features with moderate levels of intra-subject and inter-subject
consistencies showed between 50% − 75% of the subjects with consistent features,
highlighted in yellow columns three and four of Table 2.2. In general, the differ-
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ences between features and epochs were much larger than the differences between


















Figure 2.4 Intra-subject consistency (a)-(b): Box-pots show the percent of subjects
with statistically consistent features between two of their sessions across channels.
Inter-subject consistency: Points show the 100 iterations of the maximum across
channels of the percent of subjects with statistically consistent features with an-
other random subject. Green lines show high consistency threshold of 75% and
red lines show low consistency threshold of 50%. Correlation coefficients (c)-(d):
Box-plots show subjects’ correlation coefficient between two of their sessions across
channels. The negligible correlation threshold from the maximum correlation from
100 iterations of random comparisons, 0.22, is marked in red and the moderate to
high correlation threshold, 0.5, is marked in green. (n = 419)
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2.3.2.1 Spatial analysis of intra-subject consistency
To understand the spatial distribution of feature consistency within subjects,
these intra-subject consistency results were visualized topographically. Topographic
maps are constructed by piecewise linear barycentric interpolation from the 19 chan-
nel values [6]. Figure 2.5 shows the relative strength of channels’ median percent of
consistent subjects, across epoch lengths, for each feature. In general, the frontal
lobe showed the highest levels of correlation followed by the temporal lobe. How-
ever, relative band powers, lower frequency absolute band powers, spectral entropy
and mobility show the highest levels of consistency in the pre-frontal lobe.
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Figure 2.5 Topographies of subjects’ median intra-subject consistency across epoch
lengths. (n = 419)
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2.3.3 Intra-subject versus inter-subject consistency analysis: Corre-
lation coefficients
As Figure 2.4a-b shows, some features had high intra-subject but lower inter-
subject consistency. To quantify this difference, per-feature per-channel, correla-
tion coefficients between intra- and inter-subject consistencies were computed as
described in Section 2.2.7 and are shown in the fifth column of Table 2.2. Represen-
tative examples of the correlation coefficient distributions across channels are shown
in Figure 2.4c-d, again using skew and absolute α power as examples.
The distribution of correlation coefficients of features between two randomly
selected subjects had median± (range÷ 2) of 0.09± 0.07, with a maximum of 0.22
across all features. This maximum was thus taken to be the negligible correlation
threshold used for this data. Entropy, median, skew (Figure 2.4c), and kurtosis
showed correlation coefficients between the same subject’s sessions that were at or
below the negligible correlation coefficient threshold. These features are shown in
Table 2.2 (column five, in red). All other features had correlation coefficients be-
tween sessions of the same subject higher than the defined negligible correlation
coefficient threshold, though generally a low to moderate level of correlation. Fea-
tures where the median correlation across epochs was less than 0.5 are shown in
column five of Table 2.2 in yellow. Absolute θ, α, µ, and β powers, energy, and
sixth power are found to have correlations greater than 0.5, shown in column five
of Table 2.2 in green. An example feature, absolute α power, with correlation coef-
ficients greater than 0.5 is shown in Figure 2.4d.
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2.3.3.1 Spatial analysis of correlation coefficients
To understand the spatial distribution of feature consistency within versus
between subjects, these correlation coefficient results were visualized topographi-
cally as done in Section 2.3.2.1. Figure 2.6 shows the relative strength of channels’
median correlation coefficients, across epoch lengths, for each feature. In general,
the occipital lobe showed the highest levels of correlation followed by the central-
parietal lobe. However, spectral entropy and curve length show the highest levels of
correlation in the frontal lobe.
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Figure 2.6 Topographies of subjects’ median correlation coefficients between two of
their sessions. (n = 419)
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2.4 Discussion
The research presented here expands upon previous consistency and variabil-
ity studies by applying analyses to a much larger set of subjects. A reproducible
data-based, non-parametric, framework utilizing a publicly accessible data set was
developed to assess consistency of qEEG features.
The COV results of power spectra bands shown in Figure 2.2a have the same
trends as previously found [87], [130]. cv decreased as the epoch lengths increased
and stabilized at higher epoch lengths. The replication and expansion of these
results validated that the data followed known EEG trends with regard to features
measured on different epochs. Further expanding stationarity analysis through a test
of similarity, features’ dependence on epoch lengths were evaluated. As expected,
we found that absolute band powers were not stationary as evident from the COV
results which varied across epoch lengths. In general, we found that most features
with a normalizing constant (e.g. relative powers) were consistent across varying
epoch lengths and thus highly stationary (highlighted in column two of Table 2.2
in green). These normalizing constants include a division by overall information
about the signal, such as total spectral power or number of samples. However, some
features without a normalizing constant were also found to be stationary, such as
median, while features with a normalizing constant were found to be non-stationary
including energy. Other features were found to be less consistent as the differences
between epoch lengths increased making them somewhat stationary. In particular,
for minimum and maximum values it is thought to be more likely to find spurious
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extreme values as the epoch lengths are increased. Stationarity and epoch length
influence of features can further inform which features might be best to consider
depending on the application the feature is used in, and control over timing of
stimuli exposure and EEG recording time.
Table 2.2 shows that entropy, median, skew, and kurtosis had the highest per-
cent of intra-subject and inter-subject consistency yet low correlation coefficients.
This was expected and implies that these features were as consistent across subjects
as they were within subjects. These types of features could be useful in establishing
baseline features for a standard EEG signal and subsequently detect variations away
from those baselines. If these particular features are to be used for a given applica-
tion that requires high intra-subject consistency, for example, the results shown in
Figure 2.5 would generally indicate that measurements from frontal and temporal
areas would be most consistent. This information can be used to inform brain-
computer interface (BCI) design or provide more targeted analysis for diagnostic
purposes. Alternatively, features with significant differences between intra-subject
and inter-subject consistencies meant that the similarity and consistency of the
features were more influenced by the individual. Most spectral and signal shape
features reflect this pattern. These features would therefore be better for applica-
tions that require unique identification of individuals as well as the many machine
learning applications in EEG [27]. Our results showed that absolute band powers
had stronger correlation coefficients than relative band powers. However, previous
results showed relative band powers generally had a higher correlation than the
corresponding absolute band powers [50]. These differences may come from the dif-
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ferences between subjects’ tasks during recordings or the number of subjects used
in this study. The topographic information for channel consistency and importance
for each feature shows which areas of the brain, primarily the occipital lobe, would
best be targeted for the highest levels of correlation coefficients of each feature.
A new method of characterizing consistency of qEEG features using non-
parametric statistical tests is introduced in the current study. These ‘tests of sim-
ilarity’ applied to thousands of EEG recordings provided a sense of how similar
qEEG features are as a function of epoch length, both within and across subjects,
by looking at the percentage of subjects with non-significant statistical results. The
agreement between the COV results and our novel tests of similarity as well as
agreement between inter-subject and intra-subject analyses with the correlation co-
efficient results support this novel method in the context of previous works and
methods.
Limitations of many EEG studies may include sensitivity to the recording
environment and tasks being performed as well as the limited number of subjects
used in analysis. The current study provides a framework to analyze task-agnostic
recordings from thousands of individuals in order to assess the consistency of qEEG
features. There were several conclusions drawn from this work about the best fea-
tures to use for given applications. While the number of subjects analyzed in this
work impresses confidence in the consistency results, we cannot neglect the possi-
ble influence of recording condition and task performed. Additional work should
be done using large data sets to investigate the influence specific tasks have on
consistency of qEEG features. Alternatively, similarities would distinguish between
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features that represent baseline EEG and the individual rather than a biomarker of
specific tasks being performed. We provide the data pipeline (Figure 2.1) as out-
lined in this study so that these analyses can be applied to other potential qEEG
features on other data sets, or on larger versions of this data set. Future work
will investigate wavelet, connectivity, and spectral graph theoretic based features.
Finally, since differences between intra-subject and inter-subject consistencies can
quantify a qEEG feature’s discriminability between subjects, they may also be used
to inform feature selection in future machine learning classification applications.
2.5 Conclusion
This study addresses the knowledge gap in our understanding of the con-
sistency of qEEG measurements derived from ‘big’ data sets collected in noisy,
less controlled environments in healthy individuals. A data-driven non-parametric
framework is introduced to analyze task-agnostic EEG recordings from thousands
of individuals to assess the recording time dependence and inter- and intra-subject
consistency of thirty commonly used qEEG features. We identify qEEG features
and their spatial characteristics ideal for different EEG recording time protocols,
certain baseline qEEG comparisons, or machine learning applications. Results from
this work provide novel methods of evaluating the consistency of qEEG features in
a healthy population. These tools can be used to evaluate the potential efficacy of
qEEG features in future diagnostic and BCI applications of EEG. These results also
provide methodology for determining the consistency of novel qEEG features using
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an existing EEG data set.
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Chapter 3: Deep Learning and Feature Based Medication Classifica-
tions from EEG in a Large Clinical Data Set
Overview
This chapter presents work that has been submitted for journal publication.
Using EEG data from the Temple University Health EEG Corpus, we applied
kernel support vector machines (kSVM) and deep convolutional neural networks
(DCNN) to classify subjects’ medication status solely through EEG and compared
results from each method.
Motivation: Although research into applications of machine learning to EEG
has been underway for a decade, more work is needed to understand its limits in
deriving information that could inform clinical decisions. The ability to discern med-
ications taken by an individual through neurophysiological features alone could have
benefits in emergency medicine (e.g. determining appropriate life-saving interven-
tions), obtaining more objective and accurate medication reporting, and predicting
treatment outcome and effectiveness
Approach: We identified two medications that were prominently used by
subjects in the EEG data set, Dilantin (generic phenytoin) and Keppra (generic
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levetiracetam). We further separated subjects based on presence of EEG pathologies
to reduce confounds. Using previously evaluated EEG features we found optimal
kSVM feature-based models. We also adapted a deep learning model to 19 channel
EEG inputs for medication identification.
Application: We applied these methods to identify differences between sub-
ject’s taking anticonvulsants and no medications solely based on EEG signal (350 ≤
n ≤ 640). We obtained significant results with both kSVM and DCNN approaches.
KSVM and DCNN model obtained similar levels of accuracy on test data sets. We
found that results were more significant for subjects with abnormal EEG. Finally,
each of the two anticonvulsants studied seem to generate similar levels of discrim-
inability.
Research impact: This work provides a first step in determining the utility
of machine learning in medication-use classification based on neurological activity.
By investigating the abilities of different machine learning algorithms to differentiate
individuals taking different medications though neurophysiological signals provided
through EEG, this work is a step on the road to the broader utility of machine
learning in biomarker development.
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3.1 Introduction
Machine learning applied to medical research and treatment has the potential
to revolutionize the patient-care continuum. From diagnosis to prognosis, treatment
to rehabilitation, advanced algorithms are enabling more patient-specific care by
leveraging existing data from patients [112]. With this emerging analytical approach
nipping at the heels of medical practice, more portable, compact medical devices are
being developed to capture physiological and/or movement data from individuals
within controlled laboratory settings or in the real-world that can be used as input
in machine learning algorithms [102].
Electroencephalography (EEG) is one example of an application space with
a high potential for impact from machine learning, as this device technology is in-
creasingly being used for diagnostic and rehabilitative purposes [78] [117], and as a
surrogate biomarker for pharmacodynamic modelling of drugs [66] [4] [90]. EEG is
typically non-invasive, relatively inexpensive, and allows for direct tracking of neural
population activity with high temporal resolution for objective measurements of cog-
nitive function and communication between brain regions [125]. Although research
into applications of machine learning to EEG has been underway for a decade, more
work is needed to understand its limits in deriving information that could inform
clinical decisions. Specifically, adequate validation data sets with known subject or
patient characteristics are necessary in order to assess the accuracy and adequacy
of machine learning approaches to clinical problems. Up to the present, this ne-
cessity has limited the size of most research studies to a small number of patients.
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Fortunately, the creation of large clinical databases with both patient information
and corresponding physiological data will now enable deeper exploration of many
classification problems with clinical relevance. One such database is the Neural En-
gineering Data Consortium (NEDC) EEG Corpus from Temple University Hospital
(TUH).
The TUH corpus is an unprecedented data set composed of thousands of sub-
ject recordings collected under conditions less constrained than those typically em-
ployed in laboratory research settings [51]. It primarily consists of data from subjects
with EEG abnormalities, with many subjects taking anticonvulsant medications,
thus providing the means to explore medication state classification by evaluating
the neurophysiological signals of thousands of subjects. The ability to discern medi-
cations taken by an individual through neurophysiological features alone could have
benefits in emergency medicine (e.g. determining appropriate life-saving interven-
tions), obtaining more objective and accurate medication reporting, and predicting
treatment outcome and effectiveness [12]. Can EEG alone be used to differentiate
someone taking a certain medication from someone not taking any medication? Can
EEG alone be used to differentiate individuals taking two different medications from
the same drug class (e.g. anticonvulsants, opioids)? More generally, what types of
biomedical questions are amenable to conclusive retrospective analysis of EEG data?
With the increasing availability of large sets of clinical EEG data, we can begin to
explore these questions.
When applying machine learning, there are generally two different algorith-
mic approaches to consider: deep learning or feature-based algorithms, each with
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advantages and disadvantages. Since EEG data can be difficult to interpret, even
by experts, the automated feature extraction provided by deep convolution neural
network (DCNN) learning models may be advantageous and require less knowledge
about the data set and signal to perform well [27]. When expert knowledge about
the data and signals are available, application-specific features can be crafted and
used in a feature-based approach such as kernel support vector machines (kSVM).
Feature-based methods have been shown to perform well in EEG applications and
to produce consistent results [84] [19]. Thus, to determine potential differences
in classification performance and impact on understanding the underlying clinical
implications, both feature-based and deep learning models were investigated and
compared as previously done in novel classification paradigms[76] [107] [133].
The goals of this work were to (1) determine if machine learning can predict
medication states from neurophysiological activity captured through EEG and (2)
compare the accuracy of feature-based and deep learning classification methods. By
investigating the abilities of different machine learning algorithms to differentiate
individuals taking different medications though neurophysiological signals provided
through EEG, this work is a step on the road to the broader utility of machine
learning in biomarker development.
3.2 Methods
To investigate the different medication-based classifications, we applied sev-
eral processing steps to EEG data obtained and corresponding clinical reports from
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the NEDC EEG Corpus from TUH, version 1.0.0 (Fig. 3.1). This data set con-
tains 23,257 EEG recording sessions (1.1TB) from 13,551 subjects with a total of
61,802 recording files. Each session was accompanied by a report containing clinical
impressions and patient characteristics, including age and sex, as well as the medi-
cations being taken by the patient at the time of recording [51]. The pre-processing
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Figure 3.1 Data processing and classification flowchart.
3.2.1 EEG data
Since the recordings in the NEDC database were not all acquired with the
same EEG system, the channel layouts were not all consistent. A subset of channels
common across most recording sessions was identified and used in subsequent anal-
yses. From a standard 10-20 electrode montage (Section 1.1), the subset of channels
used were: Fp1, Fp2, F3, F4, C3, C4, P3, P4, O1, O2, F7, F8, T3, T4, T5, T6, Fz,
Cz, Pz. Any recording that did not include all of these channels was omitted from
analysis.
Recordings without at least one recording six minutes in length were omitted
from analysis. The first minute of each recording was excluded to reduce artifacts
present in the EEG [123]. Our analyses were applied to the next five minutes of
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EEG recordings across those 19 channels identified above [83]. If another sampling
rate was used, recordings were down-sampled to 100Hz. The data were then filtered
through a 0.5Hz to 50Hz band pass filter, and re-referenced using a common aver-
age. All pre-processing and analyses were done in Python using a combination of
available packages, published code from previous works, and custom developed code
[105] [123].
3.2.2 Classifications: Defining subject populations
A subset of patient clinical reports within the NEDC data set had been pre-
viously reviewed and labeled by curators of this database to be clinically normal or
abnormal [83]. The definitions of normal and abnormal used by the NEDC generally
followed methods neurologists use to identify abnormalities [86]. These labels were
applied broadly to recordings where the clinical reports identified an abnormality
in the EEG and do not distinguish between different abnormalities. An automated
labeling method previously developed and validated based on textual analysis of
the clinical reports was applied to categorize all available recordings as normal or
abnormal [95]. Applying this method to the entire NEDC data set resulted in a
total of 6,001 EEG recordings with normal EEG across 4,058 unique subjects and
15,347 EEG recordings with abnormal EEG across 7,432 unique subjects.
Given the majority of clinical recordings from this data set were focused on
diagnosing or monitoring individuals with epilepsy or seizure disorders, our medi-
cation classification focused on anticonvulsants. An initial textual analysis of the
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clinical notes for each EEG recording revealed hundreds of individuals taking the
drugs Dilantin (generic name phenytoin) or Keppra (generic name levetiracetam),
which are categorized as anticonvulsants [146]. For the purposes of this study, the
clinical notes were used to determine which subjects were taking either Dilantin or
Keppra, and which subjects were taking no medications. Any subject with more
than one medication listed in the clinical notes was excluded from the evaluation
to reduce results related to drug interaction effects. Furthermore, given the clinical
nature of the data set and to avoid confounds from normal and abnormal EEGs,
these classifications were performed separately on subjects with normal EEG and
abnormal EEG.
Overall, six (three medication states × two EEG pathology states) different
classifications were defined and analyzed using these data with two different machine
learning approaches. The population demographics of the entire data set used and
each group of subjects are shown in Table 3.1.
All recordings Taking Dilantin Taking Keppra No medications
Total n 35,370 718 898 5,1815
Normal EEG 6,001 179 175 1,203
Abnormal EEG 15,347 320 264 1,285
EEG status not obtained 14,022 291 459 2,693
Male 15,106 344 378 2,017
Female 16,434 320 465 1,895
Sex not obtained 3,830 54 55 1,269
Age (Mean ± SD years) 50.23±19.15 41.14±18.38 48.04±18.98 44.55±20.11
(# recordings w/ age) (n = 33, 021) (n = 692) (n = 862) (n = 4, 142)
Unique subjects 13,486 456 507 2,530
Table 3.1 Population demographics across all medications of interest and no medi-
cations.
Pre-processed data were linked to medication labels extracted from their cor-
responding clinical reports for two machine learning approaches, described below.
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We note that other patient demographics (age and sex) were well balanced across
all populations investigated.
3.2.3 qEEG feature-based classifiers
qEEG features
From the pre-processed data, a set of time and frequency domain features
(Section 1.3) were computed for each of the 19 channels on each recording. qEEG
features used in this study were found in EEG literature and previously analyzed for
inter- and intra-subject consistency [29] [50] [95]. Time domain features were com-
puted on each five-minute recording. For spectral features, the Fourier transforms
were taken on the five-minute pre-processed recording after which various spectral
features were computed.
The power spectral density (PSD) (Section 1.2) of frequency bands com-
monly analyzed in the EEG were estimated using the periodogram. The ranges
of the frequency bands applied in this study were as follows: δ(delta) : 1 − 4Hz,
θ(theta) : 4 − 8Hz, α(alpha) : 8 − 12Hz, µ(mu) : 12 − 16Hz, β(beta) : 16 − 25Hz,
γ(gamma) : 25 − 40Hz [125]. Both absolute powers and relative powers were com-
puted, with relative power equal to the power in a frequency band divided by the
total power. The entropy of the periodogram, and entropy of the normalized peri-
odogram, were found using the Shanon entropy definition [14]. In addition to the
spectral features, the following time domain features, directly from the pre-processed
EEG signal, were computed: entropy of the normalized signal, mean thresholded
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Lempel-Ziv complexity (LZC), curve length, energy, non-linear energy, sixth power,
minimum value, maximum value, median, variance, standard deviation, skew, kur-
tosis, integral, sum, mobility, complexity. The frequency and time domain features
selected resulted in a total of 570 features per recording (30 features × 19 channels).
3.2.3.1 Kernel support vector machine classifiers
Features were transformed using max normalization [132] [32]. The max
normalization transform was applied to the data by finding the mean and maximum
value of each feature across all subjects in the training data. Each value, in both the
training and testing data set, was then subtracted by the mean and divided by the
maximum values obtained from the corresponding training set. This transformation
scaled each feature to a range of values between zero and one in the training data
and approximately between zero and one in the testing data set.
A grid search was used to determine optimal dimensionality reduction method,
kernel, and hyperparameters for the kSVM classifier (Section 1.7.1). A grid search
on 500 different combinations across: (1) dimentionality reduction methods ={PCA,
K-best}, (2) number of features used = {30, 60, 90, 120, 150}, of the available 570
features, (3) kernel ={linear, radial basis function (RBF)}, (4) the penalty pa-
rameter C = {0.1, 1, 10, 100, 1000}, and (5) the RBF smoothness parameter γ =
{0.1, 0.01, 0.001, 0.0001, 0.00001}, was performed for each classification [105]. This
training and grid search was done on another 10-fold cross validation to tune the
feature-based model using a validation set extracted from the initial training data
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set, independent from the testing set.
3.2.4 Deep convolution neural network EEG classifiers
We used a variant of a DCNN model (Section 1.7.2), introduced in previous
research shown in Figure 3.2, which was applied to the abnormal TUH data set
[123] [83]. The model used required 279, 525 weights to be trained, which were
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Figure 3.2 Deep convolutional neural network architecture. Convolutions are shown
in yellow and all have stride 1x3, across the temporal dimension. Max pool layers
are shown in green. The classification is determined by the class with the highest
output probability.
exponential linear unit (ELU) function [23]. ELU is a strong alternative to the
commonly used rectified linear unit (ReLU) function since it can generate negative
outputs and decreases smoothly and slowly until its output equals the parameter
value. The network also applies batch normalization and dropout of 0.5 with each
convolution and pooling pair [61] [131]. This neural network was optimized though
the stochastic gradient descent inspired Adam algorithm [74]. The architecture used
was similar to ResNet DCNN, which has been shown to be an effective neural net-
work architecture for automated feature extraction [54]. The first convolution and
pooling pair was different from those used in most deep learning models because of
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the structure of EEG data. The two-step convolutional sequence in the first two
convolution and pooling pairs is inspired in part by the filter-bank common spa-
tial pattern (FBCSP) algorithm [80] [3] [21]. Since EEG data is a collection of
one-dimensional signals rather than a two-dimensional array where the dimensions
are coupled, such as an an image, the first convolution was applied to each channel
separately, across time. The subsequent convolution then uses this result to ap-
ply a convolution on the resulting feature maps and channel collection, over time.
Afterwards, three additional convolution and pooling pairs can be applied to the
resulting feature-maps in a more traditional fashion. The final layer takes the final
feature-map and applies a dense neural network with a softmax non-linearity to
obtain prediction probabilities for each class. The class with the highest probability
is the class determined by the deep network.
The model was trained for 35 epochs for a first run and then restarted for
a second run based on the epoch model with the highest training accuracy among
the epochs from the first run. The second run’s stopping condition was based on a
specified training loss to be met based on the first run’ results. A validation set was
taken from 10% of the training set, independent of the testing data, for 10-fold cross-
validation for model tuning. The application was run on an NVIDIA GTX-1080Ti
for training and subsequent testing through Python 3.5 and Torch [123] [98].
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3.2.5 Classification results and significance
For each binary classification, an equal number of subjects from each popu-
lation was used to ensure equal prevalence of each condition. 90% and 10% of the
data were assigned randomly to a training and testing set, respectively. This process
was repeated ten times to obtain classification test results using different subsets of
the data for a 10-fold cross-validated set of results. To measure the significance of
the results, we randomly assigned medication-status labels to the training data and
again obtained ten cross-validated test set classifications based on random group
labels. We compared the test set accuracy results of the ten models using true la-
bels and ten models using randomly labeled training data with a non-parametric
Kruskal-Wallis test (Section 1.5) to determine the true labels’ significance [77]. We
used thresholds of P < .01 and P < .001 as two levels of significance. If the true la-
bel test results were similar to the random label results and non-significant P -values
were found, the labels were considered to be non-informative in the classification
task.
3.3 Results
We report our classification results in Table 3.2 from feature-based kSVM and
deep learning DCNN classifiers on different medications for both normal EEG and
abnormal EEG populations. We report the mean and standard deviation of the 10-
fold cross validation test accuracy results as a way to represent how the method best
generalized on unseen data. We further report the P-value from Kruskal-Wallis tests
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between the test results obtained from the true data labels and randomly labeled
training data.
Classification n-total (n-test)
kSVM % DCNN %
(P -value) (P -value)
Dilantin vs. Keppra
350 (34)
51.18± 4.96 59.12± 7.49
with Normal EEG (P < .790) (P < .061)
Dilantin vs. Keppra
528 (52)
59.23± 6.25** 60.39± 5.03
with Abnormal EEG (P < .001) (P < .021)
Dilantin vs. No medications
358 (34)
67.50± 7.86** 64.12± 8.19*
with Normal EEG (P < .001) (P < .002)
Dilantin vs. No medications
640 (64)
68.91± 7.18** 68.75± 6.29**
with Abnormal EEG (P < .001) (P < .001)
Keppra vs. No medications
350 (34)
60.88± 4.17** 64.71± 6.31*
with Normal EEG (P < .001) (P < .002)
Keppra vs. No medications
528 (52)
70.00± 4.14** 68.85± 6.87**
with Abnormal EEG (P < .001) (P < .001)
Table 3.2 Mean ± Standard deviation percent test classification accuracies and
significance (P-value) for kSVM and DCNN results for six different classifications. n-
total represents all subjects used in training and testing while n-test were number of
subjects used exclusively for testing. Kruskal-Wallis P -value significance thresholds
set at: *: P < .01, **: P < .001.
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n.s. - p < .880* - p < .006
* - p < .009
n.s. - p < .649* - p < .010
* - p < .002
n.s.
n.s. n.s.
Classification results of subjects with abnormal EEG
kSVM
DCNN
Figure 3.3 Statistical comparison of kSVM and DCNN results for subjects with
abnormal EEG recordings. Kruskal-Wallis test P -value significance thresholds set
at: *: P < .01, **: P < .001, or n.s.: not significant.
Results show that the kSVM and DCNN models models yielded similar levels
of accuracies for all classifications. On average, the accuracy across all classifica-
tions with DCNN models were 1.37% higher than the kSVM models. Non-significant
results were generally observed when comparing individuals taking Dilantin vs. indi-
viduals taking Keppra (rows 1 & 2 in Table 3.2). However, kSVM models classifying
subjects with abnormal EEGs taking Dilantin vs. those taking Keppra did find sig-
nificant results. For kSVM models comparing individuals taking Dilantin versus
individuals taking no medications or individuals taking Keppra versus individuals
taking no medications, the classification accuracy and significance of the result gen-
erally increased. With a threshold of P < .01, classifications from our DCNN models
comparing only Dilantin versus Keppra were not found to be significant, P < .061
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for subjects with normal EEG and P < .021 for those with abnormal EEG. For our
kSVM model results, all results except for subjects taking Dilantin or Keppra with
normal EEG, P < 0.790, were found to be significant with P < .001. We also note
that the standard deviation of the kSVM results were, on average, 0.94% smaller
than those from the corresponding DCNN models.
From these results we see that the classification accuracies from the kSVM
and DCNN models of subjects with abnormal EEG were highest (rows 2, 4, and
6 in Table 3.2). To better assess discriminability of these classifications from the
abnormal EEG data set, an isolated statistical test was performed using the vectors
of classification accuracies from the 10-fold cross validation. Figure 3.3 shows the
results of a Kruskal-Wallis test between these three classifications. The results of
this additional statistical test showed the two anticonvulsants had the same levels
of discriminability since no significant difference was found between subjects taking
Dilantin vs. subjects taking no medications and subjects taking Keppra vs. sub-
jects taking no medications (P < .649 for kSVM models and P < .880 for DCNN
models). However, the accuracies from abnormal EEG recordings of subjects taking
Dilantin vs. subjects taking Keppra were significantly different from both accuracies
of subjects taking Dilantin vs. subjects taking no medications and subjects taking
Keppra vs. subjects taking no medications (P < .01) (Fig 3). Finally, we see that
for each classification with abnormal EEG, the kSVM and DCNN classification re-
sults were not significantly different, all P > .62. The implications of these results
are discussed in the Discussion section.
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3.4 Discussion
The goals of the current study were to (1) determine if machine learning could
predict medication state solely from EEG and (2) compare the accuracies of feature-
based and deep learning classification methods. A very limited number of previous
studies have looked at neurological marker differences using EEG between different
anticonvulsant medications in order to assess the impact of the drugs on cognitive
performance and neurological patterns [90]. To our knowledge, at the time of this
publication, this study presents the first aiming to distinguish different anticonvul-
sant medications taken by patients using solely neurological activity though machine
learning methods.
We first discuss the ability of advanced machine learning algorithms to classify
the medication taken using only neurophysiological activity data. To better under-
stand the clinical implications, we compare results using abnormal EEG which were
the most significant classification results. Though there were no significant dif-
ferences in classification accuracies between subjects taking Dilantin vs. subjects
taking no medications and subjects Keppra vs. subjects taking no medications,
there were significant differences in accuracies comparing each of the anticonvul-
sants vs. subjects taking no medications and the classification results of subjects
taking Dilantin vs. subjects taking Keppra (Figure 3.3). Our comparisons of the
cross-validated results imply that the clinical effects of Keppra and Dilantin on
neural activity on subjects with abnormal EEG produced similar levels of discrim-
inability to those not taking any medications. This is not an unexpected result
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given that both of these drugs are from the same class, anticonvulsant. Dilantin’s
(phenytoin) mechanism of action, like most anti-epileptic drugs, is believed to act
by limiting bursts of neuronal activity via blockade of sodium channels that give
rise to the action potential [115]. However, Keppra’s (leviracetam) mechanism of
action is less understood but believed to act through binding to the synaptic vesicle
protein SV2A, resulting in reduced vesicle release [2]. Since anti-convulsants would
be prescribed with the intent of reducing seizure activity, and since seizure activity
has visible macroeffects in the EEG, it is not unexpected that they might show sim-
ilar levels of discriminability. Though discriminability of each of the anticonvulsants
versus subjects taking no medications were similar, further investigation would be
needed to determine if the same differences were found for both medications.
Since the two medications used in this study are anticonvulsant drugs, with-
out controlling for the clinical impression of the EEG, classifications found may have
been based on the EEG pathology state rather than the differences in medications.
By performing classifications on each group of subjects separately, we ensured that
results found were not based on the presence of visible EEG abnormalities. Com-
paring the abnormal and normal EEG recordings, the abnormal EEG populations
tests outperformed the normal EEG populations across all medication comparisons.
This result is logical considering the medications investigated are intended to treat
those with abnormal EEGs and the expectation is that these drugs would have
a more prominent effect on those with abnormal EEGs recorded. While in the
case of diagnosis, having the highest classification accuracy may be desirable, for
medication classification, a better understanding of brain rhythms and neurological
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characteristics that separate the two populations may lead to better targeted drug
therapies. The classification accuracies obtained in this study, all at or below 70%,
do not achieve levels usually found in diagnostic applications [127]. However, they
do provide promising results of a potential avenue for inexpensive, non-invasive,
and more efficient methods to determine different neurological effects from drugs.
Recently several large pharmaceutical manufactures have obtained approval to mar-
ket existing medications for new uses using real-world data by analyzing medical
records of subjects’ who had taken those medications [128] [82]. These type of
retrospective analyses combined with methods used in this study have the potential
to accelerate the evaluation of safety and effectiveness of medications drastically by
avoiding sometimes lengthy drug trials. Furthermore, several factors suggest that
the present results may represent a lower bound on future classification performance
with data of this type. These factors include continual increases in EEG resolution,
electrode technology, and denoising techniques since the time that many of the TUH
recordings were made, as well an expected manifold increase in the data available.
We discuss next the different machine learning algorithms and the advantages
and disadvantages of each for this application. In the current study we obtain novel
classifications for patient populations in the NEDC data set based on medications
taken. Recent works have begun to focus on comparing different machine learning
methods in pharmaceutical research but there are still gaps in this area [76]. This
work addresses one such gap, namely the relative performance of feature-based and
deep learning model approaches. When compared to classification accuracies with
randomly assigned medication status labels, we found significant results (P < .01)
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for deep learning classifications comparing subjects taking either one of the anti-
convulsants against subjects taking no medications. For our feature-based classi-
fications we found significant classifications (P < .01) for all classifications except
normal EEG recordings of subjects taking Dilantin vs. subjects taking Keppra, and
comparing abnormal EEG recordings of subjects taking Keppra vs. subjects taking
no medications. The kSVM classification accuracies were comparable to the DCNN
classification accuracies, though on average slightly lower. Further, the standard
deviations of the kSVM models were lower than the corresponding DCNN model
results. This was expected given the stochastic nature of the optimization of DCNN
models that produce larger variation in the cross-validated results in contrast to
kSVM’s more deterministic approach. We also found that certain kSVM models
yielded lower P -values than corresponding DCNN models, sometimes with lower
cross-validated classification accuracies. Therefore, we see that the DCNN models
were able to obtain accuracy percentages using random labels closer to results ob-
tained from correctly labeled data. Given the automated nature of DCNN feature
extraction and recently proven efficacy in complex data sets, DCNN models are
expected to be able to find patterns where labels are non-informative [27].
Both machine learning methods yielded significant and generally comparable
results. To understand the clinical relevance of these classifications and medica-
tion effects on neural activity, investigation into what characteristics of EEG are
important to these classifications would be important. There are several well es-
tablished methods available to identify important characteristics in feature-based
classifications [85]. Some of these methods were applied in this study along with
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cross-validation to identify subsets of features that performed best in kSVM models.
Future work may investigate which specific features were chosen in these classifica-
tions and their clinical implications. However, with respect DCNN classifications,
the nature of these models limit our understanding of the important features in
EEG when making classifications since the thousands, sometimes millions, of the
features identified in the deep learning architecture remain a “black box”. This is
in stark contrast to the discrete number of known features used in feature-based al-
gorithms. Methods to investigate deep learning models have mainly been developed
in the image processing space but have rarely been used in EEG [22]. However,
recently, neurological differences between sexes and EEG pathologies have been in-
vestigated by attempting to understand what deep learning models distinguished
using subjects’ EEGs [138] [123]. Expanding available methods of investigating
deep learning models using EEG would benefit understanding the underlying neu-
rophysiological differences. Further research in explainable artificial intelligence to
classifications investigated in this work, two anti-epileptic drugs with similar target
patient populations, may better inform pharmacodynamic models.
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Chapter 4: Easy Perturbation EEG Algorithm for Spectral Impor-
tance (easyPEASI): A simple method to identify impor-
tant spectral features of EEG in deep learning models
Overview
This chapter presents work that has been submitted for publication as a con-
ference proceeding.
We developed a novel method of identifying frequency band importance in
EEG-based deep learning classifications and applied this method to EEG data from
the Temple University Health EEG Corpus.
Motivation: Recently deep learning, specifically deep convolutional neural
networks (DCNN), have shown state-of-the-art results and superb effectiveness in
EEG applications. Deep learning models have found such success in part because
it introduced automated feature extraction as part of the end-to-end algorithm.
However, in clinical applications, it may be vitally important to understand the
underlying mechanisms of what was automatically learned by the deep learning
models.
Approach: We obtained trained DCNN models on data to identify groups
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between populations. We applied frequency domain perturbations to training data
in a simple yet novel way. We next observed changes in accuracies of training
models with new perturbed data. Greater drops in accuracy indicated frequency
band importance.
Validation: We validated this method by identifying important neurological
differences when classifying EEG pathologies. Results from this method concurred
with previous findings using the same data set.
Application: We applied this method to a new application by identifying
differences between two anticonvulsants, Dilantin (generic phenytoin) and Keppra
(generic levetiracetam), and their individual effects on neural activity (350 ≤ n ≤
640). We found that for subjects with normal EEG that these drugs effected the
Alpha band most significantly but likely did so differently. For subjects with abnor-
mal EEG, we found that both medications affected the Delta band when compared
to non-medicated subjects. However, again these bands seemed affected differently
when comparing subjects taking one of these medications. We also found the Beta
band to be affected differently by the two medications.
Research impact: Results show promise for a method of obtaining explain-
able artificial intelligence to identify important frequency bands from EEG-driven




Deep learning has recently propelled the field of machine learning to new
heights. More traditional machine learning models required domain experts to engi-
neer quantitative measurements, or features, which represented the data in meaning-
ful ways. However, deep learning models have introduced automated feature extrac-
tion as part of the end-to-end algorithm. By combining the automation of feature
extraction and classification, more tailored features of the data that separate groups
defined in a classification problem can be found. In applications whose primary
objective it is to obtain the highest level of classification, these methods have led
to state-of-the-art results without an understanding of what patterns were learned
from the data [123]. However, in clinical applications, it may be vitally important
to understand the underlying mechanisms of what was automatically learned by the
deep learning models [37]. Take, for example, a case in which physiological signals
acquired from a patient population and a healthy population are applied to a deep
learning model and used for disease detection or diagnosis. By understanding the
underlying physiological differences between populations classified by deep learning
models, it is possible to discover potentially new biomarkers of disease or elucidate
the progression and impact of a disease on those physiological functions.
Electroencephalography (EEG) is one modality that captures such physiolog-
ical signals and is used both in research and clinical settings to detect or diagnose
medical conditions [125]. EEG measures brain electrical signals from the scalp in a
typically non-invasive and relatively inexpensive way and has been shown to be a
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promising neuro-monitoring technique to identify a wide range of neuro-physiological
biomarkers for many different diseases [78]. However, EEG presents complex data
that has a low signal to noise ratio (SNR), thus making the data difficult to interpret.
More difficult yet is understanding how to best quantify EEG using complex signal
processing and mathematical methods. Because of these challenges, deep learning
has recently shown promising results using EEG directly as input to distinguishing
individuals based on neurological activity. However, only about one quarter of these
studies investigate the underlying physiological implications on which these models
are based [117].
Much like the early development of deep learning models, methods to under-
stand and visualize these models have mainly developed and focused in the image
processing domain [145]. With the adoption of these models to EEG, some of these
investigation methods have also been adapted. The most common method of model
inspection analyzes model weights learned. These analyses are usually limited to
the first layer of the model because of the limited interpretability of subsequent filter
layers [138]. Another common approach has been to investigate the model activa-
tions on representative inputs [120]. Additionally, the ideas of input perturbation
and input occlusion have been explored in limited context [117]. Using established
EEG-based deep learning models, an input-perturbation network-perturbation cor-
relation map technique was developed. These methods combine both input pertur-
bation and model weight analysis to determine the correlation between input and
network characteristics [123]. When applying occlusion-based methods in image pro-
cessing, parts of the input image are occluded and the effect on the network output
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is analyzed to determine the most important area of the image to the model. Some
research in analyzing EEG-based deep learning models have generated images that
represent the EEG and subsequently applied occlusion methods on those images
[135]. Although previous research is promising and allows for better understanding
learned features in deep learning models, most of these methods require in depth
analysis of model parameters or activations and can be difficult to interpret. Given
the widespread application of deep learning in many different fields and the poten-
tial for interpretation by individuals who do not have expert knowledge in these
models, the development of a simple, easily interpretable, automated method that
manipulates EEG directly to determine important learned EEG features from deep
learning models is needed.
This work seeks to address this need and expand upon previous methods by
applying perturbation methods in image processing applications to EEG directly.
There is a long history of analyzing frequency bands in EEG to understand underly-
ing neurological mechanisms and most work in EEG has focused on understanding
frequency bands of importance [99]. We introduce a novel method of applying
frequency domain perturbations to EEG to understand how important specified fre-
quency bands are on the identifying populations based solely on EEG. The ability
to decipher important features in the EEG has many potential applications. Specifi-
cally, deep learning can been used to identify subjects’ medication status, specifically
anticonvulsant medications. To develop more informative EEG based pharmacody-
namic models, it is important to determine which, if any, specific frequency bands
are the underlying bases for the differences in anticonvulsant effects.
115
The aims of this work are to (1) introduce a novel, simpler input perturbation
method for deep-learning classification problems that allows for the determination of
important frequency band features in a clinical application, (2) validate this novel
approach by comparing those features identified as important between our novel
approach and other established approaches, and (3) apply our proposed method to
patient medication status classification problems to determine which EEG frequency
bands are important in distinguishing individuals taking different anticonvulsant
medications or individuals taking no medications.
4.2 Methods
We first introduce the novel algorithm and applied statistical methods to de-
termine important frequency bands for a given classification problem. We next
describe the specific deep learning model used to validate the novel method and the
EEG data set used for validation and application of the novel method.
4.2.1 easyPEASI: Easy Perturbation EEG Algorithm for Spectral
Importance
At a high level, the proposed easy perturbation EEG algorithm for spectral
importance (easyPEASI) is shown visually in Figure 4.1. easyPEASI requires that k-
fold samplings of the EEG data and associated labels be obtained. These k sub-sets
are used to train k binary classification deep learning models. With input data in the























Figure 4.1 easyPEASI flowchart. Blue semi-rounded items represent pre-computed
elements, purple rectangular items are intermediate elements, orange rounded items
are intermediate results, and the green circle represents the last step and result.
Elements in dotted area are repeated for each 1, 2, . . . k samplings.
is to identify important frequency bands that distinguish the labeled data. This is
accomplished by introducing perturbations (i.e. noise) to the recordings to specific
frequency bands for all recorded channels for each subject. Entire frequency bands
were analyzed rather than each individual frequency since these bands have known
clinical meanings and power within each band may not be equally and consistently
distributed across all frequencies for all recordings. Investigating single frequencies
may also smear results when analyzing results across many recordings and obscure
meaningful insights.
Using the Discrete Fourier Transform (DFT) for a real-valued signal, rFFT
(real Fast Fourier Transform) of EEG[channel],
Ω = rFFT (EEG[channel]) =
[y[0],Re (y[1]), Im(y[1]), . . . ,Re (y[n/2])] , n even













for j = {0, . . . , n− 1}, we obtain the frequency domain representation of
EEG[channel] [141].
The central manipulation in easyPEASI of the EEG data is the replacement of
the real and complex DFT coefficients of the targeted frequency band (Section 1.2)
in line 6 of the PerturbEEGBands function. These coefficients are replaced with
random numbers generated from a Normal distribution, N (µ, σ), where µ and σ are
the mean and standard deviation (SD), respectively, of the real and complex DFT
coefficients of Equation (4.1) in the targeted frequency band. Once replaced the
inverse DFT, irFFT (inverse rFFT), is computed to obtain the final perturbed EEG
channel. This specific spectral manipulation affects the spectral power dynamics
within the frequency band, the phase coupling of the frequencies within the band
and with other frequencies, and the non-stationarity of the frequencies in the band
present in signal.
From this we describe the steps for our proposed method. Two parameters
of choice that further need to be defined are frequency bands of interest and the
number of k-fold data samplings. The frequency bands commonly analyzed in the
EEG are as follows: δ (Delta) : 1− 4Hz, θ (Theta) : 4− 8Hz, α (Alpha) : 8− 12Hz,
µ (Mu) : 12 − 16Hz, β (Beta) : 16 − 25Hz, γ (Gamma) : 25 − 40Hz [125]. These
frequency band bounds were used as the f Low and f High for each subject’s EEG
data as the inputs to the perturbation function, defined in Line 3 in easyPEASI.
Further, we used a k = 10−fold cross-validation factor implementing this algorithm.
In our outline of easyPEASI below, boldface is used for keywords, italics represent
functions, underlined italics functions that are defined as part of easyPEASI, and
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all others are variables.
From the k-fold cross-validated set of results we are then able to apply statisti-
cal methods. The training results are reported by the mean and standard deviation
of the k training results, TrainAcc in line 6 of the BandImportance function. To
measure the significance of each frequency band we obtained k cross-validated clas-
sifications from the trained models of the perturbations applied training data. Next,
the training accuracy results of the k original and k perturbed results are compared
by measuring the difference between the mean results, ∆ in line 8 of the BandIm-
portance function. Finally, a Kruskal-Wallis test (Section 1.5) is used to determine
the statistical significance of the difference between sets of accuracy, P in line 9
of the BandImportance function [77]. Though k = 10 was used here, other values
k > 5 can be used to meet Kruskal-Wallis test requirements. The null hypothesis
of the Kruskal-Wallis test is that the medians of group of samples are the same
implying that the distributions of the measurements are consistent. The H statistic
was computed on ranks and a P -value obtained using a Chi-Square distribution by
Pr[χ2(df − 1) ≥ H], where df = k is the degrees of freedom. Therefore, if the
perturbed data classification results were not similar to the original training classifi-
cation results and significant P -values were found, then the effect of the perturbation
on the frequency band was informative and important in the classification task. We
used thresholds of P < .01 and P < .001 as varying levels of significance, though
other P -value thresholds could be used.
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Algorithm easyPEASI: Easy perturbation EEG algorithm for spectral importance
1: function PerturbEEGBands(EEG,F Low,F High)
2: for channel ∈ EEG do
3: Ω← rFFT (EEG[channel])
4: µ← Mean(Ω[F Low,F High])
5: σ ← SD(Ω[F Low,F High])
6: Ω[F Low,F High] ← N (µ, σ)
7: EEG[channel] ← irFFT (Ω)
8: return EEG
1: function BandImportance(k,F Low,F High)
2: for i ← 0 to k − 1 do
3: EEG, Labels ← LoadTrainData(i)
4: Model ← LoadTrainedDeepModel(i)
5: PerturbedEEG ← PerturbEEGBands(EEG,F Low,F High)
6: TrainAcc[i] ← EvalModel(Model,EEG,Labels)
7: PerturbAcc[i] ← EvalModel(Model,PerturbedEEG,Labels)
8: ∆← ‖Mean(TrainAcc) − Mean(PerturbAcc)‖
9: P ← KruskalWallisTest(TrainAcc,PerturbAcc)
10: return P, ∆
1: procedure easyPEASI( )
2: k ← 10 . k-fold samplings
3: BandFreqLim ← [1,4,8,16,25,40] . Hz
4: for b ← 0 to length(BandFreqLim)−2 do
5: F Low ← BandFreqLim[b]
6: F High ← BandFreqLim[b+1]
7: P, ∆← BandImportance(k,F Low,F High) . Results
4.2.2 Trained deep convolutional neural network
As discussed, easyPEASI requires that trained EEG-based deep learning model
and corresponding labeled training EEG data be available. We used a variant of
a deep convolutional neural network (DCNN) model (Section 1.7.2) introduced in
previous research and further modified for data used in this study (Section 4.5)
[123]. For each binary classification, population groups were evenly balanced with
recordings from each of the two labels. This was done so that there would be equal
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All recordings Normal EEG Abnormal EEG
Total n 35,370 6,001 15,347
Normal EEG 6,001 6,001 0
Abnormal EEG 15,347 0 15,347
EEG status not obtained 14,022 0 0
Male 15,106 2,371 7,088
Female 16,434 3,222 7,289
Sex not obtained 3,830 408 970
Age (Mean ± SD years) 50.23±19.15 41.14±18.38 52.90±19.04
(# recordings w/ age) (n = 33, 021) (5, 865) (n = 15, 027)
Unique subjects 13,486 4,058 7,432
Table 4.1 Population demographics of data set across recordings with EEG pathol-
ogy status.
prevalence of each condition. 90% of the available data were randomly sampled and
used to train the DCNN (line 2 in Train Deep Models). This process was repeated
k times to obtain k trained models using different random sub-sets of data. The
application was run on an NVIDIA GTX-1080Ti for training through Python 3.5
and Torch [123], [98].
Algorithm Train Deep Models
1: k ← 10 . k-fold samplings
2: Ratio ← 0.9 . Training set proportion
3: Data,Labels ← LoadData()
4: for i ← 0 to k − 1 do
5: TrainData,TrainLabels ← SampleData(Data,Labels,Ratio)




EEG data from the Neural Engineering Data Consortium (NEDC) EEG Cor-
pus from Temple University Hospital (TUH) version 1.0.0 were used as input to the
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Taking Dilantin Taking Keppra No medications
Total n 718 898 5,181
Normal EEG 179 175 1,203
Abnormal EEG 320 264 1,285
EEG status not obtained 291 459 2,693
Male 344 378 2,017
Female 320 465 1,895
Sex not obtained 54 55 1,269
Age (Mean ± SD years) 48.36±16.72 48.04±18.98 44.55±20.11
(# recordings w/ age) (n = 692) (n = 862) (n = 4, 142)
Unique subjects 456 507 2,530
Table 4.2 Population demographics of data set across recordings with medication
profiles of interest.
DCNN. This is an unprecedented real-world data set composed of thousands of sub-
ject EEG recordings collected under conditions less constrained than those typically
employed in laboratory research settings [51]. This data set contains 35,370 EEG
recordings sessions (1.1TB) from 13,486 subjects. Each session was accompanied by
a report containing clinical impressions and patient characteristics, including age and
sex, as well as the medications being taken by the patient at the time of recording.
It primarily consists of data from recordings of subjects with EEG abnormalities,
with many subjects taking anticonvulsant medications. Thus, the TUH data set
provides the means to explore EEG pathologies and medication state classifications
by evaluating the neurophysiological signals of thousands of subjects. To investi-
gate the different frequency band importance of EEG-based classifications in these
populations we applied several processing steps to the EEG data and corresponding
clinical reports from the TUH data set.
Using this data set, the two most common anticonvulsant medications taken
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alone based on the clinical reports were identified: Dilantin (generic phenytoin) and
Keppra (generic levetiracetam) (Table 4.1 and Table 4.2). Any subject with more
than one medication listed in the clinical notes was excluded from the evaluation
to reduce results related to drug interaction effects. Furthermore, given the clinical
nature of the data set and to avoid confounds from clinically-determined normal
and abnormal EEGs, these classifications were performed separately on recordings
deemed normal EEG and abnormal EEG. A subset of patient clinical reports within
the TUH data set had been previously reviewed and labeled by curators of this
database to be clinically normal or abnormal [83]. The definitions of normal and
abnormal used by the TUH generally followed methods neurologists use to identify
abnormalities [86]. These labels were applied broadly to recordings where the clin-
ical reports identified an abnormality in the EEG and do not distinguish between
different abnormalities. An automated labeling method previously developed and
validated based on textual analysis of the clinical reports was applied to categorize
all available recordings as normal or abnormal [95]. Applying this method to the
entire TUH data set resulted in a total of 6,001 EEG recordings with normal EEG
across 4,058 unique subjects and 15,347 EEG recordings with abnormal EEG across
7,432 unique subjects.
Because the recordings in the TUH data set were acquired over several years
and with different EEG systems (Section 1.1), a subset of channels following a
standard 10-20 electrode montage were used: Fp1, Fp2, F3, F4, C3, C4, P3, P4,
O1, O2, F7, F8, T3, T4, T5, T6, Fz, Cz, Pz. Our analyses were applied to five
minutes of EEG recordings across those 19 channels identified above [83]. If another
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sampling rate was used, recordings were down-sampled to 100Hz. The data were
then filtered through a 0.5Hz to 50Hz band pass filter, and re-referenced using a
common average. All pre-processing and analyses were done in Python using a
combination of available packages, published code from previous works, and custom
developed code [105], [123] (available at github.com/dbp-osel).
4.3 Results
4.3.1 Validation: Spectral importance of EEG pathology detection
We validated easyPEASI though classifying EEG pathologies, normal EEG
recordings against abnormal EEG recordings, since previous works investigating
deep learning models that used the TUH data classified EEG pathology states [123].
This allows for us to compare results from the the same classification using a similar
data set. We report the mean and standard deviation of the 10-fold cross validation
training accuracy results as the baseline for how well the deep learning model learned
classification results as a line and shaded region in Figure 4.2. With 6,001 available
normal EEG recordings and 15,347 abnormal EEG recordings, balancing these two
populations yields an n-total = 12,002 and using 90% of the data for training gives
n−train=10,802. These training models generalized well through 10−fold cross-
valued testing results with n−test=1,200. The training and testing results of this
classification are shown in Table 4.3. We further report the differences, ∆, and
P -values from Kruskal-Wallis tests between the results obtained from the training
data and perturbed data where we denote *: P < .01, **: P < .001, or n.s.: not
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significant in Figure 4.2.
Classification
n-train Train accuracy (%)
(n-test) (Test accuracy (%))
Normal EEG vs. 10,802 80.99± 2.22
Abnormal EEG (1,200) (80.40± 2.41)
Table 4.3 Classification accuracies (Mean ± Standard deviation %) for subject EEG
pathologies.































Frequency band importance identifying EEG pathologies
Training accuracy
Peturbed accuracy
Figure 4.2 easyPEASI results for models detecting EEG pathologies. Each bar
represents the classification accuracy from the DCNN model when a particular
frequency band was perturbed using the easyPEASI. Line and shaded area at
80.99% ± 2.22 are mean and standard deviation of training accuracies with no
perturbed data. Kruskal-Wallis P -value significance thresholds set at: n.s.: not
significant, *: P < .01, **: P < .001.
As in previous work identifying band importance, we find that the Delta
and Theta bands were most distinctive between populations when classifying EEG
pathologies [123], instilling confidence that our novel method to identifying these
bands is valid.
4.3.2 Application: Anticonvulsants effects on brain rhythms
Given the validation of this novel algorithm, we next report the results of
applying easyPEASI to determining those frequency bands most important to med-
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ication state classifications for anticonvulsants. These training data sets and trained
models are made available for rapid reproducibility (Section 4.5). In this work we
focus on training accuracies for comparison to perturbed data accuracy values found
with easyPEASI. We began by comparing recordings of subjects taking either only
Dilantin or only Keppra. We further separated subjects based on whether they had
abnormalities present in their EEG recordings. Using 90% of the data for training,
recordings of subjects with normal EEG taking Dilantin vs. Keppra we report train-
ing and testing accuracies in Table 4.4 and show easyPEASI results in Figure 4.3.
These models obtained results above 50%, which is considered chance for a binary
classification. Applying easyPEASI to the training data, we show the importance
of each band in the two classifications identifying anticonvulsants.
Classification
n-train Train accuracy (%)
(n-test) (Test accuracy (%))
Dilantin vs. Keppra 316 80.19± 13.86
with Normal EEG (34) (59.12± 7.49)
Dilantin vs. Keppra 476 83.91± 3.48
with Abnormal EEG (52) (60.39± 5.03)
Table 4.4 Classification accuracies (Mean ± Standard deviation %) for recordings of
subjects taking one of two anticonvulsants, either Dilantin or Keppra, with normal
or abnormal EEGs.
In the case of normal EEG recordings, no frequency bands were found to be
significant in differentiating between the effects of the two anticonvulsants Dilantin
and Keppra, though we note the Alpha band was found to have a ∆ = 16.80%,
which was 10% larger than any other frequency band. Further, for abnormal EEG





























Keppra vs. Dilantin for subjects with normal EEG
Training accuracy
Peturbed accuracy




























Keppra vs. Dilantin for subjects with abnormal EEG
Training accuracy
Peturbed accuracy
Frequency band importance identifying anticonvulsants
a.
b.
Figure 4.3 easyPEASI results for models comparing the differences between anti-
convulsants for normal and abnormal EEG recordings. Each bar represents the
classification accuracy from the DCNN model when a particular frequency band
was perturbed using the easyPEASI. Lines and shaded areas at (a) 80.19%± 13.86
and (b) 83.91%±3.48 are means and standard deviations of training accuracies with
no perturbed data. Kruskal-Wallis P -value significance thresholds set at: n.s.: not
significant, *: P < .01, **: P < .001.
this classification.
We then evaluated the bands’ importance to distinguishing recordings of sub-
jects taking either one of the two anticonvulsants against subjects taking no medi-
cations. Again, classifications and easyPEASI were applied separately for abnormal
and normal EEG recordings. Table 4.5 shows the mean and standard deviation of
the training and testing accuracies obtained, with easyPEASI results in Figure 4.4
and Figure 4.5. Table 4.5 shows that testing classification results were above chance.
Applying easyPEASI, the important bands for these classifications are shown in Fig-
ure 4.4 for normal EEG recordings and Figure 4.5 for abnormal EEG recordings.
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Classification
n-train Train accuracy (%)
(n-test) (Test accuracy (%))
Dilantin vs. No medications 324 82.22± 8.24
with Normal EEG (34) (64.12± 8.19)
Keppra vs. No medications 316 85.82± 5.83
with Normal EEG (34) (64.71± 6.31)
Dilantin vs. No medications 576 84.36± 7.21
with Abnormal EEG (64) (68.75± 6.29)
Keppra vs. No medications 476 82.69± 5.86
with Abnormal EEG (52) (68.85± 6.87)
Table 4.5 Classification accuracies (Mean ± Standard deviation %) for recordings
of subjects taking one of two anticonvulsants and subjects taking no medications.
The results for recordings of subjects taking a single medication and subjects
taking no medications show that for normal EEG recordings, both anticonvulsants
affected the Alpha band most, followed by the Theta band. The Beta band was also
found to be significant for recordings of subjects with normal EEG taking Keppra
against subjects taking no medications. In the cases of abnormal EEG recordings,
both classifications comparing subjects taking anticonvulsants and subjects taking
no medications, the Delta band was found to be most significantly affected. However,
the Theta and Alpha bands were only significant when distinguishing recordings of
subjects with abnormal EEG taking Dilantin against those taking no medications.
4.4 Discussion
In the current study, we introduce and validate a method (easyPEASI) to
investigate deep learning models that use EEG as their input to identify important
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Figure 4.4 easyPEASI results for models comparing the differences for recordings
of subjects with normal EEG taking one anticonvulsant and subjects with normal
EEG taking no medications. Each bar represents the classification accuracy from the
DCNN model when a particular frequency band was perturbed using the easyPEASI.
Lines and shaded areas at (a) 82.22%± 8.24 and (b) 85.82%± 5.83 are means and
standard deviations of training accuracies with no perturbed data. Kruskal-Wallis
P -value significance thresholds set at: n.s.: not significant, *: P < .01, **: P < .001.
how this algorithm can be applied to real clinical classifications problems. Unlike
previous methods that have applied some type of manipulation on the input data
and associated those manipulations to changes in deep learning network weights
and activations, our method only requires applications of perturbations to the input
data to determine frequency band importance. Our work focuses on frequency bands
because of its prominence in prior work to investigate underlying neuro-physiology
through EEG [99].
We first validated our method by identifying frequency bands most important
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Figure 4.5 easyPEASI results for models comparing the differences for recordings of
subjects with abnormal EEG taking one anticonvulsant and subjects with abnormal
EEG taking no medications. Each bar represents the classification accuracy from the
DCNN model when a particular frequency band was perturbed using the easyPEASI.
Lines and shaded areas at (a) 84.36%± 7.21 and (b) 82.69%± 5.86 are means and
standard deviations of training accuracies with no perturbed data. Kruskal-Wallis
P -value significance thresholds set at: n.s.: not significant, *: P < .01, **: P < .001.
sults we see that using easyPEASI to investigate EEG-driven deep learning models
shows promise in identifying important frequency bands in classification tasks. This
method allows for the investigation of important spectral characteristics of EEG
learned by deep learning models without the need to directly investigate the deep
learning model itself. The method introduced and validated in this work is sim-
pler than previous methods since it does not require investigating the deep learning
model and rather only relies on manipulation of the input data. The interpre-
tation of the results is also based upon a commonly used, well-known statistical
method, the Kruskal-Wallis test. Therefore, easyPEASI may be more accessible to
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researchers in the field of neuroscience that may not be experts in deep learning
but often require explainable artificial intelligence and explainable models to under-
stand clinical implications. The spectral perturbation that the PerturbEEGBand
function in easyPEASI applies to the EEG signal is simple in nature and affects
particular properties of the signal. Replacing the real and complex coefficients of
the DFT with normally distributed random values affects the peaks and troughs of
the spectral power profile. Further, when applying the perturbation to the data, the
phase coupling and non-stationarity of the EEG signal is affected. Therefore, it is
possible that any combination of these properties of each frequency band may have
been most influential when significant bands were identified by easyPEASI. Along
with varying the number of data samplings k used or frequency bands investigated,
different perturbations that manipulate other specific properties of frequencies may
be investigated in future works with easyPEASI.
Identification of EEG pathologies through deep learning models using solely
EEG as inputs achieved accuracies above 80% using about 3,000 EEG recordings
[123]. Our automated EEG pathology labeling method allowed for classification
of EEG pathologies with deep learning using 12,002 EEG recordings, the largest
EEG data training and testing sets to classify EEG pathologies. Using this data
set also achieved testing accuracy greater than 80% and with easyPEASI identified
the same bands important to the classification (Figure 4.2). These levels of testing
accuracy allow for deep learning models for classification to be potentially used
in diagnostic applications [127]. However, these levels of accuracy have yet to be
achieved using deep learning models to identify subject’s medications using EEG,
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but have shown the ability to distinguish these populations above chance (50%).
This means that these models generalized to unseen data to a certain degree and
identified meaningful patterns in the data. Concurrent research outside the scope
of this work is in progress that analyses and discusses the significance and impact
of these classification results (Table 4.4 and Table 4.5).
As a novel application of easyPEASI, we investigated EEG recordings from
individuals taking different anticonvulsant medications and no medications. To our
knowledge, this kind of analysis into neurophysiological differences for this drug class
is not well researched. Here, we discuss the results of the easyPEASI method and
correlate these results with expectations based on clinical literature. For normal
EEG recordings, though not statistically significant, the largest differences in effects
between medications were found to be in the Alpha band (Figure 4.3a). Comparing
recordings of subjects with normal EEG taking a single medication (i.e. Keppra
or Dilantin) to subjects taking no medications, the Alpha band was found to be
significantly different (Figure 4.4). With the Alpha band the most important band
comparing normal EEG recordings, it seems that anticonvulsants affect this band
in a similar manner when compared to recordings of subjects taking no medications
since it is not significant when compared to each other (Figure 4.3a). Similarly, the
Theta band seems to be equally important (Figure 4.4) and comparably affected by
these medications (Figure 4.3a). Finally, we note that though the Beta band was
found to be important in only classifying recordings of subjects with normal EEG
taking Keppra against subjects taking no medications (Figure 4.4b), the Beta band
was not found to be important classifying the two medications for normal EEG
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recordings (Figure 4.3a).
For abnormal EEG recordings, results showed both anticonvulsant medications
affected the Delta band (Figure 4.3a and Figure 4.5). Further, the Theta and Al-
pha bands were found to be important when classifying recordings of subjects with
abnormal EEGs taking Dilantin against those taking no medications (Figure 4.5a).
These results are consistent with known effects of EEG pathologies [123]. Delta and
Theta bands have been important for identifying EEG pathologies, so it is expected
that the medication aimed to treat epilepsy, one of the most common pathologies,
would affect these bands for abnormal EEG recordings [86]. When comparing these
medications to each other, Dilantin’s mechanism of action, like most anticonvulsant
medications, is primarily attributed to modulating voltage-gated sodium and cal-
cium channels and enhancement of GABAA (gamma aminobutyric acid, type A)
[115]. However, Keppra’s mechanism of action is less understood but is thought to
be through binding to the synaptic vesicle protein SV2A [2]. With these differences,
our finding that the Beta band was uniquely differently affected by these two medi-
cations (Figure 4.3b) is consistent with known neurophysiology since the Beta band
is known to be affected by GABA and is only known to be directly affected by one
of these medications [67]. Further, since they have different mechanisms of action,
though they may both be affecting the Delta bands, they may be doing so differently
since we observe the Delta band was important when comparing anticonvulsants to
each other (Figure 4.3b). However, we also found the Theta and Alpha bands to be
important when distinguishing these medications from each other for abnormal EEG
recordings (Figure 4.3b) and were only found to be important comparing recordings
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of subjects taking Dilantin to those taking no medications (Figure 4.5a).
A limitation of this method, however, is that the perturbations were applied
to all channels together. Future development of extensions to easyPEASI could be
done to identify brain regions that are important in classification tasks. Regarding
the applications investigated in this work, future research may investigate the differ-
ence between subjects with abnormal EEG taking anticonvulsants against subjects
with normal EEG taking no medications to potentially determine anticonvulsants’
efficacy.
4.5 Online resources for reproducibility
Software and scripts for reproducibility can be found at our GitHub Reposi-
tory: github.com/dbp-osel.
Software implementation for easyPEASI and analysis of this work are at:
github.com/dbp-osel/easyPEASI. This repository also includes saved trained
deep learning models for all classifications reported here. For the application area of
medication classifications, data and labels are also made available. These resources
allow for fast reproducibility of results presented in this work.
For other classifications using the TUH EEG Corpus to reproduce results ob-
tained here (e.g. larger EEG pathology detection data set) several pre-processing
steps need to be applied the data before these deep learning models can be trained
and subsequently applied to easyPEASI. These pre-processing tools and data are
available as part of work previously published: github.com/dbp-osel/qEEG-consistency
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[95].
The open source EEG data is available from Temple University Health at
www.isip.piconepress.com/projects/tuh_eeg [51].
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Chapter 5: Quantifying Signal Quality from Unimodal and Multi-
modal Sources: Application to EEG with ocular and mo-
tion artifacts
Overview
This chapter presents work has not been submitted for publication. It is
intended to be submitted partially or in full for publication.
We developed novel methods of scoring physiological signal quality for data
and noise from unimodal source and multimodal sources. We applied these methods
to score EEG data from two experimental data sets from the University of Houston.
Motivation: Unlike in clinical or research settings, electrophysiological data
collected in the real world is often contaminated with noise that does not represent
the physiological signal of interest. For applications where we need these data
to be reliable, consistent, and informative, the presence of noise that corrupt the
signal of interest can degrade the effectiveness of diagnostic tools and brain-machine
interfaces. If these data are to be useful, it is important to understand signal quality
which would enable more meaningful measurements from patients.
Approach: We developed two methods to evaluate quality of electrophys-
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iological signals with a continuous score that ranged from zero to one. Our first
method targeted cases when the data and noise were unimodal, recorded from the
same source (e.g. EEG and ocular artifacts from EOG). We used a Bayesian ap-
proach to estimate distributions of features of signals free from artifacts and noise
signals. Estimated distributions that met our inclusion criteria were then used to
score new signals. Our second method was designed for cases when the data and
noise were multimodal, recorded from different sources (e.g., EEG and motion arti-
facts from IMUs). For this case, we used a deep learning-based approach to train
models to identify differences between signals with noise from artifacts present and
signals without noise. Trained models were then used to score new signals.
Validation: We validated our first approach by successfully developing the
models and scoring unseen EEG data with ocular noise (192 ≤ n ≤ 2, 784). We
next validated our second approach by training models to identify motion artifacts
in EEG and appropriately score validation data (n = 548).
Application: We further applied our first method to quantifying the effec-
tiveness of EEG artifact removal algorithms targeting ocular noise (n = 2, 784). We
tested two artifact removal algorithms commonly used and available in EEGLAB.
EEG recordings were scored before and after application of the algorithms and ob-
served the differences in scores between the two algorithms.
Research impact: Results allow for rapid evaluation of signal quality of EEG
data. Models are easily extendable to other physiological measurements where noise
is often present. This work also provides a novel data-driven method to quantita-
tively evaluate and compare effectiveness of noise removal algorithms with real data.
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5.1 Introduction
Advancements in and availability of wearable technologies that can readily
collect physiological data from individuals in both controlled laboratory and real-
world settings have been growing rapidly. As such, both the volume of available
observational biometric data and its potential utility, if properly understood, are
also increasing. If these data are to be effectively applied and correctly interpreted,
it is important to understand the quality of data being recorded. We define quality
by how much of the acquired signal is from the source of interest and not noise from
external or internal (i.e. other physiological) sources. Unlike in clinical or research
settings, electrophysiological data collected in the real world is often contaminated
with noise that does not represent the physiological signal of interest.
With the ability to directly acquire signals from noise sources, there have been
greater successes in applying artifact removal algorithms when the noise signal is
known [73], [72]. In many situations, it may not be possible to directly measure
the source of artifacts, making the process by which those artifacts are removed
arduous and more error-prone. Depending on the application, it would be beneficial
to evaluate the quality of data and know how clean electrophysiological recordings
are before attempting to analyze it or use it as input to a model. To better iden-
tify data quality where noise sources are not available, we can leverage data from
studies with the appropriate data to generate models that characterize and score
electrophysiological recordings.
In the case of electrocardiography (ECG), an example of an electrophysiologi-
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cal signal, recordings often include electromyography (EMG), and movement, among
other noise sources. For ECG, there have been several efforts in developing meth-
ods to assess signal quality [121]. However, for another type of electrophysiological
signal, electroencephalography (EEG), there has been little research on developing
quality metrics. EEG, which measures brain electrical signals from the scalp, is
a common neuro-monitoring technique used in both clinical and research settings.
EEG is typically non-invasive, relatively inexpensive, and has been used for diag-
nostic, rehabilitative, and therapeutic purposes [78], [106]. For clinical applications
where we need these data to be reliable, consistent, and informative, the presence of
noise that corrupt the signal of interest can degrade the effectiveness of diagnostic
tools and brain-machine interfaces. Despite their increasing use and public health
importance, little is known about the quality of EEG with respect to neural activity
content. If these data are to be useful, it is important to understand EEG signal
quality which would enable more meaningful measurements from patients to identify
targeted neurological activity in EEG. With EEG, ocular activity (measurable by
electrooculography (EOG)), muscle activity (measurable by EMG), cardiac pulses
(measurable by ECG), and movement (measurable by inertial measurement units
(IMU)) can often corrupt the purity of neural activity that is targeted by EEG
recordings [63]. Creating metrics to determine the quality of non-invasive electro-
physiological recordings would inform those using the data how representative it
is of the desired physiological source and not riddled with noise from sources not
of interest. Human EEG data is a particularly important data type in this regard
because of its relevance to a myriad of public health challenges [78].
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There have been a few approaches to scoring EEG signal quality. One method
calculated 11 different features of EEG that were used to identify clean EEG record-
ing segments by thresholding these signal parameters [30]. Data across four data
sets were used to determine these thresholds with n = 58. Based on these thresh-
olds, features values from new EEG signals were categorized as either clean or not
clean. In another study, three quantitative EEG features were used to assess signal
quality to obtain three scores which were combined into one score [56]. The data
used was from the OPTIMI data set with n = 90, but the method may need modi-
fication to be generalized to other headsets. Recently, machine learning was applied
to this problem using 114 features from the EEG [48]. The EEGs were classified
using several classification approaches, along with feature selection and a five-fold
cross validation into three quality levels: low, medium, and high. This study used
EEG across five data sets with n = 43.
The aims of this work are to (1) develop a scoring method for data from a
unimodal source when the noise can be measured directly from the same modality
and apply it to EEG with ocular artifacts, (2) develop a scoring method for data
when the noise can only be measured from another modality, requiring multimodal
sources, and apply it to EEG with motion artifacts, and (3) apply our developed
scoring metric to evaluate artifact removal algorithms, specifically comparing two
artifact removal algorithms that target ocular artifacts.
This work proposes new methods to create a metric to quantify quality of elec-
trophysiological data. Our first proposed approach is targeted at applications when
the noise source can be recorded directly using the same measurement tool, i.e. uni-
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modal data such as EEG and EOG, which are both recorded from electrodes on the
head. Our second approach would be needed when there are noise sources that can-
not be recorded directly and can only be quantified by other means, i.e. multimodal
data such as EEG and motion, which require both EEG electrodes and IMUs. We
propose a feature-based Bayesian approach to score EEG with ocular artifacts since
EEG and EOG can be directly measured through same set of electrodes. Recently
deep learning, specifically deep convolutional neural networks (DCNN), have shown
state-of-the-art results and superb effectiveness in EEG applications [117]. As such,
we next present a deep learning-based approach to score EEG with motion artifacts
since motion cannot be directly recorded with electrodes but rather is quantified by
IMU or other motion tracking tools.
Further, we validate and apply our scoring metric to evaluate the effectiveness
of different artifact removal algorithms. We hypothesize that data cleaned with other
artifact removal algorithms will obtain higher scores than before they were processed.
Methods to compare the performance of EEG artifact removal algorithms have not
been well developed and currently rely on either visual inspection or synthetic data
[63]. Since ocular artifacts are the most common noise targeted by artifact removal
algorithms for EEG, we score recorded data with noise present and data after being
processed by different ocular artifact removal algorithms [68]. These scoring methods
could be used to evaluate the effectiveness of noise removal algorithms by comparing
scores of EEGs processed by different methods.
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5.2 Methods
We first introduce a scoring method for cases when the noise source can be
recorded directly by the same modality (Section 5.2.1). We next describe a scor-
ing method when the noise source cannot be measured directly through the same
recording modality (Section 5.2.2). Both methods are designed to generate a score
0 ≤ Q ≤ 1 (QU for data with unimodal source and QM for data with multimodal
sources). A score of zero would imply that the data is entirely noise or from sources
not of interest, while a score of one would mean that the data is entirely from the
desired electrophysiological source. Figure 5.1 shows a high-level processing pipeline
of model generation and validation of scoring methods for data with unimodal (Fig-
ure 5.1a) and multimodal (Figure 5.1b) sources. Finally, we outline two different
noise removal algorithms and how our scoring method could be used to evaluate
their performance (Section 5.2.3).
5.2.1 Scoring data with unimodal source
In cases where the noise source can be measured directly from the same record-
ing modality (referred to as ‘unimodal method’), it is possible to compare quanti-
tative features of both the signal of interest and the noise. After computing these
features and their corresponding scores, we detail how to identify which features
would be most effective to score data quality.
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Models: For each feature, 𝑓𝑓, estimate 
densities 𝑑𝑑𝑓𝑓 Θ𝒞𝒞 , 𝑑𝑑𝑓𝑓 Θℛ , 𝑑𝑑𝑓𝑓 Θ𝒩𝒩 , 
needed for feature scores, 𝑄𝑄𝑓𝑓
All clean (𝒞𝒞), recorded (ℛ), and noise (𝒩𝒩) data
Inclusion criteria: Compute 
performance metric, 𝛿𝛿, with mean 
scores, �𝑄𝑄𝑈𝑈, using sets of features with 
increasing total 𝑃𝑃(𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒) of estimated 
densities, 𝐸𝐸𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡,𝑓𝑓, to determine 𝐸𝐸𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡
threshold as inclusion criteria for 𝑄𝑄𝑈𝑈
Score: Compute total score, 𝑄𝑄𝑈𝑈, for 
𝒞𝒞𝑚𝑚𝑡𝑡𝑚𝑚𝑚𝑚𝑡𝑡, ℛ𝑚𝑚𝑡𝑡𝑚𝑚𝑚𝑚𝑡𝑡, 𝒩𝒩𝑚𝑚𝑡𝑡𝑚𝑚𝑚𝑚𝑡𝑡 from set of 𝑄𝑄𝑓𝑓
of features that meet inclusion criteria
With 𝒞𝒞𝑚𝑚𝑡𝑡𝑚𝑚𝑚𝑚𝑡𝑡, ℛ𝑚𝑚𝑡𝑡𝑚𝑚𝑚𝑚𝑡𝑡, 𝒩𝒩𝑚𝑚𝑡𝑡𝑚𝑚𝑚𝑚𝑡𝑡:
For 𝒞𝒞𝑣𝑣𝑡𝑡𝑡𝑡𝑣𝑣𝑚𝑚, ℛ𝑣𝑣𝑡𝑡𝑡𝑡𝑣𝑣𝑚𝑚, 𝒩𝒩𝑣𝑣𝑡𝑡𝑡𝑡𝑣𝑣𝑚𝑚:
Compute 𝑄𝑄𝑈𝑈 from set of 𝑄𝑄𝑓𝑓, with 
estimated densities, for features with 




Models: Train DCNN with class 
labels 𝒞𝒞: 1 and ℛ: 0
All clean (𝒞𝒞) and recorded (ℛ) data
Score: Compute scores, 𝑄𝑄𝑀𝑀, with
predicted probabilities from DCNN
With 𝒞𝒞𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚, ℛ𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚:
For 𝒞𝒞𝑣𝑣𝑣𝑣𝑚𝑚𝑣𝑣𝑚𝑚, ℛ𝑣𝑣𝑣𝑣𝑚𝑚𝑣𝑣𝑚𝑚:
Compute 𝑄𝑄𝑀𝑀 with predicted 




Figure 5.1 Flowcharts of model generation and validation of scoring methods for
data with (a) unimodal and (b) multimodal sources.
5.2.1.1 Scoring method for data with unimodal source
We begin by computing features for data without noise, hereafter referred to
as clean data (C), recorded data with noise, referred to as recorded data (R), and
the noise source, referred to as noise data (N ).
With the collection of quantitative features for each recording, we fit a distri-
bution for each feature for each type of data, (clean, recorded, and noise) through
kernel density estimations (KDE) (Section 1.6). Our KDE based models are com-
puted using Gaussian kernels and Scott’s rule for bandwidth size. For each source of
data and feature, f , a set of parameters, Θ, and subsequently distributions df (ΘC),
df (ΘR), and df (ΘN), are estimated.
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To obtain a sub-score from each feature, we use the Bayesian decision critical
value, v∗f , which minimizes the probability of error between each set of estimated
distributions, df (ΘC) and df (ΘN ) [32]. For each feature used, if the mean value
of N is less than the mean value of C, a sub-score using that recording’s feature’s
value, vf , is obtained by






P (vf > xi | xi ∈ C), if vf ≥ v∗f
1
2
P (vf ≤ xi | xi ∈ N ), if vf < v∗f
(5.1)
In essence, if vf ≥ v∗f then Qf (vf ) represents the proportion of values in C less
than vf scaled between [0.5, 1], or if vf < v
∗
f then Qf (vf ) represents the proportion
of values in N less than vf scaled between [0, 0.5]. If the mean value of N is
greater than the mean value of C, then the inequalities in Equation 5.1 are reversed
appropriately. To obtain the final quality score for our unimodal method a set of






Qf (vf ), vf ∈ V for features f that meet inclusion criteria, (5.2)
where F is the number of computed features used to obtain the overall score.
We next develop a method to identify an inclusion criteria for which features
would be best for determining QU . We compute three probabilities of errors for each
feature for each set of data as follows:
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P (error|C, f) = P (df (xi|ΘC) < df (xi|ΘN ) | xi ∈ C) (5.3)
P (error|R, f) =P (df (xi|ΘC) < df (xi|ΘN ) | xi ∈ R)
=1− P (df (xi|ΘN ) ≤ df (xi|ΘC) | xi ∈ R) (5.4)
P (error|N , f) = P (df (xi|ΘN ) < df (xi|ΘC) | xi ∈ N ) (5.5)
Ideally, the clean and noise distributions should be completely separable, with
a probability of error of zero, while the distribution of recorded data should be a
combination of values from the clean and noise distribution and thus should have
a probability of error of 0.5 between both the clean and noise distributions. Thus,
we can evaluate the utility of each feature by computing the error of each estimated
distribution from the ideal error, referred to as total error. We define the total error
for each feature as
Etotal,f = P (error|C, f) + |0.5− P (error|R, f)|+ P (error|N , f) (5.6)
where 0 ≤ Etotal,f ≤ 2.5.
Lower Etotal,f represent features best suited for scoring signal quality and only
features with low enough Etotal,f should be used. Finally, we formulate a metric to
146
determine the inclusion criteria of how low Etotal,f of all features should be, Etotal
threshold. We define a measure of the error from the ideal solution,
δ =
∣∣0.75−QU(C)∣∣+ ∣∣0.50−QU(R)∣∣+ ∣∣0.25−QU(N )∣∣ (5.7)
whereQU is the meanQU(V ) across all data of each type, VC ∈ C, VR ∈ R, and VN ∈
N , features from clean data, recorded data, and noise data, respectively.
To interpret QU from this method effectively we wish to have the mean of
QU(VC), QU(C), be 0.75 and have range between 0.5 and 1, the mean of QU(VR),
QU(R), to be 0.50 and have range between 0.25 and 0.75, and the mean of QU(VN ),
QU(N ), to be 0.25 and have range between 0 and 0.50. These constraints and
parameters make it such that ideally there will be no overlap between C and N
while R will overlap approximately half with C and half with N .
Therefore, to obtain an optimal Etotal threshold, we calculate δ with increasing
values of Etotal thresholds to observe when δ begins to increase. From this analysis,
we only use features with Etotal,f lower than the determined threshold value as an
inclusion criteria for Equation 5.2.
5.2.1.2 Data with unimodal source
As the unimodal approach is data-driven, we present here data used to gener-
ate scoring parameters and subsequently validate this method. We focus on noise
from eye-movement, EOG, since for high density EEGs they are generally captured
directly by electrodes placed near the eyes.
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A data set obtained from the University of Houston contained EEG and EOG
recordings (sampled at 100 Hz) as well as motion capture from eleven subjects
walking on a treadmill for six minutes [72]. Of these eleven subjects, eight were
used for this approach because of the availability and consistency of data. These
EEG were recorded with a 64 electrode array following labels from the extended
10-20 system (Section 1.1) with: channel FT9 used as ground; FT10 for reference;
TP9, TP10, PO9, and PO10 for EOG; and the 58 remaining channels for EEG.
For three subjects: T7 was used as ground; T8 for reference; TP9, TP10, FT9, and
FT10 were used for EOG; and the 58 remaining channels for EEG.
A robust noise removal method developed by the University of Houston re-
search group directly used available noise sources to remove them from the recorded
EEG [73]. This noise removal algorithm targeting EOG noise used an H∞ filtering
formulation (Section 1.4.2) since it guarantees robustness where small modeling er-
rors and external noise do not cause large estimation errors [52]. This algorithm and
subsequent study used four EOG channels directly recorded as reference disturbance
input. The strength and effectiveness of this algorithm are shown to out-perform
other common ocular artifact removal techniques [72].
The H∞ EOG cleaning algorithm was applied to the six minutes of record-
ing for the eight subjects. We then separated data from EEG channels and EOG
channels. This gave us 58 channels with six minutes of recording of both clean EEG
data and recorded EEG, as well as four channels with six minutes of EOG data.
For EEG, we used 30 features on segmented data of one-minute epochs since these
features have been shown to be stable with these higher epoch lengths in previous
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quantitative EEG studies [95]. This yielded CEye and REye with n = 2784 (58 chan-
nels × 6 minutes × 8 subjects = 2784), and NEye with n = 192 (4 channels × 6
minutes × 8 subjects = 192), where each sample was of size 30 × 1 (30 features),
for our method scoring data with unimodal source.
5.2.1.3 Model generation for data with unimodal source: EEG with
ocular artifacts
To obtain scoring models for this data we separated 90% of the data randomly
to generate the models and reserved 10% of the data to test and validate the results.
We present ten-fold cross-validated values from ten generated models from different
samplings of 90% of the data, denoted with the subscript ‘model’, that resulted in
CEye,model and REye,model, both with n = 2506, and NEye,model, with n = 173. We
report the mean results as well as the mean standard deviation across samples for
the ten-fold cross-validation.
As mentioned, we computed 30 features (Section 1.3) for both EEG and EOG
data. For spectral features, the Fourier transforms were taken on the pre-processed
recording after which various spectral features were computed. The power spectral
density (PSD) (Section 1.2) of frequency bands commonly analyzed in the EEG were
estimated using the periodogram. The ranges of the frequency bands applied in this
study were as follows: δ(delta) : 1 − 4Hz, θ(theta) : 4 − 8Hz, α(alpha) : 8 − 12Hz,
µ(mu) : 12− 16Hz, β(beta) : 16− 25Hz, γ(gamma) : 25− 40Hz [125]. Both absolute
powers and relative powers were computed, with relative power equal to the power
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in a frequency band divided by the total power. The entropy of the periodogram,
and entropy of the normalized periodogram, were found using the Shanon entropy
definition [14]. In addition to the spectral features, the following time domain
features, directly from the pre-processed EEG signal, were computed: entropy of
the normalized signal, mean thresholded Lempel-Ziv complexity (LZC), minimum
value, maximum value, median, mean, variance, standard deviation, skew, kurtosis,
curve length, energy, non-linear energy, sixth power, sum, mobility, complexity.
To identify the appropriate Etotal threshold for the set of Qf that will be
used to calculate QU (Equation 5.2), we analyze the relationship between the Etotal
threshold (Equation 5.6) and QU along with their associated δ (Equation 5.7) in
Figure 5.2.





















QU and  using features with increasing Etotal thresholds
Figure 5.2 (a) QU means (lines) and standard deviations (shaded area) using
features with increasing Etotal thresholds. Green represents QU(CEye,model), yel-
low QU(REye,model), and red QU(NEye,model). (b) δ values using QU obtained
from increasing Etotal thresholds. (a)-(b) Blue dashed-line marks a threshold of
Etotal = 0.35, where δ begins to increase more rapidly.
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We see from Figure 5.2a that using scores from features with lower Etotal,f
yielded better performing mean scores across data, QU . Scores of NEye,model were
lower and closer to 0.25, REye,model were closer to 0.50, and CEye,model were higher
and closer to 0.75. Further, from Figure 5.2b, the lower the Etotal threshold applied,
the lower the corresponding δ value. The best performing and most informative QU
values were obtained with an inclusion criteria of either a threshold of Etotal ≤ 0.20
or Etotal ≤ 0.35. Table 5.1 shows our probabilities of errors (Equations 5.3-5.5) and
Etotal,f (Equation 5.6) for each of the 30 features, where features with Etotal,f ≤ 0.35
are shaded and in bold. Further, to show how these features were distributed and
data types appropriately mixed and separated, we show in Figure 5.3 the estimated
distributions of CEye,model, REye,model, and NEye,model for features with Etotal,f ≤ 0.35.
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Estimated distributions of features with Etotal, f  0.35
Figure 5.3 Estimated distributions clean, recorded, and noise data for features with
Etotal,f ≤ 0.35. Etotal,f for set of estimated distributions of each feature are also
shown.
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Relative δ Power 0.12 0.18 0.73 1.17
Relative θ Power 0.14 0.50 0.33 0.47
Relative α Power 0.11 0.55 0.09 0.25
Relative µ Power 0.04 0.54 0.02 0.10
Relative β Power 0.06 0.54 0.02 0.11
Relative γ Power 0.15 0.60 0.05 0.31
Absolute δ Power 0.02 0.17 0.36 0.71
Absolute θ Power 0.06 0.13 0.43 0.86
Absolute α Power 0.23 0.23 0.64 1.14
Absolute µ Power 0.23 0.25 0.72 1.20
Absolute β Power 0.62 0.68 0.24 1.04
Absolute γ Power 0.84 0.87 0.10 1.31
Spectral Entropy 0.17 0.63 0.06 0.36
I.
T
. Entropy 0.14 0.51 0.13 0.28







Minimum 0.07 0.37 0.32 0.52
Maximum 0.10 0.47 0.31 0.44
Median 0.00 0.86 0.12 0.48
Mean 0.00 0.87 0.09 0.46
Variance 0.07 0.26 0.26 0.57
SD 0.11 0.41 0.17 0.37
Skew 0.15 0.42 0.39 0.63









Curve Length 0.29 0.27 0.61 1.13
Energy 0.00 0.31 0.47 0.66
Non-linear Energy 0.19 0.18 0.65 1.15
Sixth Power 0.00 0.27 0.59 0.83
Sum 0.00 0.87 0.09 0.46
Mobility 0.07 0.56 0.04 0.17
Complexity 0.27 0.47 0.40 0.70
Note: I.T. - Information theoretic, LZC - Lempel-Ziv complexity, SD - Standard
deviation
Table 5.1 Probabilities of error (P (error)) and total error for estimated densities of
each feature (Etotal,f ) from CEye,model, REye,model, and NEye,model used in unimodal
method. Features with Etotal,f ≤ 0.35 shaded and in bold.
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We see from Table 5.1 that the three features with the lowest Etotal,f were rela-
tive µ power, relative β power, and mobility, followed by relative α power, relative γ
power, entropy, and LZC. Visually, we see that features with Etotal,f ≤ 0.35 show the
following similar traits (Figure 5.3): (1) the clean data and noise data distributions
had little overlap, (2) the mean value of the recorded data distributions were close
to the critical value (Equation 5.1), and (3) all data distributions were generally
smooth and had a single mode.
We verify numerically in Table 5.2 the appropriate Etotal inclusion criteria
threshold by using sets of features with increasing Etotal thresholds.
Data
QU QU QU
(Etotal,f ≤ 0.20) (Etotal,f ≤ 0.35) (Etotal,f ≤ 0.50)
CEye,model 0.73± 0.14 0.72± 0.13 0.71± 0.08
REye,model 0.50± 0.15 0.49± 0.14 0.51± 0.13
NEye,model 0.26± 0.15 0.27± 0.15 0.38± 0.12
δ 0.03 0.06 0.18
Table 5.2 Mean scores QU ± standard deviation and δ values of unimodal method
across model generation cross-validation using features with incremental Etotal
thresholds. Values with chosen threshold, Etotal,f ≤ 0.35, in bold.
We find that increasing the Etotal threshold from 0.20 to 0.35 and including
features with 0.20 < Etotal,f ≤ 0.35 did not have much of an impact in performance
since δ only increased by 0.03. However, further including features with 0.35 <
Etotal,f ≤ 0.50 did seem to affect score more negatively since δ further increased by
0.12. Thus, to include more features and capture more characteristics of the signals
we set the inclusion criteria of features’ Qf to use when computing QU (Equation
5.2) to features with Etotal,f ≤ 0.35. We can visualize estimated distributions of
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QU and see in Figure 5.4 that distributions of CEye,model and NEye,model scores were
well separated with wider distributions and intersected at QU = 0.53, while the
estimated distribution of QU of NEye,model had a more narrow distribution with
relatively symmetric decreasing tails centered at 0.47.










Distributions of scores of unimodal data using features with Etotal  0.35
Figure 5.4 Estimated distributions of QU for CEye,model, REye,model, and NEye,model
using features with Etotal,f ≤ 0.35. Distributions of QU of CEye,model and NEye,model
intersect at QU = 0.53. Distribution of QU of REye,model centered at 0.47.
5.2.2 Scoring data with multimodal sources
In cases when the noise source cannot be captured directly from the same
recording modality and require multiple recording modalities (referred to as ‘multi-
modal method’), it may not be possible to directly compare distributions of quanti-
tative features of both the signal of interest and noise. Therefore, we must compare
clean signals and recorded signals with noise present to formulate models to identify
differences.
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5.2.2.1 Scoring method for data with multimodal sources
This problem can be formulated as a two-class classification machine learning
problem. In one class we have clean data (C) and in the second class we have recorded
data with noise present (R). For classification these two data are assigned numeric
labels, {C : 1, R : 0}. The deep learning classifier can then find the difference
between the two data sets which here is the presence of the noise. Once trained,
new data can be classified with a probabilistic prediction using Softmax functions in
the last layer. The closer the probability is to zero, the more similar the signal is to
the noise source, while probabilities closer to one would represent predicted signals
without noise.
The deep learning model (Section 1.7.2) would traditionally select the class
with the highest probabilities as the prediction. To score the data from the deep
learning models, we used the prediction probabilities directly (Equation 5.8). Here,
PC is the predicted probability of input data being part of the clean data class and
PR is the predicted probability of input data being part of the recorded data class













, if PC < PR
(5.8)
The motivation of this definition is such that if PC = 1, PR = 0 then QM = 1,
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if PC = 0, PR = 1 then QM = 0, and if PC = 0.5, PR = 0.5 then QM = 0.5.
Further, when differences between the probabilities are larger, QM should be made
higher when PC >> PR and lower when PC << PR. This is desired since larger
differences between PC and PR would imply that the predictions of the model are
more confident and therefore scores should be adjusted accordingly.
5.2.2.2 Data with multimodal sources
To generate trained models and subsequently validate the multimodal ap-
proach, we focused on EEG with noise from motion since it cannot be recorded
directly from EEGs and are only present in EEG as embedded noise.
We again used the data set obtained from the University of Houston that
contained EEG recordings (sampled at 100 Hz) as well as motion capture from
eleven subjects walking on a treadmill for six minutes (Section 5.2.1.2) [72]. EEG
was recorded from the same electrodes and configuration referred to above with
data from all eleven subjects available, where channel FT9 was used as ground,
FT10 for reference, TP9, TP10, PO9, and PO10 were used for EOG, and the 58
remaining channels for EEG. Further, the experimental protocol had subjects walk
on a treadmill at one, two, three, and four miles-per-hour.
Another noise removal algorithm was used to remove motion artifacts [72].
This algorithm also used an H∞ filter formulation with Voltera series and time-
varying weight assumption. Unlike EOG data which was directly measured from
the same modality, the reference signal used to identify the motion artifacts in
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EEG signals were 3-axis acceleration values, after gravity compensation, using the
quaternion of IMUs.
We further supplemented this data with recorded EEG data from another
study. EEG was recorded from 20 subjects while walking around an art exhibit
[75]. These EEG were recorded with a 32 electrode array labeled in accordance with
the extended 10-20 system where, P09 and P019 for EOG, and Fp1, Fp2, F7, F8,
T7, T8, TP9, TP10, P7, and P8 were generally unused and contained mostly zero-
values, and the remaining 20 channels had consistently available EEG. Each trial
began with a baseline wall stair of approximately one-minute. Afterwards, subjects
walked around an art exhibit for at least seven minutes.
To obtain a robust model that scored EEG quality based on the presence
of motion artifacts we combined data from both these sources to obtain a CMotion
that represented EEG data from recordings where motion was removed through
an artifact removal algorithm and recordings where motion was known to not be
present. Similarly, we combined data from both sources to obtain a RMotion that
represented EEG data from recordings where motion was present under different
circumstances, in both controlled environments with different walking speeds, and
in an uncontrolled setting where subjects walked through an art exhibit. Since data
from our second source ([75]) only had 20 EEG channels available, we used the same
20 channels from our first data source ([72]). Each recording from both sources were
segmented into 30-second epochs for our multimodal method. Combining these we
obtained CMotion with n = 568 (12 30-second segments from 6-minutes × 4 walking
speeds× 11 subjects + 2 30-second segments from 1-minute of baseline× 20 subjects
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= 568), and RMotion with n = 808 (12 30-second segments from 6-minutes × 4
walking speeds × 11 subjects + 14 30-second segments from 7-minutes of walking
× 20 subjects = 808), where each sample was of size 3000× 20 (30-second segments
sampled at 100Hz across 20 channels), for our method scoring data with multimodal
source.
5.2.2.3 Model generation for data with multimodal sources: EEG
with motion artifacts
To obtain scoring models for this data we separated 90% of the data randomly
to generate the models and reserved 10% of the data to test and validate the results.
We present ten-fold cross-validated values from ten generated models from different
balanced samplings of 90% of the data, denoted with the subscript ‘model’, that
resulted in CMotion,model and RMotion,model, each with n = 512. We report the mean
results as well as the mean standard deviation across samples for the ten-fold cross-
validation. For this application we used deep learning models used in previous
research that used multi-channel EEGs as input and output class predictions [123].
We show in Table 5.3 predicted probabilities and associated scores (Equation
5.8) using model training data from our deep learning-based scoring for our multi-
modal scoring method.
Data Probability of CMotion Probability of RMotion QM
CMotion,model 0.79± 0.13 0.18± 0.12 0.81± 0.13
RMotion,model 0.28± 0.26 0.67± 0.26 0.30± 0.26
Table 5.3 Mean predicted probabilities ± standard deviation and corresponding
mean scores, QM , of multimodal method across model generation cross-validation.
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We see that the recorded data was in fact scored well below 0.5 while data
without walking artifacts were scored well above 0.5, instilling confidence in the
trained deep learning models. We visualize estimated distributions of QM and see
in Figure 5.5 that the distribution of CMotion,model scores was negatively skewed,
the distribution RMotion,model scores was positively skewed, and both distributions
intersected at QM = 0.62.









Distributions of scores of multimodal data
Figure 5.5 Estimated distributions of QM for CMotion,model and RMotion,model. Distri-
butions of QM of CMotion,model and RMotion,model intersect at QM = 0.62.
5.2.3 Evaluating artifact removal algorithms: Removing ocular arti-
facts from EEG
Using scoring methods introduced in this study, we can evaluate the efficacy
of artifact removal algorithms (Section 1.4) that target a specific type of noise.
The most common type of noise that artifact removal algorithms target in EEG
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recordings is from ocular activity. Therefore, we use our unimodal method (Section
5.2.1) to evaluate these types of algorithms. A MATLAB software toolbox that
is commonly used in EEG processing is EEGLAB. We used two artifact removal
algorithms with different approaches that aim to remove ocular artifacts. Though
different, both methods rely on independent component analysis (ICA) which is the
most common method used for removing ocular artifacts [68].
Using EEGLAB (version 14.1.1) and available plug-ins, we applied the in-
dependent component artifact classification multiple artifact rejection algorithm
(MARA) to REye [143], [62]. This method uses trained classifiers to identify compo-
nents from ICA that are artifactual for rejection. The FastICA method was used for
obtaining ICA components and components identified by MARA were automatically
rejected [57].
We also applied automatic artifact removal (AAR) (version 1.3) targeting EOG
removal using blind source separation (BSS) to REye [69], [70]. AAR with BSS was
applied with all defaults, using the SOBI algorithm in MATLAB which has been
shown to be effective for BSS [9], [118]. To automatically apply AAR with BSS to
EOG, the method identifies ICA components that represent EOG noise by removing
components with the lowest mean fractal dimension values [45].
To evaluate and compare the effectiveness of these artifact removal algorithms
we obtained the average score of QU(REye) and compared the average scores of the
data after being processed with MARA, QU(CEye−MARA), and ARR, QU(CEye−AAR).
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5.3 Results
We show mean results as well as the mean standard deviation across samples
for our unimodal and multimodal scoring methods for the data sets specified. For
both methods, we report the ten-fold cross-validated values from ten generated
models with the remaining 10% unseen data, denoted with the subscript ‘valid’.
For the unimodal method, we scored CEye,valid and REye,valid, both with n = 278,
and NEye,valid, with n = 19. For the multimodal method, we scored CMotion,valid
and RMotion,valid, each with n = 56. These validation results are presented below in
Section 5.3.1 (unimodal method) and Section 5.3.2 (multimodal method). Section
5.3.3 shows results using all data and validation data.
5.3.1 Scoring data with unimodal source: EEG with ocular artifacts
Applying the unimodal method to data not used for model development we
scored the data (Equation 5.2) and present cross-validation results using features








Table 5.4 Mean scores QU ± standard deviation and δ values of unimodal method
results across cross-validation using features Etotal,f ≤ 0.35.
We see that the models developed performed well, obtaining δ = 0.04 from
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ideal mean score characteristics. The QU and δ found using the unseen validation
data were similar to those from data used generating these models. Further, esti-
mated distributions of QU of validation data followed closely those shown in Figure
5.4 with distributions of QU of CEye,valid and NEye,valid intersecting at 0.52.
5.3.2 Scoring data with multimodal sources: EEG with motion arti-
facts
We next show results of our multimodal data scoring method. We show the
cross-validated predicted probabilities for each data type as well as the quality score
(Equation 5.8) using our deep learning-based scoring method on unseen data (Table
5.5).
Data Probability of CMotion Probability of RMotion QM
CMotion,valid 0.77± 0.13 0.19± 0.12 0.79± 0.13
RMotion,valid 0.28± 0.27 0.67± 0.28 0.31± 0.28
Table 5.5 Mean predicted probabilities ± standard deviation and corresponding
mean scores, QM , of multimodal method results across cross-validation.
We see that the predicted probabilities and QM from unseen data were similar
to those from the model generation data. The model was able to score recorded data
with noise well below 0.5 while also scoring clean data well above 0.5. Estimated
distributions of QM of unseen validation data followed closely those shown in Figure
5.5 with distributions of QM of CEye,valid and REye,valid intersecting at 0.57. We note
that mean cross-validated standard deviations of QM(RMotion) data were twice as
large as QM(CMotion) data, which we discuss in Section 5.4.
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Since the data used was a combination of data of both baseline recordings
without walking and data where walking artifacts were removed from data, we
wished to determine what the deep learning models identified as important in scoring
EEG quality from motion artifacts. We applied easyPEASI, a method that identifies
frequency bands that were important to the deep learning models (Chapter 4).































Frequency band importance identifying motion artifacts in EEG
Training accuracy
Peturbed accuracy
Figure 5.6 easyPEASI results for models comparing the differences between EEG
with walking artifacts against EEG without walking and cleaned data. Each bar
represents the classification accuracy from the DCNN model when a particular
frequency band was perturbed using the easyPEASI. Lines and shaded area at
84.63% ± 01.68 are the mean and standard deviation of training accuracies with
no perturbed data. ∆ values are the difference between the mean training accuracy
and the mean perturbed accuracy. P -value significance thresholds set at: n.s.: not
significant, *: P < .01, **: P < .001.
From Figure 5.6 we see that the lower frequencies were found to be important
in scoring EEG quality which is consistent with known artifact properties [68].
5.3.3 Evaluating algorithms removing ocular artifacts from EEG
As an extension and further application of our unimodal scoring method we
score REye data with artifacts removed by two different methods, MARA and AAR
(Section 5.2.3). To compare their effectiveness we score all REye data (Section
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Table 5.6 Comparison of mean scores QU ± standard deviation of unimodal method
across cross-validation of all data and validation data processed by MARA and AAR
methods.
We see that for both sets of data, QU(CEye−MARA) > QU(CEye−AAR). That is,
data processed with MARA, CEye−MARA, was scored higher than data processed with
AAR, CEye−AAR. This means that MARA may have been more effective than AAR
at removing ocular artifacts from EEG. Further, as hypothesized, data processed
by both artifact removal algorithms resulted in data with mean scores higher than
QU(REye).
5.4 Discussion
We present in this work two novel methods to score electrophysiological signal
quality. These methods were separated by the differences between the source of the
signal noise and thus how it could be characterized. Specifically, we applied our
method to quantify signal quality when the noise source could be recorded from the
same modality to EEG with ocular artifacts. In such cases, the same quantitative
features can generally be computed on both the signal of interest (EEG) and noise
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source (EOG), and compared directly to each other.
For other sources of artifacts, such as motion, supplemental physiological mea-
surement tools would be needed to measure the motion directly. In these cases, it is
not usually possible to compare quantitative features computed on both the signal
of interest and noise source directly. For example, in our application scoring EEG
with motion artifacts, the value of entropy of an EEG channel may not be directly
comparable to the entropy of acceleration in the X-axis from an IMU. Therefore,
we apply a method which only requires signals that are free of noise and recordings
with noise present.
With both methods, we generate models to score signal quality of EEG with
either ocular or motion artifacts. Though in research settings high density EEG
headsets, which usually have electrodes to measure EOG, are commonly used, low
density EEGs are becoming more common and have been shown to be effective for
many applications [71]. Even when high density EEG sets are used, other artifact
sources, like motion, are not generally directly captured. These data-driven models,
once generated, can be used to evaluate the quality of EEG and potential presence of
noise from artifacts of other data without the need to directly record noise sources.
For our unimodal method, in addition to the scoring models, we also formulate
criteria to quantify features that are effective for scoring EEG. Results show that
the Etotal measure and δ performance metric do meaningfully represent a feature’s
ability to score EEG in a unimodal data source setting. We determine that features
should be used only if they have a Etotal,f ≤ 0.35. From analyses shown in Figure
5.2 and Table 5.2, we see that features with Etotal,f ≤ 0.35 performed better than
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those with higher Etotal. Incorporating features with 0.35 < Etotal,f ≤ 0.50 along
with features with lower Etotal,f decreased performance.
In general, our unimodal method was able to generalize to data not used in
generating the scoring models. Results in Table 5.4 and score distributions matched
values found from generating these models in Table 5.2 and shown in Figure 5.4.
For our multimodal method, we were able to score data from two different data sets
well. Combined data that had artifacts removed and baseline data when subjects
were known to be still were both scored as generally clean data. Both in the model
generation and validation of this method, we found that the cross-validated standard
deviations of recorded data scores, QM(RMotion), were twice as large as standard
deviations of clean data scores, QM(CMotion) (Tables 5.3 and 5.5). This may have
been because the data sources used had many different types of walking. Some
subjects walked at various speeds, varying from one to four miles-per-hour, while
others walked through an art exhibit at their own pace, even potentially with stops
to view art pieces which may explain the second mode with higher scores seen in
Figure 5.5 [72], [75].
Examining the application of our unimodal method to evaluate the effective-
ness of artifact removal algorithms, we see that MARA was more effective than
AAR in removing artifacts, obtaining higher scores for the processed recorded data.
Strictly speaking, this means that MARA removed ocular artifacts more similarly
to the H∞ method used to develop our models than AAR did. Further, we see that
these results were consistent both across all data, including those used to generate
our models, and the independent validation data (Table 5.6). These results present
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a significant advancement to evaluating artifact removal algorithms by providing
quantitative measures on real EEG recordings as opposed to qualitative evaluations
or using synthetic data [63].
Both methods were applied to EEG to score different recordings with different
noise artifacts. However, future work may apply multiple models to the same record-
ings to obtain several quality scores that may be combined to assess an overall data
quality score. We also note that though the unimodal method can only be applied
when the noise source is available from the same modality, the multimodal method
can be applied to data with unimodal source. Our multimodal approach, which is
deep learning-based, requires a large amount of data to generate accurate models.
If more data were available, we may attempt to apply our multimodal method to
score data from a unimodal source, in this case using only CEye and REye to score
these data with QM .
Comparing these approaches, we see that our multimodal method required
only an appropriate deep learning model designed to classify the input signal. These
deep learning models identify signal features important to distinguish the two input
classes, clean signals and signals with noise, automatically. Our unimodal method
on the other hand, required more manual selection of both the features of the signal
to compute and feature importance for scoring signal quality. However, as opposed
to our multimodal method, our unimodal method allows for us to identify which
specific quantitative features of the signal of interest were important for scoring
signal quality with respect to the targeted noise.
Both our unimodal and multimodal methods present advancements and im-
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provements from existing methods by evaluating EEG signal quality with continuous
scores. Previous methods have generally evaluated signal quality by classifying EEG
into discrete quality categories [30], [56], [48]. Our scoring models allow for rapid
evaluation of signal quality of EEG data. Future work may expand the type of data
used to generate these models, such as including signals known to have no ocular
artifacts present. To further validate scores generated by these models, data could
be obtained or generated with known levels of noise. Signals with more noise in-
troduced should result in lower scores. Our analyses presented signals of each type
in aggregate, averaging across samples, future analyses may investigate recordings
more specifically to identify the level of noise in signals.
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Chapter 6: Conclusions and future work
6.1 Conclusions
We began by providing a brief background on the advanced methods used
throughout the research chapters presented. Altogether, the research chapters pre-
sented here all advance quantitative methods to analyze and interpret neural activity
from electroencephalography (EEG).
Our contributions begin by developing methods to evaluate the utility of com-
monly used quantitative EEG features for different applications. We proposed a
non-parametric method based on counts of non-significant statistical tests using a
large data set. We evaluated feature values’ dependencies on epoch length of EEG
recordings used as well as their relationship between intra- and inter-subject con-
sistency. This work provides data-driven methods of identifying EEG features and
their spatial characteristics ideal for various EEG applications, and determining fu-
ture EEG feature consistencies using an existing EEG data set. These types of
features could also be useful in establishing baseline features for a standard EEG
signal and subsequently detect variations away from those baselines.
With features of EEG computed and associated clinical reports available from
an unprecedentedly large data base we sought to apply machine learning methods
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to determine if leveraging these data could identify novel classifications. We subse-
quently applied textual analysis on clinical reports associated with EEG recordings
to obtain patient characteristics for the quantitative EEG data. Given the clinical
nature of the data set and novelty we focused on classifying subject’s medications
based on their EEG. Kernel support vector machine (kSVM) models have a well-
established history of good performance as a feature-based classifier in EEG applica-
tions. However, recently, deep convolutional neural network (DCNN) models have
shown state-of-the-art results and superb effectiveness in EEG applications. We
identified the two most common medications taken by subjects in the data set, two
anticonvulsants: Dilantin (generic phenytoin) and Keppra (generic levetiracetam).
As novel EEG-based classifications, we compared kSVM and DCNN models’ effec-
tiveness to determine medications taken from solely from EEG. Results showed a
first step in determining the utility of machine learning in drug classification based
on neurological activity. By investigating the abilities of learning algorithms to dif-
ferentiate individuals taking different medications through EEG, this work is a step
on the road to the broader utility of machine learning in biomarker development.
Though the ability to accurately classify subject’s medications present a po-
tential tool for pharamacodynamics, as a clinically relevant application it would
also be informative to understand the underlying neurological differences between
classified groups. With feature-based approaches such as kSVM, there are several
methods to identify feature importance in classifications among features used. On
the other hand, deep learning models identify important features automatically as
part of the end-to-end algorithm. However, understanding what was learned by
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these models can be difficult, particularly for EEG-driven DCNNs. To address this,
we developed easyPEASI as a simple method to identify important frequency bands
manipulating input data only and without the need to investigate the model itself.
We validated easyPEASI and applied it to EEG-based medication-use classifications
to identify relevant frequency bands. Beyond identifying frequency bands that are
important in medication classifications, easyPEASI shows promise as method of ob-
taining explainable artificial intelligence and interpretable models from EEG-driven
deep learning through a simpler more accessible method perturbing only input data.
Until this point, our work used a large data set with well segmented recordings
from clinical settings to identify important characteristics of EEG. However, EEG
is usually corrupted by noise which can degrade the effectiveness of diagnostic tools
and brain-machine interfaces. Analyzing artifacts present in EEG recordings is an
active area of research and often the most difficult processing step in analysis and
interpretation. We therefore used data from experiments where artifactual data
and artifact-free data were available. From these data we validated scoring models
formulated to identify signal quality for data with ocular and motion noise sources
with a continuous score ranging from zero to one. Our scoring models allow for rapid
evaluation of signal quality of EEG data. Models are easily extendable to other
physiological measurements where noise is often present. This work also provides a
novel data-driven method to evaluate and compare quantitatively the effectiveness
of noise removal algorithms utilizing real data.
This dissertation successfully achieves our aims to (1) develop population con-
sistency metrics and apply them to commonly analyzed quantitative EEG features,
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(2) apply and compare feature-based and deep learning-based classifications to iden-
tify, solely through EEG, medication profiles of subjects taking anticonvulsants, (3)
propose and validate a new method to identify frequency band of importance in
EEG-driven deep learning classifications, and (4) develop methods to score signal
quality of electrophysiological signals, specifically EEG with noise from ocular and
motion artifacts.
6.2 Future work
There are several potential ways results and methods from our works might
be followed up with or applied in future research.
Our consistency metrics may be applied to new quantitative EEG features
that are developed to better understand their utility. Furthermore, since differences
between intra-subject and inter-subject consistencies can quantify a qEEG feature’s
discriminability between subjects, they may also be used to inform feature selection
in future machine learning classification applications.
As such, future work may investigate which specific features were chosen in
feature-based medication classifications and their clinical implications. Though we
investigated deep learning classifications through easyPEASI, future development of
extensions to easyPEASI could be done to identify brain regions that are important
in classification tasks. Regarding the applications investigated in this work, investi-
gating the differences between subjects with abnormal EEG taking anticonvulsants
against subjects with normal EEG taking no medications may potentially determine
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anticonvulsants’ efficacy.
Finally, with respect to our data quality scoring methods, future work may
expand the type of data used to generate these models, such as including signals
known to have no ocular artifacts present. Our analyses presented signals of each
type in aggregate, averaging across samples, future analyses may also investigate
recordings more specifically to identify the level of noise in signals.
We hope results and methods presented in this dissertation are useful in future
research beyond the potential works described here and help further advance the
field of computational neuroscience.
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Appendix A: EEG Spectral Connectivity Analysis in a Large Clini-
cal Population
Overview
This appendix presents work that was published as a conference proceedings
as part of the 9th IEEE/EMBS Neural Engineering (NER) conference in 2019 [93].
We applied coherence-based connectivity analyses to EEG data of clinically
determined normal and abnormal recordings from the Temple University Health
University EEG Corpus to identify differences in connectivity between populations.
Motivation: Recent studies, usually with less than 50 subjects, have shown
the utility of brain connectivity in the diagnosis and understanding of various neu-
rological conditions. A better understanding of the baseline brain connectivity in
resting state on a larger group of subjects could improve the efficacy of medical
devices that use neurological biomarkers for treatment or diagnosis of a medical
condition.
Approach: We obtained coherence-based connectivity networks by averag-
ing coherence measures for all subjects in populations to construct default mode
networks. We then computed network connectivity parameters to quantify fea-
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tures of these networks from each subject. We also computed Fiedler vectors using
coherence based networks, which represented groups of nodes in the connectivity
adjacency matrix identified through spectral graph methods.
Application: We applied these methods to identify differences between sub-
jects with normal or abnormal EEG recordings. We established default mode net-
works for the different populations on several frequency bands. We found that
frequency bands differed across the populations more than specific graph proper-
ties. Further, we found that there was an increased level of connectivity in the
population with abnormal EEG recordings.
Research impact: This work represents a novel application of network theory
to the largest available EEG data set. We show network theory methods applied to
EEG are able to distinguish between normal and abnormal EEG recordings. These
results may lead to neural connectivity-based diagnostic aides.
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A.1 Introduction
Brain connectivity is the pattern of links between neurons, neuronal popula-
tions, or anatomically separated brain regions. Brain function and how information
is shared throughout the brain are dependent on these connections. Recent studies
have shown the utility of brain connectivity in the diagnosis and understanding of
various neurological conditions such as epilepsy, schizophrenia, Alzheimer’s, alex-
ithymia, and dyslexia [31], [33], [35], [60], [46]. Connectivity in the brain has also
been shown to change with age [41]. Electroencephalography (EEG), which mea-
sures brain electrical signals from the scalp, is a common non-invasive, relatively
inexpensive, neuro-monitoring technique that can be used to assess brain connec-
tivity. Unlike some EEG biomarkers, connectivity based analyses explicitly utilize
spatial information present in EEG. A better understanding of the baseline brain
connectivity in resting state, or default mode network (DMN), could improve the ef-
ficacy of medical devices that use neurological biomarkers for treatment or diagnosis
of a medical condition [20].
The DMN has mainly been studied through fMRI or PET imaging [111], [18].
With EEG, previous studies have also investigated the DMN between eyes-open and
eyes-closed [20]. However, as with most previous EEG work, the number of subjects
used to identify connectivity differences between populations has generally been
below 50. With the availability of big data resources it is now possible to expand
these types of analyses to a larger group of subjects and examine neural connectivity
under noisy, less controlled conditions. These type of data also provide a more het-
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erogeneous population than typically analyzed. In this study, EEG recordings were
used to study neural connectivity in patients both with and without neurological
disorders. To analyze neural connectivity we use spectral coherence (SC) [16]. SC is
a mathematical method that describes how similar neuronal oscillatory activity of
two or more sensors, or brain regions, are with each other. With the demographic
and clinical information about each patient, connectivity results were studied across
age, sex, clinical impression, and medications taken. However, we report here only
on the work and results related to differences in clinical impressions of the EEG. The
aim of this study is to compare connectivity properties of a normative and abnormal
population obtained from a large clinical data set.
A.2 Methods
To investigate connectivity differences in these populations we applied three
evaluation methods to labeled graphs obtained from analyzing the Neural Engineer-
ing Data Consortium (NEDC) EEG Corpus from Temple University Health, version
1.0.0 (Figure A.1). This data set contained 23,257 EEG recording sessions (1.1TB)
from 13,551 subjects. Each session was accompanied by a report containing clinical




Patient characteristics: normal vs. abnormal
Labeled graphs
Analysis of Fiedler vectors
DMN from spectral connectivityCoherence-based connectivity
Statistics on graph parameters
Figure A.1 Data processing and analysis flowchart.
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A.2.1 Data set: Defining normal and abnormal
Patient information and clinical impressions of the EEG recordings were ob-
tained through textual analysis of the clinical reports. Since the recordings in the
NEDC database were not all acquired with the same EEG system, the channel lay-
outs were not all consistent. A subset of channels common across most recording
sessions was identified and used in subsequent analyses. From a standard 10-20
electrode montage, the subset of channels used were: Fp1, Fp2, F3, F4, C3, C4, P3,
P4, O1, O2, F7, F8, T3, T4, T5, T6, Fz, Cz, Pz.
Five minute recordings were used for the connectivity analyses based on record-
ing lengths used in previous DMN studies [31], [46], [41]. From each session that
contained at least six minutes of EEG data, minutes 1-6 were used across the same
19 channels. The first minute of each recording was excluded to reduce artifacts
present in the EEG [123].
The NEDC also released a subset of patient sessions that have been reviewed
and labeled to be clinically normal or abnormal with 99% inter-rater agreement [83].
In order to expand the labeled data set, we developed and applied an automated la-
beling method based on textual analysis of the clinical reports to the entire NEDC.
The automated labeling method matched the known labels with 98.8% accuracy,
instilling confidence in the accuracy of the labeling in the expanded data set [94].
Using this expanded data set, we further defined the criteria for the “normal” and
“abnormal” populations. The normal population was defined as subjects whose
EEG recordings were labeled as normal and were not taking any medications at the
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time of recording, resulting in a total of 1,167 recordings across 944 unique subjects.
The abnormal population was defined as subjects whose EEG recordings were la-
beled as abnormal and were taking a clinically relevant anti-epileptic medication
[36]. The mean age of the abnormal population, initially 50.39, was significantly
higher than the mean age of the normal population (Table A.1). To ensure a similar
age distribution within each population the oldest subjects in the abnormal data set
were removed sequentially until the mean age was the same across the normal and
abnormal populations, resulting in 2,940 abnormal recordings across 1,197 unique
subjects. The patient demographics extracted from the reports for the two popula-






Sex not determined 110 175
Mean Age 34.12±18.90 34.12±11.41
Table A.1 Normal and abnormal population demographics
A.2.2 Pre-processing and spectral coherence
If necessary, recordings were down-sampled to 100Hz. The data were then
filtered through a 0.5Hz to 50Hz band pass filter, and re-referenced using a common






where cross-spectral density Sxy(ω) is the Fourier transform of the cross-correlation













0 ≤ Cxy(ω) ≤ 1 where a value of zero implied there was no spectral correlation and
a value of one implied a direct spectral correlation. We computed average coherence
values for frequency bands commonly used in EEG analysis: δ(delta) : 1 − 4Hz,
θ(theta) : 4 − 8Hz, α(alpha) : 8 − 12Hz, µ(mu) : 12 − 16Hz, β(beta) : 16 − 25Hz,
γ(gamma) : 25 − 40Hz [125]. Based on coherence values of two electrode sites (i.e.
vertices), we connected them with edges and formed a graph. In this study we say
x ∼ y, x is connected to y, if Cxy(ω) ≥ 0.3. This threshold was based on the notion
that the coherence can be interpreted as a correlation and correlations below 0.3
are typically negligible [91]. To establish a population DMN, we averaged graphs in
each population for each frequency band.
A.2.3 Graph parameters
With our connected graphs, we analyzed five parameters of the graph gener-
ated for each EEG recording session for a given frequency band. A graph, G, was
defined by a set of vertices, V , and edges, E. We defined the degree of x ∈ V , dx, to
be the number of edges connected to vertex x, and the cardinality of V , |V |, as the
number of vertices in a graph. Further, let A be the adjacency matrix, a |V | × |V |
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matrix, and D the degree matrix, a diagonal |V | × |V | matrix, where
A(i, j) =







Note in this definition of A, we considered undirected graphs (i.e. A(i, j) = A(j, i))
and did not allow vertices to connect to themselves. In a weighted graph, wij was the
coherence value between the two vertices. In an unweighted graph, wij = 1,∀wij > 0.
In this study we maintained the coherence values as the weights of the edges. Using
A and D we computed three graph connectivity parameters [31].
(i) The number of edges in a graph, |E|.
(ii) The graph density,
∂ =
2|E|
|V |(|V | − 1)
(A.4)
where ∂ = 1 meant all possible connections have been made.





where v>k was the number of vertices x ∈ V with dx ≥ k and e>k was the number
of edges between those vertices. If φ(k) was high that meant that the graph had
many connections with vertices with a high dx.
Further, to analyze spectral graph properties we defined the Graph Laplacian,
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L, as
L = D − A (A.6)
From L, two spectral graph parameters were computed [31].
(iv) The algebraic connectivity of a graph, defined as the second smallest eigenvalue
of L, λ2.





the sum of the absolute values of the real components of the eigenvalues of L.
To determine how different the graphs were between populations we applied a
non-parametric Kruskal-Wallis test to each of the five graph parameters computed
on each of the six frequency bands.
A.2.4 Fiedler vectors
Using the Graph Laplacian defined in Equation A.6, the eigenvector corre-
sponding to the smallest eigenvalue of L is constant. However, the eigenvector
corresponding to the second smallest eigenvalue, known as the Fiedler vector, repre-
sents clusters of vertices and partitions of how the graph is connected. The Fiedler
vector shows how EEG electrodes group based on connectivity and how they differ
across the populations. When computing the spectrum of the graph, any vertices
that were not connected to any other vertices were removed. Disconnected graphs
were analyzed so long as each subgraph had more than one vertex.
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A.3 Results
A.3.1 Spectral coherence connectivity
Figure A.2 shows an example of the averaged DMN across the normal pop-
ulation where the strength of the connections were the coherence values for the α
band. Though the majority of the connections fall between 0.3 and 0.5, the strongest
connections were present in the occipital-temporal and frontal lobes, between T6-
O2, (F3,F4)-Fz, and Fp1-Fp2. The δ, θ, and µ bands show similar connections
without the stronger (F3,F4)-Fz connections but with the addition of stronger con-
nections between T5-O1 and O1-O2. The β and γ band DMNs had a significant
decrease in the number of connections. In general, the strength of connections and
connectivity of the graph decreased as the frequency range of the bands increased.
Specifically, the connectivity between the frontal and occipital-temporal regions be-
gan to separate as the frequency increased until it was no longer present in the γ
band. Furthermore, while there were generally more connections in the DMNs of
the abnormal population, the connections present in the DMNs of both populations
were generally stronger in the normal population.
A.3.2 Graph parameters
Comparing the normal and abnormal populations, we compute the five graph
parameters for each of the six frequency bands. Table A.2 shows the mean and























Normal population DMN in Alpha band
Figure A.2 Color shows connection strength through coherence. Strongest connec-
tions seen between T6-O2, (F3,F4)-Fz, and Fp1-Fp2 (n = 1, 167).
populations. Applying a Kruskal-Wallis test we bold the pairs which were found
to be significantly different between the two populations. Table A.2 shows the
frequency bands were more influential than the graph parameters for whether the
two groups would be statistically different. The θ, α, and γ bands showed most or
all graph parameters to differ significantly with p < 0.0001, unless otherwise noted.
A.3.3 Fiedler vectors
The Fiedler vectors of the Graph Laplacian are shown in Figure A.3. The
colors represent the eigenvector’s values at each vertex. Strong positive and negative
values, as well as near-zero values represented prominent groups of vertices of the
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Parameter Population δ (Delta) θ (Theta) α (Alpha) µ (Mu) β (Beta) γ (Gamma)
# Edges - |E|
Normal
62.29 51.81*** 63.43*** 42.06 29.26*** 23.81***
± 31.63 ± 26.48 ± 29.24 ± 27.37 ± 26.21 ± 27.04
Abnormal
63.00 58.00*** 56.82*** 45.24 35.01*** 29.07***
± 29.02 ± 27.26 ± 29.50 ± 31.50 ± 32.27 ± 33.04
Density - ∂
Normal
0.36 0.30*** 0.37*** 0.25 0.17*** 0.14***
± 0.18 ± 0.15 ± 0.17 ± 0.16 ± 0.15 ± 0.16
Abnormal
0.37 0.34*** 0.33*** 0.26 0.20*** 0.17***
± 0.17 ± 0.16 ± 0.17 ± 0.18 ± 0.19 ± 0.19
Rich Club - φ
Normal
0.62*** 0.52* 0.60*** 0.48 0.42* 0.4**
± 0.17 ± 0.17 ± 0.17 ± 0.18 ± 0.19 ± 0.20
Abnormal
0.59*** 0.54* 0.55*** 0.48 0.44* 0.44**
± 0.17 ± 0.17 ± 0.18 ± 0.19 ± 0.20 ± 0.22
Connectivity - λ2
Normal
0.47*** 0.43*** 0.48*** 0.30 0.21 0.19***
± 1.50 ± 1.37 ± 0.90 ± 1.45 ± 1.44 ± 1.61
Abnormal
0.52*** 0.54*** 0.51*** 0.44 0.32 0.30***
± 1.31 ± 1.47 ± 1.57 ± 1.82 ± 1.79 ± 1.89
Energy - Λ
Normal
64.96 50.21*** 63.06*** 39.61 27.48*** 23.91***
± 47.39 ± 38.53 ± 36.67 ± 38.54 ± 37.64 ± 41.36
Abnormal
65.03 58.06*** 56.84*** 44.96 35.37*** 30.82***
± 44.57 ± 42.56 ± 44.63 ± 48.36 ± 49.03 ± 51.37
Table A.2 Mean ± stand. dev. of graph parameters per frequency band across
populations - Bold ***: p < 0.0001; **: p < 0.0015; *: p < 0.05
.
Fiedler vector. The scale of the color bars depended on the range of the eigenvector
to visualize these groups since each Fiedler vector shown was derived from a different
graph. The differences between the clusters of the eigenvector’s values, rather than
the values themselves, were analyzed between the two populations. In θ, α, µ, and
β bands, the clusters in the abnormal population are more central and globally
connected than in the normal population.
A.4 Discussion
This study explored differences in connectivity in resting EEG data between a
normative and abnormal population from a large clinical data set. Unlike previous
works where subjects’ EEGs were recorded under known conditions and commonly
performing instructed tasks, it is not known which activities or tasks the subjects
were performing during EEG recordings used in this study. However, we note that
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an ever-increasing volume of available human EEG data will share this task-agnostic
characteristic, and so it is important to understand these types of data. Spectral
graph parameters λ2 and Λ values were higher in the abnormal population as previ-
ously observed in Dasgupta et al. [31]. There was also generally greater variability
in these two parameters in the abnormal population [31]. However, our parameter
results show there were generally more connections in the abnormal population’s
graphs as compared to previous work [31]. The Fiedler vectors of the Graph Lapla-
cian showed a similar trend as well. This may have been from differences in how
the graphs were formed. Alternatively, it is possible that these differences are from
abnormal neural activity propagating throughout the brain given the the clinical na-
ture of this data set and the fact that individuals included in this abnormal subset
were actively taking anti-epileptic drugs.
These results present connectivity in the sensor space of EEG which has ap-
plications in medical devices and analytic tools. However, further analysis is needed
to better understand the neurophysiological implications and source connectivity.
Future work will investigate connectivity correlates with other patient characteris-
tics such as age and sex. Graph theoretic neural connectivity methods will also be
explored to better model machine learning architectures and as features in classifi-
cation applications.
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Normal-Delta band Abnormal-Delta band
Normal-Theta band Abnormal-Theta band
Normal-Alpha band Abnormal-Alpha band
Normal-Mu band Abnormal-Mu band
Normal-Beta band Abnormal-Beta band




































































Normal vs. abnormal populations graph spectrum - Fiedler vector
Figure A.3 Fiedler vectors of the graph plotted for each frequency band for Normal
(n = 1, 167) and Abnormal (n = 2, 940) populations. Color bar scales are different
to permit visualization of clusters of positive, negative and near-zero groups based
on values of the Fiedler vector.
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[96] Makus Näpflin, Marc Wildi, and Johannes Sarnthein. Test-restest reliability
of EEG spectra validates a statistical signature of persons. Clinical Neuro-
physiology, 118:2519–2524, 2007.
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[115] M. Rogawski and W Löscher. The neurobiology of antiepileptic drugs. Na-
ture Review Neuroscience, 5:553 – 564, 2004. doi: https://doi.org/10.1038/
nrn1430.
198
[116] Murray Rosenblatt. Remarks on some nonparametric estimates of a density
function. Ann. Math. Statist., 27(3):832–837, 09 1956. doi: 10.1214/aoms/
1177728190. URL https://doi.org/10.1214/aoms/1177728190.
[117] Yannick Roy et al. Deep learning-based electroencephalography analysis: a
systematic review. Journal of Neural Engineering, 16(051001), 2019. doi:
10.1088/1741-2552/ab260c/.
[118] Guillermo Sahonero-Alvarez and Humberto Calderon. A comparison of sobi,
fastica, jade and infomax algorithms. Proceedings of the 8th International
Multi-Conference on Complexity, Informatics and Cybernetics (IMCIC 2017),
pages 17–22, 2017.
[119] M.C. Salinsky, B.S. Oken, and L. Morehead. Test-retest in EEG frequency
analysis. Electroencephalography and Clinical Neurophysiology, 79:382–392,
1991.
[120] W. Samek, A. Binder, G. Montavon, S. Lapuschkin, and K. Müller. Eval-
uating the visualization of what a deep neural network has learned. IEEE
Transactions on Neural Networks and Learning Systems, 28(11):2660–2673,
Nov 2017. ISSN 2162-2388. doi: 10.1109/TNNLS.2016.2599820.
[121] Udit Satija et al. A review of Signal Processing Techniques for Electrocardio-
gram Signal Quality Assessment. IEEE Reviews in Biomedical Engineering,
11:36–52, 2018.
[122] J. Sayers. The world health report 2001—mental health: new under-
standing, new hope. World Health Organization Bulletin, 79:1085–1085,
2001. doi: https://doi.org/10.1016/j.clinph.2019.08.007. URL http://www.
sciencedirect.com/science/article/pii/S1388245719311939.
[123] R. Schirrmeister, L. Gemein, Eggensperger, F. Hutter, and T. Ball. Deep
learning with convolutional neural networks for decoding and visualization
of EEG pathology. The IEEE Signal Processing in Medicine and Biology
Symposium, December 2017. doi: 10.1109/SPMB.2017.8257015.
[124] B Schölkopf, K. Sung, C. Burges, F. Girosi, P. Niyogi, T. Poggio, , and V. Vap-
nik. Comparing support vector machines with gaussian kernels to radial basis
function classifiers. IEEE Transactions in Signal Processing, 45:2758–2765,
1997.
[125] Donald L. Schomer and Fernando H. Lopes da Silva. Niedermeyer’s Electroen-
cephalography: Basic Principles, Clinical Applications, and Related Fields.
Lippincott Williams & Wilkins, 6 edition, 2010.
[126] S. S. Shapiro and M.B. Wilk. An Analysis of Variance Test for Normality.
Biometrika, 52(3/4):591–611, 1965.
199
[127] J. Shen, C. Zhang, B. Jiang, J. Chen, Z. Song, J.and Liu, and W. K.. Ming.
Artificial intelligence versus clinicians in disease diagnosis: Systematic review.
JMIR medical informatics, 7(3)(e10010), 2019. doi: 10.2196/10010.
[128] Jessica Smith. U.s. fda approves ibrance (palbociclib) for the treatment of




[129] S. M. Snyder, T. A. Rugino, M. Hornig, and M. A. Stein. Integration of an
EEG biomarker with a clinician’s ADHD evaluation. Brain and Behavior, 5
(4):5–6, 2015.
[130] David Soltysik. Reproducibility of EEG Power Spectral Density. Proceedings
of the 22nd Annual Meeting of the Organization of Human Brain Mapping, 1
(1736), June 2016.
[131] N. Srivastava, G. Hinton, A. Krizhevsky, I. Sutskever, and R. Salakhutdinov.
Dropout: A simple way to prevent neural networks from overfitting. Journal
of Machine Learning Research, 15(1):1929–1958, 2014.
[132] Adbulhamit Subasi and M. Ismail Gursoy. EEG signal classification using
PCA, ICA, LDA and support vector machines. Expert Systems with Applica-
tions, 37:8659–8666, 2010.
[133] J. Tang, R. Liu, Y. L. Zhang, M. Z. Liu, M. J. Hu, Y. F.and Shao, and
W. Zhang. Application of machine-learning models to predict tacrolimus stable
dose in renal transplant recipients. Nature: Scientific reports, 7(42192):1680–
1691, 2017. doi: 10.1038/srep42192.
[134] William O. Tatum IV, Aatif M. Husain, Selim R. Bendadis, and Peter W.
Kaplan. Handbook of EEG Interpretation. Demos, 2008.
[135] Pierre Thodoroff, Joelle Pineau, and Andrew Lim. Learning robust features
using deep learning for automatic seizure detection. CoRR, abs/1608.00220,
2016. URL http://arxiv.org/abs/1608.00220.
[136] Trevor Trevor Hastie, Robert Tibshirani, and Jerome Friedman. The Elements
of Statistical Learning. Springer, 2 edition, 2009.
[137] P. P. Vaidyanathan. Multirate Systems and Filter Banks. Prentice Hall, 1993.
[138] Michel J.A.M. vanPutten, Sebastian Olbrich, and Martijn Arns. Predicting
sex from brain rhythms with deep learning. Nature: Scientific Reports, 8
(3069), 2018.
[139] Vladimir N. Vapnik. Estimation of Dependences Based on Empirical Data [in
Russian]. Nauka, 1979.
200
[140] Vladimir N. Vapnik. The Nature of Statistical Learning Theory. Springer-
Verlag, 1995.
[141] Pauli Virtanen, Ralf Gommers, Travis E. Oliphant, Matt Haberland, Tyler
Reddy, David Cournapeau, Evgeni Burovski, Pearu Peterson, Warren
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Moore, Jake Vand erPlas, Denis Laxalde, Josef Perktold, Robert Cimr-
man, Ian Henriksen, E. A. Quintero, Charles R Harris, Anne M. Archibald,
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